data_6c8u_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6c8u _Structure_validation_residue.Date_analyzed 2019-01-25 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 2.8 tpt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.409 0.147 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -115.81 137.41 52.12 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.813 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -114.1 146.13 40.68 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.259 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -99.95 137.88 37.8 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.656 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -98.71 138.87 35.25 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.024 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -126.56 145.26 50.6 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.65 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -95.63 143.89 26.53 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.831 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 41.9 p -108.71 -34.58 6.65 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.575 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 4.0 t -94.46 94.83 8.46 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.107 0.48 . . . . 0.0 110.789 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 47.7 p -128.49 125.78 39.12 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.302 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 13.1 t -108.49 -40.26 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.242 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -81.44 157.06 25.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.928 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 pp -78.52 157.79 28.75 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.806 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.31 71.32 0.5 Allowed Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.629 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -134.55 -4.04 2.61 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 122.448 0.299 . . . . 0.0 111.75 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -103.81 -35.04 8.33 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -73.75 -3.96 31.64 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 mp -92.42 -38.06 12.21 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.835 0.35 . . . . 0.0 111.42 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -80.89 132.27 35.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.33 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -140.3 0.12 1.67 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -83.96 -43.83 14.81 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 51.2 p -92.59 107.68 19.4 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.932 0.396 . . . . 0.0 111.604 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -137.46 -48.24 0.58 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.109 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.77 145.03 30.68 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.417 0.448 . . . . 0.0 112.007 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.21 -5.55 8.23 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.025 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 22' ' ' LYS . . . . . 0.441 ' HZ3' HG23 ' 1' ' 68' ' ' THR . 15.1 mttp -87.35 154.67 20.49 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 122.909 0.484 . . . . 0.0 112.289 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 23' ' ' MET . . . . . . . . . . . . . 5.8 mtp -123.68 131.32 53.58 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.782 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -93.21 108.19 19.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.09 -1.413 . . . . 0.0 109.018 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mm -96.27 116.15 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.29 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 26' ' ' GLY . . . . . 0.701 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -108.35 158.61 14.69 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 114.99 -1.004 . . . . 0.0 115.044 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 27' ' ' GLY . . . . . 0.594 ' O ' HG21 ' 1' ' 91' ' ' ILE . . . 69.99 23.63 76.95 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 115.506 0.962 . . . . 0.0 115.506 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 18.4 mt -56.17 169.6 0.39 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 117.704 0.752 . . . . 0.0 110.918 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 29' ' ' SER . . . . . 0.771 ' H ' ' HG1' ' 1' ' 32' ' ' THR . 4.2 t -99.5 174.42 6.27 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.659 0.742 . . . . 0.0 110.388 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 30' ' ' TRP . . . . . 0.426 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.1 p-90 -72.2 -17.21 61.94 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.333 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -97.69 -24.87 15.3 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.067 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 32' ' ' THR . . . . . 0.771 ' HG1' ' H ' ' 1' ' 29' ' ' SER . 0.7 OUTLIER -65.26 114.3 4.63 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 33' ' ' SER . . . . . 0.514 ' OG ' ' HD2' ' 1' ' 34' ' ' PRO . 4.7 t -105.39 158.43 32.23 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.791 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 34' ' ' PRO . . . . . 0.514 ' HD2' ' OG ' ' 1' ' 33' ' ' SER . 13.0 Cg_endo -56.26 -25.86 58.36 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.242 1.961 . . . . 0.0 112.518 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.21 -33.79 37.83 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.961 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 36' ' ' SER . . . . . 0.429 ' HB3' ' H ' ' 1' ' 33' ' ' SER . 23.2 t -70.9 -35.59 72.36 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.516 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 37' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.4 mt -72.66 -39.05 67.42 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 123.742 0.817 . . . . 0.0 110.267 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 38' ' ' ARG . . . . . 0.599 ' O ' ' HB2' ' 1' ' 42' ' ' SER . 22.1 ttm180 -69.0 -42.05 77.0 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.73 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.78 -39.96 84.04 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.737 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 40' ' ' TYR . . . . . 0.696 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 6.0 t80 -72.11 -50.4 28.39 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 122.374 0.269 . . . . 0.0 111.648 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 41' ' ' PHE . . . . . 0.502 ' C ' HD13 ' 1' ' 47' ' ' ILE . 24.2 m-85 -71.17 -25.57 62.59 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 42' ' ' SER . . . . . 0.599 ' HB2' ' O ' ' 1' ' 38' ' ' ARG . 11.4 t -63.07 -14.05 43.44 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.444 1.116 . . . . 0.0 109.563 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 43' ' ' LYS . . . . . 0.696 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 14.7 mttt -82.67 -13.28 56.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 112.178 -2.283 . . . . 0.0 111.797 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.08 -31.48 10.15 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.98 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 45' ' ' GLY . . . . . 0.467 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -170.88 -161.99 22.46 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -102.74 133.7 47.35 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 121.823 0.821 . . . . 0.0 110.543 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 47' ' ' ILE . . . . . 0.502 HD13 ' C ' ' 1' ' 41' ' ' PHE . 4.1 mt -107.43 138.92 31.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 113.069 -1.878 . . . . 0.0 111.604 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -87.63 -42.38 12.73 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.317 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -164.01 157.86 18.9 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.596 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 50' ' ' CYS . . . . . . . . . . . . . 43.9 t -136.79 149.11 47.59 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.609 0.763 . . . . 0.0 109.443 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 26.3 ttt -145.71 133.9 21.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.653 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 57.3 t -129.23 126.76 64.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 113.859 -1.519 . . . . 0.0 108.693 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 1.3 mmt -71.72 117.28 13.1 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.205 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -131.8 159.72 37.67 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.259 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.48 118.14 55.34 Favored Pre-proline 0 N--CA 1.44 -0.937 0 C-N-CA 123.231 0.612 . . . . 0.0 110.551 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -62.41 -9.27 14.91 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 122.501 2.134 . . . . 0.0 113.845 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 18.3 p -81.74 -44.04 17.57 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 74.5 p -117.68 -9.4 10.75 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.348 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 45.3 mmtt 62.9 12.42 5.78 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.371 1.069 . . . . 0.0 111.863 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -89.78 147.47 23.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.6 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 51.1 p -87.88 156.67 19.25 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.407 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -92.62 -7.56 46.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.819 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.25 20.81 34.37 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-O 119.83 -0.428 . . . . 0.0 113.933 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -148.72 154.88 40.23 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 117.107 0.454 . . . . 0.0 111.226 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.76 -169.65 29.65 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 66' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -136.67 163.99 29.29 Favored 'General case' 0 N--CA 1.424 -1.751 0 C-N-CA 124.719 1.208 . . . . 0.0 109.853 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 67' ' ' VAL . . . . . . . . . . . . . 69.1 t -147.38 131.86 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 68' ' ' THR . . . . . 0.447 ' O ' HG23 ' 1' ' 47' ' ' ILE . 1.2 m -105.82 106.09 16.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.722 -1.581 . . . . 0.0 111.744 -177.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -84.09 124.97 31.67 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.677 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.17 4.46 17.36 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 71' ' ' ASP . . . . . 0.578 ' OD2' ' HB1' ' 1' ' 73' ' ' ALA . 13.6 t0 -130.16 132.35 24.02 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.525 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.6 -16.45 24.0 Favored 'Trans proline' 0 C--N 1.36 1.172 0 C-N-CA 121.971 1.78 . . . . 0.0 111.918 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 73' ' ' ALA . . . . . 0.578 ' HB1' ' OD2' ' 1' ' 71' ' ' ASP . . . -77.64 -30.79 52.37 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.929 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 74' ' ' SER . . . . . 0.479 ' O ' HG22 ' 1' ' 78' ' ' VAL . 3.6 t -70.07 -32.21 70.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.24 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 75' ' ' VAL . . . . . 0.647 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 11.5 t -70.13 -31.89 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.583 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -70.8 -41.9 71.0 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.132 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 77' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -65.82 -40.51 91.89 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.862 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 78' ' ' VAL . . . . . 0.479 HG22 ' O ' ' 1' ' 74' ' ' SER . 99.8 t -77.69 -32.28 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.117 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 79' ' ' LEU . . . . . 0.647 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.3 OUTLIER -61.95 -39.47 92.23 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.55 0.74 . . . . 0.0 111.912 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 80' ' ' GLY . . . . . 0.468 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -74.52 -22.41 77.36 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.423 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -100.62 98.18 7.76 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 123.089 0.555 . . . . 0.0 110.267 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 82' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 4.2 Cg_exo -77.65 -31.99 3.02 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.805 2.337 . . . . 0.0 114.132 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -84.82 125.27 32.45 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.871 0.367 . . . . 0.0 111.782 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -137.6 122.01 18.29 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.805 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -113.64 135.0 54.4 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 122.132 0.968 . . . . 0.0 111.162 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 86' ' ' LEU . . . . . 0.542 HD21 ' OG1' ' 1' ' 32' ' ' THR . 6.2 tp -145.25 134.16 22.47 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 112.925 -1.943 . . . . 0.0 107.26 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 10.8 t70 52.11 37.14 20.79 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 122.587 1.184 . . . . 0.0 111.832 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 66.4 m 68.96 10.22 7.81 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 112.865 -1.97 . . . . 0.0 112.03 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . 0.483 ' HZ3' ' HA ' ' 1' ' 29' ' ' SER . 10.1 pttp -126.16 152.2 46.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.044 0.926 . . . . 0.0 110.489 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.6 m -81.52 125.32 30.35 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 113.357 -1.747 . . . . 0.0 111.712 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 91' ' ' ILE . . . . . 0.701 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 49.7 pt -108.99 170.06 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 O-C-N 123.56 0.537 . . . . 0.0 110.166 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -112.32 80.7 3.55 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 93' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' 1' ' 91' ' ' ILE . 4.0 Cg_exo -83.43 122.86 3.27 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.168 1.912 . . . . 0.0 111.189 175.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 94' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -144.68 154.07 42.39 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.596 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 11.5 t -82.4 144.69 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.803 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.74 143.91 45.46 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -114.43 135.04 22.21 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.283 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -77.06 162.83 31.47 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.05 2.5 . . . . 0.0 113.311 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.76 150.7 23.42 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.585 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -109.3 160.12 16.4 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.574 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.33 176.26 9.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.136 0.574 . . . . 0.0 112.397 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -106.31 140.11 20.97 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.801 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -78.84 175.36 11.07 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.738 2.292 . . . . 0.0 113.425 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -85.78 153.75 22.07 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.699 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 20.7 mmt 57.3 135.55 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.53 1.132 . . . . 0.0 113.968 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.73 -56.37 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.529 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.6 m -103.22 106.31 16.79 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -100.84 -35.59 9.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.213 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 16.9 p -103.19 103.41 13.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.886 0.374 . . . . 0.0 111.764 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -102.92 140.64 36.92 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.023 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.561 -0.733 . . . . 0.0 111.131 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 44.1 mtt . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -136.62 -38.42 0.66 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.285 0.366 . . . . 0.0 111.982 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -88.89 -43.83 10.9 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -97.31 -40.77 8.58 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.256 0.347 . . . . 0.0 111.822 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -108.46 137.99 45.5 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.288 0.368 . . . . 0.0 111.098 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -126.43 130.8 51.4 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.936 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -118.88 117.46 28.92 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.183 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 55.0 m -130.05 157.23 42.94 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.848 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -80.63 119.2 22.95 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.851 0.46 . . . . 0.0 111.345 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -95.13 142.25 27.81 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.786 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 20.7 t -114.8 -50.44 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.277 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.32 147.87 24.56 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.132 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 9' ' ' LEU . . . . . 0.432 HD23 ' N ' ' 1' ' 10' ' ' GLY . 0.4 OUTLIER -89.76 163.67 14.98 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.148 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 10' ' ' GLY . . . . . 0.432 ' N ' HD23 ' 1' ' 9' ' ' LEU . . . -126.91 70.62 0.49 Allowed Glycine 0 C--N 1.339 0.749 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.468 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -120.27 -5.4 9.92 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.595 0.358 . . . . 0.0 111.036 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -97.0 -57.45 2.27 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.691 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -79.41 14.26 1.64 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.137 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 14' ' ' LEU . . . . . 0.424 HD13 ' O ' ' 1' ' 10' ' ' GLY . 4.2 tp -82.27 149.63 27.72 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.622 0.369 . . . . 0.0 111.497 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -90.56 152.53 20.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.253 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.71 -43.79 0.19 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.026 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -86.05 123.11 31.0 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.385 0.428 . . . . 0.0 110.972 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 49.0 m -100.41 124.73 46.29 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.449 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -142.74 -56.0 0.42 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.621 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -91.33 148.53 22.27 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.45 0.469 . . . . 0.0 111.32 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.86 -2.94 17.28 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.773 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 43.7 mttt -85.62 152.26 23.26 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 23' ' ' MET . . . . . 0.507 ' SD ' HG13 ' 1' ' 78' ' ' VAL . 2.6 mtm -122.95 126.27 46.88 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.999 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -91.34 108.15 19.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.933 -1.485 . . . . 0.0 108.694 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -95.29 115.66 34.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.504 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 26' ' ' GLY . . . . . 0.631 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -108.86 160.41 13.63 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.7 -1.136 . . . . 0.0 114.688 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 27' ' ' GLY . . . . . 0.605 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 69.14 22.66 76.14 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 115.249 0.859 . . . . 0.0 115.249 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 22.7 mt -55.87 168.71 0.43 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 117.703 0.752 . . . . 0.0 110.781 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 29' ' ' SER . . . . . 0.677 ' H ' ' HG1' ' 1' ' 32' ' ' THR . 4.5 t -98.83 174.24 6.48 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.577 0.703 . . . . 0.0 110.307 -178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 30' ' ' TRP . . . . . 0.425 ' HD1' ' OG ' ' 1' ' 29' ' ' SER . 0.9 OUTLIER -72.08 -15.45 62.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.466 -179.484 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -100.35 -24.91 14.4 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.111 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 32' ' ' THR . . . . . 0.677 ' HG1' ' H ' ' 1' ' 29' ' ' SER . 0.7 OUTLIER -67.53 113.66 5.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -179.015 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 33' ' ' SER . . . . . . . . . . . . . 57.7 m -104.89 160.3 26.45 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.98 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 34' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.06 -25.64 55.34 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.138 1.892 . . . . 0.0 112.531 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.96 -34.76 38.47 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.929 178.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 36' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' 1' ' 40' ' ' TYR . 16.9 t -70.49 -35.73 73.41 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 114.22 -1.354 . . . . 0.0 109.441 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 37' ' ' LEU . . . . . 0.559 ' HB3' ' HG ' ' 1' ' 50' ' ' CYS . 1.7 mt -73.03 -37.33 66.94 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 123.736 0.814 . . . . 0.0 110.303 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 38' ' ' ARG . . . . . 0.467 ' HE ' ' HB3' ' 1' ' 50' ' ' CYS . 14.6 ttm180 -70.54 -41.34 72.65 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.695 177.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -40.11 83.22 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.716 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 40' ' ' TYR . . . . . 0.705 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 3.3 t80 -71.89 -51.05 24.17 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 122.682 0.393 . . . . 0.0 111.645 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 41' ' ' PHE . . . . . 0.509 ' C ' HD12 ' 1' ' 47' ' ' ILE . 27.6 m-85 -71.42 -25.51 62.36 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 42' ' ' SER . . . . . 0.519 ' N ' HD12 ' 1' ' 47' ' ' ILE . 3.1 m -62.75 -14.05 40.11 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 122.444 1.116 . . . . 0.0 109.621 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 43' ' ' LYS . . . . . 0.705 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 14.1 mmtt -82.04 -13.7 56.96 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 112.222 -2.263 . . . . 0.0 111.676 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.87 -32.08 10.84 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.92 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 45' ' ' GLY . . . . . 0.495 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -173.03 -159.08 19.0 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -103.22 133.03 48.99 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.713 0.768 . . . . 0.0 110.635 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 47' ' ' ILE . . . . . 0.519 HD12 ' N ' ' 1' ' 42' ' ' SER . 4.4 mt -104.71 140.03 23.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 113.186 -1.825 . . . . 0.0 111.494 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -88.08 -43.22 11.84 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.005 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -165.6 157.5 14.67 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.265 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 50' ' ' CYS . . . . . 0.559 ' HG ' ' HB3' ' 1' ' 37' ' ' LEU . 53.0 t -135.78 149.86 49.28 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.261 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 26.8 ttt -146.16 133.53 20.71 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.023 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 56.3 t -129.83 125.87 61.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.148 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -69.63 122.33 18.9 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.816 -178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -136.85 154.9 50.39 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.643 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.51 115.05 65.83 Favored Pre-proline 0 N--CA 1.445 -0.725 0 C-N-CA 122.849 0.46 . . . . 0.0 111.019 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.6 -8.31 7.03 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.889 2.393 . . . . 0.0 114.573 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 19.6 p -80.82 -44.58 18.25 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 58' ' ' THR . . . . . 0.48 ' HG1' ' CD ' ' 1' ' 60' ' ' ARG . 80.5 p -129.1 -8.09 4.85 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.347 0.405 . . . . 0.0 112.077 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.23 53.32 6.62 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 122.597 1.189 . . . . 0.0 112.184 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 60' ' ' ARG . . . . . 0.48 ' CD ' ' HG1' ' 1' ' 58' ' ' THR . 68.6 mtp180 -110.64 136.35 49.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.121 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 75.1 m -89.62 150.33 22.43 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.3 0.375 . . . . 0.0 111.183 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -98.57 -10.77 22.93 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.87 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.08 32.24 8.55 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 119.812 -0.438 . . . . 0.0 113.777 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -151.82 149.37 28.93 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.983 0.391 . . . . 0.0 110.995 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.92 -169.33 27.28 Favored Glycine 0 N--CA 1.427 -1.908 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 66' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -136.5 162.5 32.9 Favored 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 125.117 1.367 . . . . 0.0 109.456 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 67' ' ' VAL . . . . . 0.535 HG22 ' SG ' ' 1' ' 50' ' ' CYS . 74.3 t -149.28 129.39 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 68' ' ' THR . . . . . 0.42 ' O ' HG21 ' 1' ' 47' ' ' ILE . 1.5 m -104.64 107.23 18.08 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 113.353 -1.749 . . . . 0.0 111.922 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -83.44 122.08 28.03 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.867 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.98 2.85 16.29 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 71' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -129.42 134.33 26.12 Favored Pre-proline 0 C--N 1.311 -1.081 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.485 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -73.19 -16.2 25.23 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.107 1.871 . . . . 0.0 111.622 176.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.42 -32.13 60.61 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.795 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 74' ' ' SER . . . . . 0.495 ' OG ' ' HA3' ' 1' ' 45' ' ' GLY . 4.0 t -69.86 -31.81 69.86 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.156 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 75' ' ' VAL . . . . . 0.692 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 14.2 t -69.89 -31.93 49.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.392 178.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.17 -41.69 70.04 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.983 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -65.82 -41.57 91.66 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.728 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 78' ' ' VAL . . . . . 0.507 HG13 ' SD ' ' 1' ' 23' ' ' MET . 98.8 t -75.72 -31.75 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.754 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 79' ' ' LEU . . . . . 0.692 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.2 OUTLIER -62.39 -37.29 85.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.001 0.921 . . . . 0.0 112.115 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 80' ' ' GLY . . . . . 0.556 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -76.7 -27.58 60.69 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.963 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -105.74 88.61 2.95 Favored Pre-proline 0 N--CA 1.444 -0.764 0 C-N-CA 123.212 0.605 . . . . 0.0 110.342 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 82' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 2.9 Cg_exo -76.64 -19.91 14.16 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.719 2.28 . . . . 0.0 113.775 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -87.81 124.47 33.66 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.209 0.318 . . . . 0.0 111.046 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -135.91 122.64 21.06 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -113.19 134.39 54.6 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.762 0.792 . . . . 0.0 110.266 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 86' ' ' LEU . . . . . 0.645 HD22 ' OG1' ' 1' ' 32' ' ' THR . 8.8 tp -143.17 131.83 22.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 113.349 -1.751 . . . . 0.0 107.464 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 12.8 t70 51.77 37.1 19.49 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.632 1.205 . . . . 0.0 111.492 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 74.5 m 69.67 8.95 7.0 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 112.833 -1.985 . . . . 0.0 112.219 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -121.85 152.19 39.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 122.014 0.911 . . . . 0.0 110.38 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.3 m -82.25 124.41 29.92 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.25 -1.795 . . . . 0.0 111.744 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 91' ' ' ILE . . . . . 0.631 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 43.1 pt -109.9 170.27 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.986 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 92' ' ' ASP . . . . . 0.454 ' OD1' ' HE2' ' 1' ' 94' ' ' LYS . 8.0 t70 -116.59 83.05 13.18 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -83.0 123.46 3.58 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 121.952 1.768 . . . . 0.0 110.825 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 94' ' ' LYS . . . . . 0.454 ' HE2' ' OD1' ' 1' ' 92' ' ' ASP . 18.5 mmtt -136.53 146.81 46.62 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 t -92.62 121.95 43.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.235 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . 53.5 169.5 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -99.5 108.16 49.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.861 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -81.14 152.05 18.35 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.676 2.251 . . . . 0.0 113.55 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -110.73 131.44 55.05 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.662 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -122.67 135.29 54.55 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.391 0.432 . . . . 0.0 111.233 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -91.16 172.39 8.59 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 123.589 0.555 . . . . 0.0 111.956 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -109.61 143.84 28.64 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.211 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.93 175.83 10.69 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.695 2.263 . . . . 0.0 112.982 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -88.81 127.18 35.61 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.27 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -102.76 116.88 33.44 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.931 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 26.4 t -105.79 -57.4 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.752 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.5 m -96.09 96.06 8.59 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.579 0.549 . . . . 0.0 109.813 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -87.37 136.57 32.89 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.566 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 14.6 p -111.87 -45.74 3.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.158 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -85.16 142.17 29.66 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.39 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 56.6 pttt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.037 -0.982 . . . . 0.0 111.032 179.721 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 14.1 ttm . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -108.09 135.46 49.41 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.894 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 71.3 m80 59.29 130.14 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.281 1.032 . . . . 0.0 113.097 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -115.56 149.25 38.5 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.701 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -115.43 151.76 34.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.935 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -98.71 132.82 43.79 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.85 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -123.27 144.39 49.44 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.95 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 44.9 p -108.27 -52.38 2.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.609 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 4.3 t -105.67 103.35 12.84 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.438 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -102.33 140.74 36.21 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.857 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 10.4 t -100.09 133.14 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.203 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -84.26 121.55 27.65 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.368 0.418 . . . . 0.0 112.042 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 tp -94.98 153.8 17.48 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.491 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.31 75.37 0.3 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 121.067 -0.587 . . . . 0.0 113.1 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 5.2 t -135.96 -10.2 2.04 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.313 0.245 . . . . 0.0 111.323 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -94.75 -49.0 5.8 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.331 0.395 . . . . 0.0 111.375 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -80.39 20.84 0.66 Allowed 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.822 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 tp -76.84 151.46 35.87 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.819 0.448 . . . . 0.0 111.678 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -85.82 131.58 34.28 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.413 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -146.2 55.9 1.17 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.494 0.664 . . . . 0.0 109.723 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -85.3 130.89 34.5 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.082 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 75.4 m -104.01 142.61 34.15 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.82 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -107.51 -58.11 2.0 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.631 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.98 122.78 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.471 1.108 . . . . 0.0 113.511 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.73 5.64 0.12 Allowed Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.978 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -91.32 174.03 7.6 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.537 0.208 . . . . 0.0 111.276 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 23' ' ' MET . . . . . . . . . . . . . 12.5 mtp -123.06 152.47 40.97 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.651 0.739 . . . . 0.0 110.967 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -104.91 107.1 17.89 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.403 -1.726 . . . . 0.0 107.78 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -96.03 116.31 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 123.098 0.559 . . . . 0.0 110.304 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 26' ' ' GLY . . . . . 0.666 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -108.52 161.34 13.33 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.17 -0.923 . . . . 0.0 115.039 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 27' ' ' GLY . . . . . 0.613 ' O ' HG21 ' 1' ' 91' ' ' ILE . . . 69.8 21.03 76.44 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 27.2 mt -54.46 169.05 0.21 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 117.601 0.701 . . . . 0.0 111.35 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 29' ' ' SER . . . . . 0.403 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 5.7 t -100.89 174.22 6.13 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 121.538 0.685 . . . . 0.0 110.467 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 30' ' ' TRP . . . . . 0.44 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.8 p-90 -72.34 -16.4 61.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.423 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -100.12 -24.85 14.48 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.236 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 32' ' ' THR . . . . . 0.663 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 1.2 m -68.89 113.76 6.6 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.446 0.641 . . . . 0.0 112.557 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 33' ' ' SER . . . . . . . . . . . . . 62.7 m -103.76 160.95 24.46 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.014 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 34' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' 1' ' 38' ' ' ARG . 14.1 Cg_endo -56.33 -25.41 56.7 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.077 1.851 . . . . 0.0 112.257 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.87 -33.36 40.13 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.984 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 36' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' 1' ' 40' ' ' TYR . 16.9 t -70.64 -36.79 73.62 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.078 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 37' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.8 mt -73.15 -35.67 66.52 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 124.134 0.974 . . . . 0.0 110.443 178.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 38' ' ' ARG . . . . . 0.626 ' O ' ' HB2' ' 1' ' 42' ' ' SER . 10.7 ttp180 -72.88 -38.43 66.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.791 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -39.44 71.69 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.679 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 40' ' ' TYR . . . . . 0.713 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 6.0 t80 -71.7 -51.65 21.88 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 122.743 0.417 . . . . 0.0 111.673 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 41' ' ' PHE . . . . . 0.498 ' C ' HD12 ' 1' ' 47' ' ' ILE . 29.8 m-85 -71.15 -25.64 62.65 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 42' ' ' SER . . . . . 0.626 ' HB2' ' O ' ' 1' ' 38' ' ' ARG . 8.3 t -65.49 -14.38 60.87 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 122.481 1.134 . . . . 0.0 109.547 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 43' ' ' LYS . . . . . 0.713 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 6.2 mmtp -81.33 -12.74 58.94 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 112.339 -2.209 . . . . 0.0 111.605 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -106.02 -33.92 7.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.068 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 45' ' ' GLY . . . . . 0.439 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -164.79 -162.2 15.34 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -105.26 133.72 49.56 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.851 0.834 . . . . 0.0 110.477 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 47' ' ' ILE . . . . . 0.555 HD12 ' N ' ' 1' ' 42' ' ' SER . 4.2 mt -106.3 139.55 27.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 113.15 -1.841 . . . . 0.0 111.498 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -87.52 -41.14 13.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.233 -1.348 . . . . 0.0 109.888 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -166.23 156.46 12.37 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.515 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 50' ' ' CYS . . . . . . . . . . . . . 40.1 t -132.72 150.63 52.13 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.296 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 60.9 ttp -144.7 134.24 23.33 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.921 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.67 126.05 62.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 113.728 -1.578 . . . . 0.0 108.285 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 1.5 mmt -70.62 111.47 6.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.949 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -137.1 154.02 50.4 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.087 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.56 113.45 65.83 Favored Pre-proline 0 N--CA 1.444 -0.744 0 C-N-CA 122.596 0.358 . . . . 0.0 110.917 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.16 -8.62 8.59 Favored 'Trans proline' 0 C--N 1.365 1.426 0 C-N-CA 122.518 2.145 . . . . 0.0 114.386 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 17.9 p -81.25 -44.09 18.25 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 73.8 p -124.7 -8.49 7.34 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.229 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 5.2 mptt 56.68 53.28 8.56 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.777 1.275 . . . . 0.0 112.216 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -104.02 136.27 43.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 112.665 -2.061 . . . . 0.0 110.872 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 61.3 m -96.56 136.77 36.6 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.97 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -93.96 -9.09 38.14 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.47 29.95 17.57 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 114.393 0.517 . . . . 0.0 114.393 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -153.65 149.67 27.8 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.193 0.496 . . . . 0.0 111.295 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.2 -167.33 21.51 Favored Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 66' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -138.34 161.96 35.59 Favored 'General case' 0 N--CA 1.424 -1.759 0 C-N-CA 124.988 1.315 . . . . 0.0 109.703 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 67' ' ' VAL . . . . . . . . . . . . . 70.3 t -145.29 129.01 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 68' ' ' THR . . . . . 0.461 ' O ' HG23 ' 1' ' 47' ' ' ILE . 1.1 m -103.64 106.42 16.93 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 113.493 -1.685 . . . . 0.0 111.882 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -84.75 124.11 31.17 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.679 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.98 2.07 9.49 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -129.88 135.07 26.92 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.196 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.4 -16.52 24.51 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 121.972 1.781 . . . . 0.0 111.987 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 73' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' 1' ' 77' ' ' LYS . . . -77.47 -32.19 54.22 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.596 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 74' ' ' SER . . . . . 0.439 ' OG ' ' HA3' ' 1' ' 45' ' ' GLY . 3.0 t -69.97 -32.57 70.86 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.326 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 75' ' ' VAL . . . . . 0.731 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 5.7 t -70.44 -32.5 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.658 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -72.26 -41.83 66.3 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.088 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 77' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' 1' ' 73' ' ' ALA . 45.4 mttm -68.1 -39.0 82.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 113.748 -1.569 . . . . 0.0 112.505 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 78' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.86 -32.28 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.397 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 79' ' ' LEU . . . . . 0.731 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.8 OUTLIER -66.79 -31.92 72.88 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 122.499 0.32 . . . . 0.0 110.8 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 80' ' ' GLY . . . . . 0.516 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -74.43 -14.66 80.77 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.466 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -95.44 99.93 5.31 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 122.748 0.419 . . . . 0.0 110.592 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 82' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 4.6 Cg_exo -77.25 -34.67 2.0 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.6 2.2 . . . . 0.0 113.565 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -90.91 122.1 33.32 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.282 0.364 . . . . 0.0 111.077 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -139.52 122.45 16.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.058 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -114.58 134.6 54.92 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.003 0.906 . . . . 0.0 110.886 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 86' ' ' LEU . . . . . 0.663 HD21 ' OG1' ' 1' ' 32' ' ' THR . 8.4 tp -143.75 132.93 23.06 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.043 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t70 51.46 36.84 17.76 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.683 1.23 . . . . 0.0 111.526 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 10.2 t 69.5 8.89 7.01 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 112.69 -2.05 . . . . 0.0 112.206 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 25.8 pttt -121.79 152.06 39.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.022 0.915 . . . . 0.0 110.392 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.0 m -81.06 124.03 28.86 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.26 -1.791 . . . . 0.0 111.573 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 91' ' ' ILE . . . . . 0.666 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 28.2 pt -111.1 168.85 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.032 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -117.06 86.9 21.1 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -83.43 123.96 3.53 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 122.254 1.969 . . . . 0.0 111.363 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 144.19 23.27 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.581 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 3.9 t -70.53 141.36 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.813 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.15 156.95 25.47 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.697 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -110.19 129.84 23.5 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.144 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -71.0 171.6 15.49 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.734 2.289 . . . . 0.0 113.014 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -93.61 -13.21 27.91 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -97.58 124.93 42.03 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.48 170.08 11.2 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -120.38 153.98 56.27 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.759 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.86 177.92 8.22 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.301 2.0 . . . . 0.0 113.155 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.94 140.98 32.49 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.726 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 21.5 mmt -95.97 135.11 38.15 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.198 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 27.2 t -112.12 -58.54 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.3 m -100.53 95.34 6.65 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.531 0.52 . . . . 0.0 109.846 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -94.74 147.6 23.15 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.645 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 12.3 p -95.75 146.85 24.2 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.322 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -109.07 -42.44 4.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.439 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 66.1 mttm . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.459 -0.781 . . . . 0.0 111.614 -179.891 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.485 0.184 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -98.44 153.5 18.54 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.228 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.99 136.74 43.06 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.017 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -132.97 136.94 46.37 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.613 0.57 . . . . 0.0 111.039 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -108.53 136.58 47.9 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.808 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -131.91 148.53 52.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.788 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -100.98 129.98 46.91 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.082 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 16.3 t -95.72 133.86 39.32 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.896 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 5.1 t -127.27 -50.03 1.42 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.493 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 68.6 m -96.98 130.73 44.26 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.445 0.466 . . . . 0.0 111.08 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 7.5 t -97.21 122.32 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.328 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -88.22 139.64 30.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.065 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 15.8 mt -88.87 -177.77 5.58 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.785 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.28 70.8 0.15 Allowed Glycine 0 C--N 1.34 0.785 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.199 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 61.6 p -127.91 -20.11 3.91 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.709 0.299 . . . . 0.0 111.115 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -95.16 -41.93 8.84 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.456 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -79.49 37.6 0.34 Allowed 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.915 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 tp -83.17 157.9 22.56 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.248 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -85.88 -12.19 51.32 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -77.85 -3.03 39.53 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -85.72 132.37 34.15 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.279 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 50.0 m -89.12 146.63 24.68 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.5 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -128.84 -44.37 1.33 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.95 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.5 152.63 30.1 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.991 0.516 . . . . 0.0 111.641 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.88 -1.89 17.4 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.224 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -80.82 149.85 29.4 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 23' ' ' MET . . . . . 0.428 ' O ' ' HA ' ' 1' ' 66' ' ' PHE . 5.8 mtp -120.66 127.56 52.17 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.057 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -91.52 105.92 18.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.846 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 mm -96.13 111.45 26.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.481 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 26' ' ' GLY . . . . . 0.664 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -103.35 159.16 17.15 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 115.485 0.954 . . . . 0.0 115.485 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 27' ' ' GLY . . . . . 0.701 ' O ' HG21 ' 1' ' 91' ' ' ILE . . . 70.01 26.14 74.69 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 17.0 mt -58.16 170.61 0.65 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 117.764 0.782 . . . . 0.0 111.169 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 29' ' ' SER . . . . . 0.716 ' H ' ' HG1' ' 1' ' 32' ' ' THR . 4.5 t -99.42 174.48 6.26 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.568 0.699 . . . . 0.0 110.531 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 30' ' ' TRP . . . . . 0.434 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.5 p-90 -71.34 -16.9 62.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.515 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -99.1 -24.53 14.85 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.218 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 32' ' ' THR . . . . . 0.716 ' HG1' ' H ' ' 1' ' 29' ' ' SER . 0.7 OUTLIER -64.74 113.95 4.12 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 33' ' ' SER . . . . . . . . . . . . . 58.2 m -105.95 159.6 29.06 Favored Pre-proline 0 N--CA 1.467 0.378 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.977 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 34' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -56.65 -25.88 62.08 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.015 1.81 . . . . 0.0 112.557 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.29 -32.96 38.05 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.947 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 36' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' 1' ' 40' ' ' TYR . 16.7 t -70.69 -36.0 73.08 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.239 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 37' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.5 mt -72.96 -37.95 66.9 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 123.829 0.851 . . . . 0.0 110.148 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 38' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -68.81 -43.69 75.1 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.569 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.6 -40.15 88.74 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.871 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 40' ' ' TYR . . . . . 0.706 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 6.8 t80 -71.81 -51.0 24.73 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 122.651 0.381 . . . . 0.0 111.553 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 41' ' ' PHE . . . . . 0.515 ' C ' HD13 ' 1' ' 47' ' ' ILE . 23.3 m-85 -71.37 -25.7 62.48 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 42' ' ' SER . . . . . 0.526 ' N ' HD13 ' 1' ' 47' ' ' ILE . 3.3 m -63.61 -13.96 47.09 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 122.458 1.123 . . . . 0.0 109.71 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 43' ' ' LYS . . . . . 0.706 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 6.4 mmtp -80.47 -11.89 59.62 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 112.33 -2.214 . . . . 0.0 111.625 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.84 -33.89 9.19 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.002 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 45' ' ' GLY . . . . . 0.427 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -170.59 -159.77 17.39 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -102.16 133.17 47.45 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.885 0.85 . . . . 0.0 110.571 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 47' ' ' ILE . . . . . 0.526 HD13 ' N ' ' 1' ' 42' ' ' SER . 5.0 mt -104.99 138.94 27.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 113.017 -1.901 . . . . 0.0 111.403 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -87.96 -42.21 12.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.11 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -163.95 157.58 18.72 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.198 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 50' ' ' CYS . . . . . 0.443 ' SG ' HG21 ' 1' ' 67' ' ' VAL . 41.3 t -137.38 149.52 47.02 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 123.551 0.74 . . . . 0.0 109.287 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 61.8 ttp -146.84 136.9 23.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.138 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 91.9 t -126.27 123.87 64.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.573 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 1.2 mmt -75.4 124.33 26.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.408 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -136.61 158.4 44.54 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.277 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.15 118.21 56.55 Favored Pre-proline 0 N--CA 1.44 -0.951 0 C-N-CA 122.749 0.419 . . . . 0.0 110.826 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -64.06 -9.53 19.71 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 122.437 2.092 . . . . 0.0 113.541 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 18.7 p -81.99 -44.2 17.0 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 77.0 p -118.52 -9.18 10.35 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt 62.39 12.41 5.28 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.254 1.022 . . . . 0.0 111.927 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -92.81 143.06 26.65 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.392 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 38.1 m -94.79 154.82 17.09 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.894 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -97.87 -9.97 25.44 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.935 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.54 37.45 5.84 Favored Glycine 0 C--N 1.339 0.705 0 CA-C-O 119.766 -0.464 . . . . 0.0 114.032 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -153.47 151.94 30.42 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 117.134 0.467 . . . . 0.0 111.325 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.48 -169.69 22.26 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 66' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' 1' ' 23' ' ' MET . 83.0 m-85 -137.39 161.48 36.19 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 125.002 1.321 . . . . 0.0 109.808 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 67' ' ' VAL . . . . . 0.443 HG21 ' SG ' ' 1' ' 50' ' ' CYS . 74.0 t -147.65 132.28 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 68' ' ' THR . . . . . 0.416 ' O ' HG22 ' 1' ' 47' ' ' ILE . 1.4 m -105.7 105.59 15.7 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.59 -1.641 . . . . 0.0 111.609 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -82.82 123.99 29.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.365 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.58 3.52 15.96 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 71' ' ' ASP . . . . . 0.592 ' OD2' ' HB2' ' 1' ' 73' ' ' ALA . 14.9 t0 -129.93 132.85 24.4 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.562 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.63 -16.3 24.01 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.04 1.827 . . . . 0.0 111.797 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 73' ' ' ALA . . . . . 0.592 ' HB2' ' OD2' ' 1' ' 71' ' ' ASP . . . -77.35 -30.9 54.1 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.83 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 74' ' ' SER . . . . . 0.493 ' O ' HG23 ' 1' ' 78' ' ' VAL . 4.1 t -70.05 -31.78 69.57 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.293 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 75' ' ' VAL . . . . . 0.633 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 6.4 t -70.09 -31.41 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.519 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -71.76 -40.79 69.09 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.985 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 77' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -66.01 -42.07 90.2 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.051 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 78' ' ' VAL . . . . . 0.493 HG23 ' O ' ' 1' ' 74' ' ' SER . 59.7 t -75.89 -32.48 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.128 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 79' ' ' LEU . . . . . 0.633 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.3 OUTLIER -64.13 -35.14 79.79 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.388 0.675 . . . . 0.0 111.726 179.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 80' ' ' GLY . . . . . 0.486 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -74.58 -20.31 79.59 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.253 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -99.63 98.28 6.84 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 122.961 0.504 . . . . 0.0 110.316 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 82' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 2.8 Cg_exo -76.51 -34.31 2.7 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.895 2.397 . . . . 0.0 113.979 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -88.48 125.16 34.62 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.689 0.281 . . . . 0.0 111.68 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -134.56 119.68 18.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -115.38 134.66 54.9 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.974 0.893 . . . . 0.0 110.649 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 86' ' ' LEU . . . . . 0.552 HD22 ' OG1' ' 1' ' 32' ' ' THR . 7.2 tp -145.08 134.24 22.76 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.19 -1.823 . . . . 0.0 107.199 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 10.7 t70 51.79 37.01 19.33 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.679 1.192 . . . . 0.0 111.827 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 66.3 m 68.95 9.75 7.57 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 112.914 -1.948 . . . . 0.0 111.963 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -123.99 152.14 42.89 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.995 0.902 . . . . 0.0 110.267 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.6 m -80.94 126.73 31.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.398 -1.728 . . . . 0.0 111.743 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 91' ' ' ILE . . . . . 0.701 HG21 ' O ' ' 1' ' 27' ' ' GLY . 43.4 pt -112.85 166.5 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 123.661 0.601 . . . . 0.0 109.612 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 92' ' ' ASP . . . . . 0.541 ' OD2' ' HD3' ' 1' ' 94' ' ' LYS . 6.1 t70 -114.92 91.46 26.55 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -175.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -82.91 124.01 3.78 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.357 2.038 . . . . 0.0 111.025 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 94' ' ' LYS . . . . . 0.541 ' HD3' ' OD2' ' 1' ' 92' ' ' ASP . 21.0 pttt -143.39 140.54 30.51 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.1 136.85 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.788 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . 51.17 164.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.31 121.6 52.89 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.657 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.14 155.48 25.78 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.625 2.217 . . . . 0.0 112.276 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -93.2 119.95 32.94 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.018 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -149.51 137.11 20.16 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.19 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.72 172.72 13.4 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.19 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -114.23 123.7 32.09 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.445 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.41 -178.59 4.57 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.508 2.139 . . . . 0.0 113.044 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.63 142.88 31.39 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.68 0.392 . . . . 0.0 111.314 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 22.5 mmt -92.1 130.96 37.71 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.575 0.547 . . . . 0.0 111.81 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.03 162.67 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.672 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.2 m -94.17 93.6 7.88 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.108 0.48 . . . . 0.0 110.758 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -101.57 132.88 46.98 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.508 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 7.4 t -101.84 144.94 29.87 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.915 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.6 -49.74 0.78 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.269 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 80.4 mttt . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.016 179.623 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 11.2 mmt . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.66 0.267 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 65.4 m80 62.79 139.6 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.285 1.034 . . . . 0.0 112.873 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -110.62 145.36 38.03 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.996 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -107.74 144.79 34.38 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.652 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -96.65 111.22 23.45 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.288 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -144.53 133.43 22.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.508 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -131.6 143.01 50.02 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.375 0.422 . . . . 0.0 111.589 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 43.3 p -133.98 -48.01 0.8 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.431 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 4.8 t -125.96 106.56 9.72 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.205 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 10.6 t -102.93 -15.32 16.19 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.109 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 t -95.21 109.12 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 123.357 0.411 . . . . 0.0 110.19 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -122.03 -47.27 2.17 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.809 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 pp -88.49 134.81 33.75 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.461 0.476 . . . . 0.0 111.138 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.55 72.84 0.29 Allowed Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.299 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 11' ' ' THR . . . . . 0.558 ' HA ' ' HB2' ' 1' ' 15' ' ' TYR . 10.0 t -144.03 8.25 1.44 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -102.77 -58.95 1.78 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.878 0.371 . . . . 0.0 111.724 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -79.51 -38.7 33.74 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.9 -46.04 9.23 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 15' ' ' TYR . . . . . 0.558 ' HB2' ' HA ' ' 1' ' 11' ' ' THR . 3.8 m-85 -88.41 132.62 34.38 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.102 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -145.2 -43.47 0.22 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.844 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -88.68 151.32 22.52 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 123.382 0.426 . . . . 0.0 111.517 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 66.7 m -89.06 156.58 18.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.493 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -100.73 -12.95 18.7 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.272 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.47 147.89 32.08 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.712 0.405 . . . . 0.0 111.97 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.79 -15.74 4.84 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.985 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -100.26 173.65 6.51 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 123.561 0.212 . . . . 0.0 110.798 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 23' ' ' MET . . . . . . . . . . . . . 8.6 mtp -122.55 151.96 40.86 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 121.651 0.738 . . . . 0.0 111.178 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.55 108.29 19.73 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.471 -1.695 . . . . 0.0 107.875 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -96.58 120.21 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 123.387 0.675 . . . . 0.0 110.087 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 26' ' ' GLY . . . . . 0.724 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -113.57 160.1 13.33 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.019 -0.991 . . . . 0.0 114.876 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 27' ' ' GLY . . . . . 0.58 ' O ' HG23 ' 1' ' 91' ' ' ILE . . . 70.56 21.6 77.7 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 115.409 0.924 . . . . 0.0 115.409 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 mt -55.37 167.41 0.48 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 117.734 0.767 . . . . 0.0 111.338 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 29' ' ' SER . . . . . 0.411 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 5.8 t -100.46 174.72 5.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.448 0.642 . . . . 0.0 110.156 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 30' ' ' TRP . . . . . 0.434 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.6 p-90 -71.42 -16.85 62.41 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 124.753 1.221 . . . . 0.0 111.48 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -97.16 -24.52 15.69 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.216 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 32' ' ' THR . . . . . 0.549 ' HG1' HD23 ' 1' ' 86' ' ' LEU . 0.4 OUTLIER -70.58 113.84 8.09 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.08 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 33' ' ' SER . . . . . 0.415 ' H ' ' HB3' ' 1' ' 36' ' ' SER . 75.3 m -105.77 160.09 27.3 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.059 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 34' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.38 -25.66 58.43 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.09 1.86 . . . . 0.0 112.37 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.84 -34.11 39.65 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.797 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 36' ' ' SER . . . . . 0.415 ' HB3' ' H ' ' 1' ' 33' ' ' SER . 15.1 t -71.02 -36.14 72.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.57 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 37' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.6 mt -73.01 -35.87 66.89 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 124.026 0.93 . . . . 0.0 110.254 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 38' ' ' ARG . . . . . 0.498 ' HE ' ' HB3' ' 1' ' 50' ' ' CYS . 13.2 ttm180 -72.39 -41.38 66.38 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.548 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.58 -38.74 80.92 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.756 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 40' ' ' TYR . . . . . 0.714 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 6.1 t80 -72.16 -51.82 19.48 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 122.549 0.34 . . . . 0.0 111.354 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 41' ' ' PHE . . . . . 0.466 ' C ' HD12 ' 1' ' 47' ' ' ILE . 37.1 m-85 -71.41 -24.98 62.14 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 42' ' ' SER . . . . . 0.519 ' N ' HD12 ' 1' ' 47' ' ' ILE . 3.1 m -62.45 -14.24 38.81 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.483 1.135 . . . . 0.0 109.241 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 43' ' ' LYS . . . . . 0.714 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 7.0 mttm -85.03 -14.91 45.88 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 112.109 -2.314 . . . . 0.0 111.205 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.52 -31.6 11.19 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.925 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.42 -158.99 16.54 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -106.09 133.77 50.28 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.767 0.794 . . . . 0.0 110.404 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 47' ' ' ILE . . . . . 0.519 HD12 ' N ' ' 1' ' 42' ' ' SER . 4.3 mt -107.92 140.46 26.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-N 113.217 -1.81 . . . . 0.0 111.713 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -92.82 -40.76 10.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.199 -1.364 . . . . 0.0 110.053 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -163.45 157.52 19.92 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.238 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 50' ' ' CYS . . . . . 0.56 ' SG ' HG22 ' 1' ' 67' ' ' VAL . 50.6 t -138.06 147.86 44.5 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.2 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 63.0 ttp -144.02 133.61 23.55 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.073 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.21 124.32 60.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 113.686 -1.597 . . . . 0.0 108.048 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 5.7 mmt -74.51 126.76 31.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.698 -1.137 . . . . 0.0 113.003 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 22.9 mtt180 -132.25 159.57 38.7 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.509 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.39 119.04 54.16 Favored Pre-proline 0 N--CA 1.441 -0.886 0 C-N-CA 122.885 0.474 . . . . 0.0 110.77 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.51 -10.25 23.53 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 122.353 2.035 . . . . 0.0 113.436 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 20.4 p -82.13 -44.34 16.6 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 74.0 p -116.29 -9.98 11.47 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt 62.54 11.89 5.05 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.416 1.086 . . . . 0.0 111.98 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 7.5 mmt85 -94.32 146.07 24.3 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.968 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 58.3 p -86.83 155.66 20.19 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.519 0.512 . . . . 0.0 111.465 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -94.87 -10.93 29.77 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.364 0.415 . . . . 0.0 111.959 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.7 32.98 8.17 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 116.387 -0.369 . . . . 0.0 113.518 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -150.94 152.61 33.85 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.753 0.277 . . . . 0.0 111.103 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.83 -169.5 30.51 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 66' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -137.52 161.81 35.41 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 125.19 1.396 . . . . 0.0 109.484 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 67' ' ' VAL . . . . . 0.56 HG22 ' SG ' ' 1' ' 50' ' ' CYS . 90.8 t -146.81 127.82 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 68' ' ' THR . . . . . 0.489 ' O ' HG22 ' 1' ' 47' ' ' ILE . 0.8 OUTLIER -101.6 107.96 19.37 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 113.468 -1.696 . . . . 0.0 111.513 -177.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -83.72 122.85 29.19 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.074 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.47 3.34 9.47 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -131.34 134.84 26.18 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.135 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -72.93 -16.07 26.05 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 122.013 1.809 . . . . 0.0 111.792 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 73' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' 1' ' 77' ' ' LYS . . . -76.7 -28.8 56.02 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.103 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 74' ' ' SER . . . . . 0.573 ' O ' HG21 ' 1' ' 78' ' ' VAL . 5.9 t -69.69 -31.9 70.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.169 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 75' ' ' VAL . . . . . 0.685 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 13.8 t -70.44 -32.0 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.576 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -71.54 -40.82 69.79 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.037 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 77' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' 1' ' 73' ' ' ALA . 81.3 mttt -65.53 -42.16 92.3 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 113.825 -1.534 . . . . 0.0 112.134 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 78' ' ' VAL . . . . . 0.573 HG21 ' O ' ' 1' ' 74' ' ' SER . 32.6 t -77.28 -31.48 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.052 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 79' ' ' LEU . . . . . 0.685 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.2 OUTLIER -63.28 -35.96 82.1 Favored 'General case' 0 C--N 1.346 0.438 0 C-N-CA 123.915 0.886 . . . . 0.0 112.016 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 80' ' ' GLY . . . . . 0.407 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -74.87 -27.75 64.09 Favored Glycine 0 C--N 1.346 1.087 0 O-C-N 123.62 0.575 . . . . 0.0 113.091 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -104.01 96.03 8.81 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.14 0.576 . . . . 0.0 110.064 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 82' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 3.8 Cg_exo -76.7 -31.55 4.09 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.781 2.321 . . . . 0.0 114.292 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -84.82 127.37 34.1 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.703 0.287 . . . . 0.0 111.464 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -138.65 125.65 21.25 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -113.06 134.59 54.46 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 121.946 0.879 . . . . 0.0 110.622 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 86' ' ' LEU . . . . . 0.549 HD23 ' HG1' ' 1' ' 32' ' ' THR . 7.6 tp -144.03 132.67 22.34 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.154 -1.839 . . . . 0.0 107.208 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t70 52.13 36.98 20.43 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 122.712 1.244 . . . . 0.0 111.529 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 62.6 m 68.49 9.68 7.42 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.747 -2.024 . . . . 0.0 112.122 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -122.87 152.42 40.78 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.071 0.939 . . . . 0.0 110.49 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.4 m -82.17 122.46 27.91 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.45 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 91' ' ' ILE . . . . . 0.724 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 21.3 pt -109.38 171.55 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.372 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 92' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -114.04 81.35 6.11 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -83.48 123.66 3.43 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 121.988 1.792 . . . . 0.0 110.987 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.56 150.72 31.59 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.24 141.69 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.118 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.98 150.98 40.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.255 0.622 . . . . 0.0 112.641 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -106.0 115.64 60.95 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.306 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.31 175.16 11.7 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.716 2.277 . . . . 0.0 112.93 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -99.34 -37.79 9.1 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.442 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -95.79 153.84 17.53 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.222 0.326 . . . . 0.0 110.96 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.37 170.79 14.17 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 123.535 0.522 . . . . 0.0 112.253 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -123.77 139.79 33.03 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.982 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.69 178.03 7.93 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.461 2.107 . . . . 0.0 113.0 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -82.03 127.33 32.97 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.585 0.354 . . . . 0.0 111.304 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 82.5 mtp -93.87 146.66 23.74 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.341 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 2.7 t -97.36 161.48 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.554 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.3 m -97.03 97.22 9.05 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.117 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -91.08 149.21 21.91 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.953 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 16.1 p -143.5 -34.74 0.4 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.431 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -80.21 -32.29 38.56 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.858 0.463 . . . . 0.0 112.16 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 96.2 mttt . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.066 -0.969 . . . . 0.0 111.487 179.959 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 48.6 mtt . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -96.75 136.62 37.03 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.342 0.401 . . . . 0.0 111.34 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -127.47 -41.7 1.7 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.842 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -112.38 139.76 47.67 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.729 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -101.77 139.2 37.73 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.048 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -118.85 141.58 48.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.599 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -107.01 141.95 37.41 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.579 0.549 . . . . 0.0 111.188 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 52.0 m -95.68 145.25 25.42 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.017 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 6.9 t -96.55 125.63 41.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.117 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 60.5 m -113.45 -18.23 12.04 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.963 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 t -92.94 107.39 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 123.434 0.459 . . . . 0.0 109.991 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -88.5 149.89 23.4 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.351 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 tp -89.15 153.41 20.97 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.986 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.19 71.84 0.38 Allowed Glycine 0 C--N 1.339 0.745 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.616 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 64.0 p -114.36 -21.57 10.32 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.384 0.274 . . . . 0.0 111.367 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -108.71 -41.85 4.67 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.867 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -76.79 9.39 2.88 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.11 156.65 24.41 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.57 0.224 . . . . 0.0 111.551 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -84.18 161.48 20.55 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.581 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -142.62 -42.81 0.32 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.075 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -83.76 155.49 23.02 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.18 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -114.23 -9.01 12.9 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.22 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -98.11 -16.43 19.55 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.02 150.38 27.62 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.662 0.385 . . . . 0.0 111.645 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.1 1.4 29.98 Favored Glycine 0 C--N 1.34 0.797 0 O-C-N 123.569 0.543 . . . . 0.0 113.816 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -78.4 162.84 26.13 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 23' ' ' MET . . . . . 0.429 ' SD ' HG13 ' 1' ' 78' ' ' VAL . 2.4 ttm -128.98 151.4 49.73 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.166 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -120.18 109.61 15.63 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 125.159 1.384 . . . . 0.0 108.295 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 25' ' ' ILE . . . . . 0.44 HD13 ' CZ ' ' 1' ' 41' ' ' PHE . 0.9 OUTLIER -98.51 116.44 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.444 -178.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 26' ' ' GLY . . . . . 0.657 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -105.21 157.57 16.36 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.741 -1.118 . . . . 0.0 114.612 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 27' ' ' GLY . . . . . 0.649 ' O ' HG23 ' 1' ' 91' ' ' ILE . . . 72.0 21.17 79.18 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 177.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 25.7 mt -54.94 168.42 0.3 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.895 0.847 . . . . 0.0 111.101 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 29' ' ' SER . . . . . 0.4 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 4.1 t -100.25 174.4 6.15 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.684 0.754 . . . . 0.0 110.381 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 30' ' ' TRP . . . . . 0.43 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.7 p-90 -72.22 -16.08 61.94 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.532 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -98.41 -25.06 14.93 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.22 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 32' ' ' THR . . . . . 0.597 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 0.6 OUTLIER -68.45 113.63 6.17 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.514 0.673 . . . . 0.0 112.686 -179.03 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 33' ' ' SER . . . . . . . . . . . . . 25.3 p -103.4 159.82 28.1 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.253 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 34' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.44 -25.7 49.95 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.061 1.841 . . . . 0.0 112.54 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.19 -33.94 37.84 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.068 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 36' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' 1' ' 40' ' ' TYR . 19.4 t -70.49 -35.23 73.13 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.04 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 37' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.5 mt -72.57 -40.37 66.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.176 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 38' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -67.2 -42.54 83.97 Favored 'General case' 0 C--N 1.347 0.457 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.92 -40.28 87.61 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.791 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 40' ' ' TYR . . . . . 0.733 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 5.8 t80 -72.01 -50.69 26.51 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-O 120.802 0.334 . . . . 0.0 111.446 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 41' ' ' PHE . . . . . 0.505 ' C ' HD13 ' 1' ' 47' ' ' ILE . 20.0 m-85 -71.4 -25.66 62.44 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -178.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 42' ' ' SER . . . . . 0.476 ' N ' HD13 ' 1' ' 47' ' ' ILE . 36.7 p -62.88 -14.18 43.2 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.496 1.141 . . . . 0.0 109.565 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 43' ' ' LYS . . . . . 0.733 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 13.7 mmtt -79.44 -12.8 59.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 112.238 -2.255 . . . . 0.0 111.534 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -101.53 -34.63 9.46 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.083 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 45' ' ' GLY . . . . . 0.406 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -171.19 -160.29 19.37 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -101.52 132.14 47.3 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-O 121.884 0.85 . . . . 0.0 110.308 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 47' ' ' ILE . . . . . 0.505 HD13 ' C ' ' 1' ' 41' ' ' PHE . 5.0 mt -103.08 138.27 28.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 112.97 -1.923 . . . . 0.0 111.667 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -86.13 -43.42 13.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.314 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -162.97 157.71 21.35 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.296 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 50' ' ' CYS . . . . . . . . . . . . . 44.5 t -138.19 148.7 45.1 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.268 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 64.0 ttp -146.96 135.41 21.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.161 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 70.4 t -127.43 125.1 65.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 113.639 -1.618 . . . . 0.0 108.48 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 11.5 mmt -77.2 116.98 18.28 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.219 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -136.37 155.06 50.57 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.554 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.33 116.18 65.21 Favored Pre-proline 0 N--CA 1.437 -1.081 0 C-N-CA 122.837 0.455 . . . . 0.0 110.84 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.99 -10.17 21.97 Favored 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 122.258 1.972 . . . . 0.0 113.188 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 19.1 p -82.08 -44.21 16.84 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 58' ' ' THR . . . . . 0.514 ' OG1' ' HG2' ' 1' ' 60' ' ' ARG . 46.9 p -114.48 -12.64 12.29 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.344 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt 61.2 11.97 3.84 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.646 1.178 . . . . 0.0 112.633 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 60' ' ' ARG . . . . . 0.514 ' HG2' ' OG1' ' 1' ' 58' ' ' THR . 19.1 ptp180 -99.05 132.41 44.38 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.382 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 8.7 t -87.09 157.8 19.33 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.165 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -97.66 -9.26 27.11 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.172 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.1 42.85 4.55 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.663 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -152.87 144.14 23.21 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.765 0.282 . . . . 0.0 110.951 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.22 -170.5 25.95 Favored Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 66' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -135.2 168.35 19.32 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 124.798 1.239 . . . . 0.0 110.092 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 67' ' ' VAL . . . . . . . . . . . . . 79.2 t -153.23 132.78 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -107.2 105.32 15.25 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 113.956 -1.475 . . . . 0.0 111.624 -178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -83.13 124.41 30.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.458 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.82 2.29 27.0 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 71' ' ' ASP . . . . . 0.545 ' OD1' ' HB1' ' 1' ' 73' ' ' ALA . 15.5 t0 -126.97 132.53 24.36 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.458 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -73.57 -16.18 24.22 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 122.023 1.816 . . . . 0.0 111.682 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 73' ' ' ALA . . . . . 0.545 ' HB1' ' OD1' ' 1' ' 71' ' ' ASP . . . -77.33 -30.97 54.23 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.867 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 74' ' ' SER . . . . . 0.464 ' O ' HG22 ' 1' ' 78' ' ' VAL . 3.1 t -70.16 -31.86 69.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.316 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 75' ' ' VAL . . . . . 0.677 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 5.6 t -69.02 -31.93 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.392 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -71.84 -41.94 67.56 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.869 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 77' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' 1' ' 73' ' ' ALA . 90.3 mttt -64.56 -42.79 95.44 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 113.868 -1.514 . . . . 0.0 112.091 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 78' ' ' VAL . . . . . 0.464 HG22 ' O ' ' 1' ' 74' ' ' SER . 95.2 t -74.92 -31.97 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.792 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 79' ' ' LEU . . . . . 0.677 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.2 OUTLIER -65.24 -32.91 74.82 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.877 0.871 . . . . 0.0 112.207 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 80' ' ' GLY . . . . . 0.409 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -79.14 -19.16 72.91 Favored Glycine 0 C--N 1.343 0.955 0 O-C-N 123.697 0.623 . . . . 0.0 113.47 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -98.65 100.74 10.07 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 122.881 0.472 . . . . 0.0 110.835 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 82' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 4.7 Cg_exo -79.23 -35.33 0.9 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.44 2.093 . . . . 0.0 113.676 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -91.16 128.79 37.12 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.767 0.317 . . . . 0.0 111.252 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -139.65 123.71 17.77 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.021 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -117.35 134.67 54.55 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.845 0.831 . . . . 0.0 110.861 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 86' ' ' LEU . . . . . 0.597 HD21 ' OG1' ' 1' ' 32' ' ' THR . 9.2 tp -143.25 133.35 24.34 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 113.331 -1.759 . . . . 0.0 107.492 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 11.8 t70 51.92 37.31 20.59 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 122.591 1.186 . . . . 0.0 111.78 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 12.6 t 69.88 9.62 7.19 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 112.842 -1.981 . . . . 0.0 112.063 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -124.14 152.39 42.85 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.902 0.858 . . . . 0.0 110.529 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.3 m -80.87 127.45 32.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.542 -1.663 . . . . 0.0 111.817 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 91' ' ' ILE . . . . . 0.657 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 44.6 pt -115.26 168.71 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.896 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 92' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -116.64 90.42 31.2 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.5 124.12 3.54 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.347 2.031 . . . . 0.0 111.44 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 94' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -149.4 154.07 38.34 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 6.4 t -76.85 129.85 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.777 0.431 . . . . 0.0 111.501 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.54 156.26 17.14 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -114.02 124.25 31.3 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.377 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.63 137.07 26.92 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.584 2.19 . . . . 0.0 113.016 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -134.6 142.51 46.94 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.964 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -125.6 131.0 52.78 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.259 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -154.85 168.35 27.2 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.771 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 60.11 148.66 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 124.601 1.16 . . . . 0.0 113.465 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.26 176.58 9.78 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.74 2.294 . . . . 0.0 113.557 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -85.52 154.72 21.58 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.331 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 26.2 mmt -90.53 160.91 15.72 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.478 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 2.7 t -94.41 165.27 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.098 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.6 m -101.02 -44.5 5.7 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.082 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -95.53 124.75 39.71 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.287 0.367 . . . . 0.0 111.137 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 19.7 p -100.49 122.36 43.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.264 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -91.03 145.5 24.64 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.269 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 84.4 mttt . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.503 179.92 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.535 0.207 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -117.35 148.18 41.96 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.081 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -116.83 -42.96 2.91 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.149 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -104.0 145.41 30.2 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.378 0.424 . . . . 0.0 110.958 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -104.72 -40.24 6.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.47 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -97.66 142.42 29.49 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 123.276 0.36 . . . . 0.0 111.44 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -130.02 138.07 50.59 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.553 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 55.9 m -94.11 128.81 40.73 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.508 0.505 . . . . 0.0 111.891 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 6.0 t -103.77 138.43 40.4 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.78 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 50.6 m -93.1 146.6 23.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.684 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 13.0 t -98.1 126.23 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.941 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.69 150.4 23.64 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.61 0.569 . . . . 0.0 111.716 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.23 -38.62 3.55 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.524 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.9 70.33 0.84 Allowed Glycine 0 CA--C 1.517 0.177 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.324 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 11' ' ' THR . . . . . 0.55 ' O ' HD12 ' 1' ' 14' ' ' LEU . 71.0 p -121.87 -22.94 5.59 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.616 0.366 . . . . 0.0 110.602 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 12' ' ' GLU . . . . . 0.441 ' O ' HD11 ' 1' ' 14' ' ' LEU . 38.7 tt0 -116.83 -52.79 2.52 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.467 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -80.07 51.67 1.4 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.381 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 14' ' ' LEU . . . . . 0.55 HD12 ' O ' ' 1' ' 11' ' ' THR . 1.7 mp -80.48 -30.93 37.38 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.578 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -82.09 120.41 25.25 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.064 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -84.14 -15.91 45.47 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -93.59 108.26 20.0 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.199 0.312 . . . . 0.0 110.659 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 13.8 t -120.11 137.2 54.28 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.367 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -116.87 -44.96 2.79 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.613 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.92 146.48 24.89 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.02 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.92 -2.73 6.88 Favored Glycine 0 C--N 1.335 0.51 0 O-C-N 123.578 0.549 . . . . 0.0 113.023 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -87.17 174.66 8.48 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.544 0.338 . . . . 0.0 111.005 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 23' ' ' MET . . . . . . . . . . . . . 10.8 mtp -121.7 152.47 39.36 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.887 0.851 . . . . 0.0 111.554 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -103.98 106.88 17.53 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.014 -1.903 . . . . 0.0 107.988 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 25' ' ' ILE . . . . . 0.427 HD13 ' CZ ' ' 1' ' 41' ' ' PHE . 1.1 mm -96.75 110.39 24.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 122.882 0.473 . . . . 0.0 110.618 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 26' ' ' GLY . . . . . 0.663 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -101.38 160.34 18.36 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.906 -1.043 . . . . 0.0 115.243 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 27' ' ' GLY . . . . . 0.638 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 73.54 20.92 79.91 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 115.195 0.838 . . . . 0.0 115.195 177.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 18.1 mt -58.27 168.33 1.1 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 117.875 0.838 . . . . 0.0 110.818 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 29' ' ' SER . . . . . 0.425 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 5.7 t -101.66 174.53 5.92 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.502 0.668 . . . . 0.0 110.01 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 30' ' ' TRP . . . . . 0.438 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.4 p-90 -71.64 -16.0 62.25 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.782 1.233 . . . . 0.0 111.481 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -97.99 -24.97 15.14 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.977 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 32' ' ' THR . . . . . 0.631 ' OG1' HD23 ' 1' ' 86' ' ' LEU . 0.7 OUTLIER -65.4 113.73 4.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.456 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 33' ' ' SER . . . . . . . . . . . . . 71.6 m -103.03 159.21 30.0 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.938 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 34' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.53 -25.71 60.04 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.11 1.873 . . . . 0.0 112.271 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.13 -32.26 39.01 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.927 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 36' ' ' SER . . . . . . . . . . . . . 21.7 t -70.96 -36.43 72.55 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.218 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 37' ' ' LEU . . . . . 0.517 ' HB3' ' HG ' ' 1' ' 50' ' ' CYS . 1.7 mt -72.9 -37.96 67.09 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 123.933 0.893 . . . . 0.0 110.038 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 38' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -69.08 -42.6 75.98 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.609 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -38.98 91.79 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 123.866 0.729 . . . . 0.0 111.161 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 40' ' ' TYR . . . . . 0.701 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 0.3 OUTLIER -71.51 -52.96 15.5 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 122.941 0.496 . . . . 0.0 111.649 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 41' ' ' PHE . . . . . 0.507 ' C ' HD12 ' 1' ' 47' ' ' ILE . 21.7 m-85 -71.28 -25.42 62.44 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 42' ' ' SER . . . . . 0.516 ' N ' HD12 ' 1' ' 47' ' ' ILE . 25.2 p -63.53 -14.18 48.62 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.418 1.104 . . . . 0.0 109.619 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 43' ' ' LYS . . . . . 0.701 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 6.0 mmtp -80.42 -12.09 59.61 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 112.333 -2.212 . . . . 0.0 112.148 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.57 -32.79 7.9 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.922 0.489 . . . . 0.0 110.405 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.88 -161.06 16.71 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -103.0 133.32 48.33 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.697 0.76 . . . . 0.0 110.429 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 47' ' ' ILE . . . . . 0.516 HD12 ' N ' ' 1' ' 42' ' ' SER . 4.6 mt -105.78 136.86 38.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 113.263 -1.789 . . . . 0.0 111.498 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -86.57 -41.37 14.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.306 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -163.96 157.63 18.76 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.954 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 50' ' ' CYS . . . . . 0.517 ' HG ' ' HB3' ' 1' ' 37' ' ' LEU . 40.5 t -135.54 150.48 49.75 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.06 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 27.6 ttt -145.17 133.41 21.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.424 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 82.2 t -127.5 124.28 63.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 113.448 -1.705 . . . . 0.0 108.221 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 1.2 mmt -76.52 133.68 39.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.919 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 54' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' 1' ' 59' ' ' LYS . 7.9 ttm180 -131.3 160.69 34.22 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.986 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.41 118.78 51.38 Favored Pre-proline 0 N--CA 1.441 -0.923 0 C-N-CA 122.575 0.35 . . . . 0.0 110.509 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.33 -10.71 19.55 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.484 2.122 . . . . 0.0 113.539 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 19.0 p -82.03 -44.25 16.89 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 72.5 p -117.01 -6.81 11.4 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.408 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 59' ' ' LYS . . . . . 0.47 ' O ' ' HD3' ' 1' ' 54' ' ' ARG . 17.6 mmtp 61.57 11.63 3.98 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.435 1.094 . . . . 0.0 111.723 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -100.64 154.5 18.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.261 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 49.9 m -92.36 154.24 18.68 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.557 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -91.73 -5.81 53.0 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.638 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.06 38.6 5.97 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.454 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -154.86 144.41 21.38 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.402 0.281 . . . . 0.0 111.167 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.2 -168.83 18.96 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 66' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -138.92 161.38 37.45 Favored 'General case' 0 N--CA 1.423 -1.794 0 C-N-CA 124.948 1.299 . . . . 0.0 109.537 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 67' ' ' VAL . . . . . . . . . . . . . 73.5 t -145.1 132.13 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 68' ' ' THR . . . . . 0.504 ' O ' HG21 ' 1' ' 47' ' ' ILE . 0.9 OUTLIER -105.54 107.06 17.85 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.935 -177.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -86.07 125.56 33.54 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.925 -1.488 . . . . 0.0 111.937 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.05 2.18 9.38 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -129.55 134.6 26.41 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.999 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -73.43 -16.31 24.55 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.1 1.867 . . . . 0.0 112.173 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 73' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' 1' ' 77' ' ' LYS . . . -77.31 -31.28 54.56 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.763 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 74' ' ' SER . . . . . . . . . . . . . 2.2 t -70.1 -31.94 69.74 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.281 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 75' ' ' VAL . . . . . 0.722 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 11.3 t -69.98 -33.12 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.652 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -72.02 -40.79 68.19 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.008 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 77' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' 1' ' 73' ' ' ALA . 43.5 mttp -66.61 -41.34 88.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.518 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 78' ' ' VAL . . . . . . . . . . . . . 88.4 t -81.33 -31.85 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.646 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 79' ' ' LEU . . . . . 0.722 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.8 OUTLIER -65.94 -35.16 79.84 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 122.775 0.43 . . . . 0.0 111.439 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 80' ' ' GLY . . . . . 0.468 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -77.49 -15.24 81.63 Favored Glycine 0 C--N 1.343 0.936 0 O-C-N 123.575 0.547 . . . . 0.0 113.877 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -98.53 99.96 8.44 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 122.69 0.396 . . . . 0.0 111.286 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 82' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 5.3 Cg_exo -78.36 -21.31 10.45 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.578 2.186 . . . . 0.0 113.819 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -89.04 115.26 26.45 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.027 0.442 . . . . 0.0 111.482 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -139.76 119.95 13.76 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.838 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -116.89 134.6 54.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.997 0.903 . . . . 0.0 111.094 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 86' ' ' LEU . . . . . 0.631 HD23 ' OG1' ' 1' ' 32' ' ' THR . 6.3 tp -145.66 133.34 21.03 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.273 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 11.5 t70 52.0 36.95 19.9 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 122.646 1.212 . . . . 0.0 111.721 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 67.8 m 69.23 9.64 7.44 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 112.856 -1.975 . . . . 0.0 112.076 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -123.87 152.46 42.32 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 122.108 0.956 . . . . 0.0 110.697 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.5 m -80.41 124.8 29.21 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.177 -1.829 . . . . 0.0 112.211 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 91' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 43.7 pt -112.03 167.34 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.794 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 92' ' ' ASP . . . . . 0.583 ' OD1' ' HD3' ' 1' ' 94' ' ' LYS . 4.9 t70 -117.71 96.18 49.03 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -175.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -83.07 124.24 3.76 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.129 1.886 . . . . 0.0 111.017 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 94' ' ' LYS . . . . . 0.583 ' HD3' ' OD1' ' 1' ' 92' ' ' ASP . 23.5 pttt -147.54 139.9 24.52 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 t -74.39 125.19 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 122.715 0.406 . . . . 0.0 111.157 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.42 149.88 25.7 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -109.82 130.62 22.6 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.886 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -73.19 139.98 30.22 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.64 2.227 . . . . 0.0 113.179 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -149.43 118.85 6.88 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.025 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -99.89 128.16 46.0 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.337 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.74 170.9 10.04 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -116.63 144.6 33.58 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.666 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.45 174.62 12.26 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.555 2.17 . . . . 0.0 113.603 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -88.07 158.13 18.67 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.461 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 62.0 mtt -95.13 -6.01 42.85 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.034 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 2.7 t -91.01 162.21 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.507 0.323 . . . . 0.0 110.239 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 9.7 t -92.35 -47.61 7.09 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 -100.48 132.6 45.78 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.205 0.315 . . . . 0.0 111.113 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 17.0 p -94.11 136.86 33.95 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.333 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -87.81 128.31 35.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.561 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.398 -0.811 . . . . 0.0 111.397 179.966 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 31.7 mtm . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.6 0.238 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -121.78 -40.79 2.51 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.24 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -96.25 154.91 17.0 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.427 0.454 . . . . 0.0 111.098 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -95.72 141.65 28.94 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.252 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -117.09 139.75 50.35 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.443 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -127.64 142.07 51.45 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.322 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -102.74 154.15 19.44 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.884 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 60.2 m -112.54 -32.46 6.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.937 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 4.8 p -82.87 117.03 22.44 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 122.936 0.495 . . . . 0.0 111.873 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 50.3 m -135.66 137.91 42.31 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.197 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 t -89.43 143.68 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.879 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -106.86 -44.46 4.42 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.411 0.445 . . . . 0.0 111.645 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.18 148.69 26.61 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.226 0.329 . . . . 0.0 111.401 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 10' ' ' GLY . . . . . 0.407 ' O ' HD22 ' 1' ' 14' ' ' LEU . . . -149.18 72.09 0.3 Allowed Glycine 0 C--N 1.336 0.569 0 O-C-N 123.619 0.574 . . . . 0.0 112.552 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -148.54 13.35 0.94 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.625 0.37 . . . . 0.0 111.378 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -102.95 -55.71 2.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.261 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -77.25 -44.06 31.21 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.934 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 14' ' ' LEU . . . . . 0.407 HD22 ' O ' ' 1' ' 10' ' ' GLY . 3.4 pp -82.98 157.64 22.88 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.43 0.456 . . . . 0.0 111.328 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -76.35 153.08 36.11 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.335 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -140.22 -6.3 1.23 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.54 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -87.4 -5.34 58.9 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 51.8 p -83.79 152.21 24.76 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.488 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -118.84 -30.49 5.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.585 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.55 149.3 33.07 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 122.895 0.478 . . . . 0.0 111.643 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.37 -16.85 3.82 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.46 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -98.84 173.65 6.76 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 123.795 0.35 . . . . 0.0 110.911 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 23' ' ' MET . . . . . . . . . . . . . 14.5 mtp -117.3 152.57 34.6 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 122.005 0.907 . . . . 0.0 111.039 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -105.86 105.2 15.13 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 112.944 -1.934 . . . . 0.0 107.716 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mm -94.82 116.97 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.131 0.572 . . . . 0.0 110.102 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 26' ' ' GLY . . . . . 0.717 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -108.32 159.79 14.1 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.086 -0.961 . . . . 0.0 115.044 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 27' ' ' GLY . . . . . 0.613 ' O ' HG21 ' 1' ' 91' ' ' ILE . . . 71.9 21.32 79.05 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 115.372 0.909 . . . . 0.0 115.372 177.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 16.2 mt -57.17 169.62 0.55 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 117.858 0.829 . . . . 0.0 110.902 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 29' ' ' SER . . . . . 0.419 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 5.4 t -100.99 174.45 6.0 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.483 0.659 . . . . 0.0 110.181 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 30' ' ' TRP . . . . . 0.427 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.2 p-90 -72.02 -16.64 62.06 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.424 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -97.65 -24.93 15.29 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.006 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 32' ' ' THR . . . . . 0.571 ' OG1' HD23 ' 1' ' 86' ' ' LEU . 0.6 OUTLIER -65.83 114.04 4.78 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.637 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 33' ' ' SER . . . . . . . . . . . . . 71.5 m -103.72 158.53 31.66 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.977 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 34' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.26 -25.83 58.22 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.136 1.89 . . . . 0.0 112.468 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 35' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' 1' ' 39' ' ' ASP . 0.4 OUTLIER -80.23 -33.35 38.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.113 177.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -70.5 -35.82 73.44 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.044 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 37' ' ' LEU . . . . . 0.494 ' HB3' ' HG ' ' 1' ' 50' ' ' CYS . 1.6 mt -72.91 -38.81 66.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.19 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 38' ' ' ARG . . . . . 0.546 ' O ' ' HB2' ' 1' ' 42' ' ' SER . 12.5 ttm180 -68.01 -42.76 80.19 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.792 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 39' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' 1' ' 35' ' ' ASP . 0.1 OUTLIER -67.0 -40.19 87.29 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.582 178.04 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 40' ' ' TYR . . . . . 0.695 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 5.6 t80 -72.09 -50.05 31.29 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 122.609 0.364 . . . . 0.0 111.556 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 41' ' ' PHE . . . . . 0.523 ' C ' HD11 ' 1' ' 47' ' ' ILE . 17.5 m-85 -71.47 -25.18 62.18 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 42' ' ' SER . . . . . 0.546 ' HB2' ' O ' ' 1' ' 38' ' ' ARG . 16.9 t -61.53 -14.08 26.61 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.51 1.147 . . . . 0.0 109.526 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 43' ' ' LYS . . . . . 0.695 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 13.1 mmtt -82.97 -14.83 53.31 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 112.191 -2.277 . . . . 0.0 111.537 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 44' ' ' PHE . . . . . 0.447 ' CD1' HG21 ' 1' ' 78' ' ' VAL . 0.3 OUTLIER -97.63 -33.2 11.41 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.105 178.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.05 -160.44 22.29 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -100.09 132.72 45.29 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.839 0.828 . . . . 0.0 110.357 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 47' ' ' ILE . . . . . 0.523 HD11 ' C ' ' 1' ' 41' ' ' PHE . 4.9 mt -107.68 137.79 37.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 113.037 -1.892 . . . . 0.0 111.549 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -88.02 -41.35 13.16 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.971 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -166.45 157.22 12.55 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.421 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 50' ' ' CYS . . . . . 0.494 ' HG ' ' HB3' ' 1' ' 37' ' ' LEU . 42.3 t -133.71 151.42 51.62 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.329 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 57.3 ttp -146.54 133.67 20.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.032 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 64.8 t -126.51 124.79 66.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.197 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.99 117.27 12.27 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.178 -177.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -137.36 155.9 48.85 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.566 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.84 115.59 65.75 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 122.814 0.446 . . . . 0.0 110.777 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.74 -8.34 4.23 Favored 'Trans proline' 0 C--N 1.364 1.355 0 C-N-CA 122.963 2.442 . . . . 0.0 115.054 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 20.1 p -81.01 -45.31 16.76 Favored 'General case' 0 C--N 1.347 0.46 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 61.9 p -130.02 -5.92 4.45 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 mptt 58.56 53.07 6.37 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 122.722 1.249 . . . . 0.0 111.434 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -98.89 130.66 45.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.664 -2.062 . . . . 0.0 110.845 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 49.1 m -92.82 142.05 27.76 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.412 0.445 . . . . 0.0 111.201 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -96.09 -10.1 29.19 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.457 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.98 33.07 8.45 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 116.015 -0.539 . . . . 0.0 113.755 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -153.5 151.4 29.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 117.162 0.481 . . . . 0.0 111.514 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.06 -168.2 23.62 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 66' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -138.08 163.07 32.53 Favored 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 124.729 1.211 . . . . 0.0 109.855 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 67' ' ' VAL . . . . . 0.421 HG23 ' HG ' ' 1' ' 50' ' ' CYS . 58.9 t -144.53 133.12 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 68' ' ' THR . . . . . 0.443 ' O ' HG22 ' 1' ' 47' ' ' ILE . 1.1 m -106.91 105.97 16.26 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.743 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -83.73 126.81 33.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.051 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.03 2.66 6.58 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 71' ' ' ASP . . . . . 0.552 ' OD1' ' HB1' ' 1' ' 73' ' ' ALA . 11.6 t0 -131.7 133.0 23.69 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.825 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -73.42 -16.11 24.65 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 122.014 1.809 . . . . 0.0 111.934 176.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 73' ' ' ALA . . . . . 0.552 ' HB1' ' OD1' ' 1' ' 71' ' ' ASP . . . -77.48 -28.84 52.38 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.124 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 74' ' ' SER . . . . . 0.478 ' O ' HG23 ' 1' ' 78' ' ' VAL . 3.8 t -69.42 -31.73 70.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.215 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 75' ' ' VAL . . . . . 0.716 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 16.7 t -67.26 -32.68 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.655 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.21 -37.8 69.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.772 -1.103 . . . . 0.0 110.178 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 77' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -69.5 -43.13 73.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 113.815 -1.539 . . . . 0.0 112.209 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 78' ' ' VAL . . . . . 0.478 HG23 ' O ' ' 1' ' 74' ' ' SER . 53.0 t -77.16 -31.81 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.343 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 79' ' ' LEU . . . . . 0.716 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.4 OUTLIER -71.09 -29.35 65.17 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 122.683 0.393 . . . . 0.0 110.79 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 80' ' ' GLY . . . . . 0.54 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -74.33 -28.83 63.11 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.046 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -98.61 97.64 5.05 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 122.821 0.449 . . . . 0.0 110.413 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 82' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 2.6 Cg_exo -76.1 -27.93 7.88 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.021 2.481 . . . . 0.0 114.293 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -81.94 116.15 21.44 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.962 0.411 . . . . 0.0 111.304 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -136.16 121.63 19.41 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.08 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -115.36 134.65 54.91 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.801 0.81 . . . . 0.0 110.464 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 86' ' ' LEU . . . . . 0.571 HD23 ' OG1' ' 1' ' 32' ' ' THR . 6.4 tp -145.67 133.95 21.74 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 113.349 -1.751 . . . . 0.0 107.555 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 12.8 t70 51.69 37.15 19.38 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.628 1.171 . . . . 0.0 111.844 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 53.4 m 68.97 10.19 7.79 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 112.953 -1.93 . . . . 0.0 111.852 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -124.61 151.64 44.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.974 0.893 . . . . 0.0 110.302 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.9 m -81.99 126.87 32.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.536 -1.665 . . . . 0.0 111.83 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 91' ' ' ILE . . . . . 0.717 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 44.4 pt -110.51 169.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.339 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 92' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -113.16 93.87 27.82 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.15 124.37 3.76 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.46 2.107 . . . . 0.0 111.513 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 94' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -143.26 163.45 32.93 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.139 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -95.28 147.4 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 120.71 0.29 . . . . 0.0 110.773 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.98 165.91 10.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.848 0.859 . . . . 0.0 112.674 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 97' ' ' PHE . . . . . 0.408 ' HA ' ' HD3' ' 1' ' 98' ' ' PRO . 25.6 m-85 -103.36 144.14 28.04 Favored Pre-proline 0 N--CA 1.446 -0.671 0 C-N-CA 123.446 0.698 . . . . 0.0 110.773 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 98' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' 1' ' 97' ' ' PHE . 15.0 Cg_exo -74.33 -175.95 2.48 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 123.197 2.598 . . . . 0.0 113.367 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -73.88 156.75 37.37 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.315 0.646 . . . . 0.0 112.659 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 51.85 92.02 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.451 1.101 . . . . 0.0 113.345 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -112.28 -175.91 2.79 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.823 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -110.03 126.03 29.86 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 119.621 -0.228 . . . . 0.0 110.639 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.49 173.62 14.18 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.485 2.123 . . . . 0.0 113.236 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -84.66 150.32 25.23 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.964 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 19.6 ptm -129.67 -14.99 4.03 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.963 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 2.6 t -98.99 160.61 3.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 O-C-N 123.46 0.475 . . . . 0.0 110.067 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 3.0 m -109.73 -55.29 2.45 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.638 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -98.1 142.24 30.04 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.476 0.485 . . . . 0.0 111.274 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 17.7 p -100.91 121.25 41.41 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.334 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -91.2 147.48 23.03 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.384 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 22.5 mttm . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.423 179.681 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 17.5 mmt . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.522 0.201 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -128.74 133.54 48.15 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.984 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -103.83 -35.52 8.15 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.714 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -88.81 -36.28 16.14 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -94.08 131.0 40.03 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 123.305 0.378 . . . . 0.0 111.34 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -108.26 149.07 29.1 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -123.34 -43.96 2.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.649 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 57.9 m -90.97 123.52 34.52 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 123.208 0.317 . . . . 0.0 111.7 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 9.7 p -91.51 159.21 16.05 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.677 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 42.2 p -87.5 130.72 34.6 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.39 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 15.0 t -108.87 -49.11 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.51 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.47 128.72 34.75 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.32 0.387 . . . . 0.0 111.713 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.96 163.56 14.9 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.72 70.43 0.5 Allowed Glycine 0 C--N 1.341 0.844 0 C-N-CA 121.41 -0.424 . . . . 0.0 112.521 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 9.1 t -138.73 13.89 2.71 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 123.769 0.335 . . . . 0.0 111.596 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -121.37 -46.41 2.28 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.534 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -75.11 8.64 2.46 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.449 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 pp -79.71 164.79 23.44 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -78.5 122.92 26.48 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.479 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -104.78 -15.46 15.21 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.316 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -82.25 148.78 28.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 55.0 m -93.07 160.61 14.78 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.542 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -137.04 79.93 1.78 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.366 0.603 . . . . 0.0 110.43 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.71 136.68 39.26 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.291 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.54 -1.39 2.09 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.741 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -81.09 147.73 29.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 23' ' ' MET . . . . . 0.455 ' O ' ' HA ' ' 1' ' 66' ' ' PHE . 5.8 mtp -117.23 129.62 56.04 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.662 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -91.26 103.78 16.41 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 126.093 1.757 . . . . 0.0 109.088 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mm -92.28 109.88 22.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.291 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 26' ' ' GLY . . . . . 0.633 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -99.56 154.45 19.71 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 116.077 1.191 . . . . 0.0 116.077 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 27' ' ' GLY . . . . . 0.632 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 72.53 27.0 70.34 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 113.996 -1.102 . . . . 0.0 115.717 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 18.9 mt -58.11 170.88 0.61 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 117.964 0.882 . . . . 0.0 111.149 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 29' ' ' SER . . . . . 0.422 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 5.7 t -100.25 174.31 6.2 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.456 0.646 . . . . 0.0 110.388 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 30' ' ' TRP . . . . . 0.439 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.3 p-90 -72.75 -16.78 61.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.197 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -98.62 -24.98 14.87 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.995 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 32' ' ' THR . . . . . 0.585 ' OG1' HD22 ' 1' ' 86' ' ' LEU . 1.0 OUTLIER -66.78 114.08 5.38 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.599 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 33' ' ' SER . . . . . . . . . . . . . 57.8 m -104.22 160.21 26.78 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.287 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 34' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -56.45 -25.69 59.29 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.167 1.911 . . . . 0.0 112.374 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.9 -33.32 39.98 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.913 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 36' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' 1' ' 40' ' ' TYR . 19.9 t -70.81 -35.92 72.72 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.383 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 37' ' ' LEU . . . . . 0.443 ' HB3' ' SG ' ' 1' ' 50' ' ' CYS . 1.9 mt -72.77 -37.16 67.71 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.396 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 38' ' ' ARG . . . . . 0.601 ' O ' ' HB2' ' 1' ' 42' ' ' SER . 6.0 ttm180 -71.19 -42.05 69.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.664 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.44 -39.58 85.39 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.868 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 40' ' ' TYR . . . . . 0.708 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 2.5 t80 -71.91 -52.04 19.23 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-O 120.851 0.358 . . . . 0.0 111.641 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 41' ' ' PHE . . . . . 0.469 ' C ' HD13 ' 1' ' 47' ' ' ILE . 33.9 m-85 -71.5 -25.69 62.37 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 42' ' ' SER . . . . . 0.601 ' HB2' ' O ' ' 1' ' 38' ' ' ARG . 9.4 t -63.0 -14.04 42.81 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.5 1.143 . . . . 0.0 109.465 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 43' ' ' LYS . . . . . 0.708 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 14.8 mttt -82.48 -13.5 56.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 112.15 -2.295 . . . . 0.0 111.82 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -104.69 -31.15 9.5 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.305 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 45' ' ' GLY . . . . . 0.432 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -168.2 -163.26 21.85 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -102.82 132.77 48.77 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.826 0.822 . . . . 0.0 110.744 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 47' ' ' ILE . . . . . 0.503 HD13 ' N ' ' 1' ' 42' ' ' SER . 4.9 mt -107.41 137.85 36.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 113.029 -1.896 . . . . 0.0 111.44 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -87.66 -41.7 13.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.974 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -164.7 157.38 16.62 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.251 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 50' ' ' CYS . . . . . 0.496 ' SG ' HG21 ' 1' ' 67' ' ' VAL . 43.4 t -135.36 150.58 49.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.286 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 27.4 ttt -145.42 135.92 24.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.919 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.47 125.19 63.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 113.659 -1.609 . . . . 0.0 107.653 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -69.53 117.02 10.62 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.141 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 38.7 mtt-85 -137.27 150.92 48.15 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.625 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.34 115.6 60.65 Favored Pre-proline 0 N--CA 1.44 -0.947 0 C-N-CA 122.918 0.487 . . . . 0.0 110.594 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -63.9 -8.97 17.25 Favored 'Trans proline' 0 C--N 1.363 1.313 0 C-N-CA 122.297 1.998 . . . . 0.0 113.36 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 19.9 p -82.18 -44.23 16.68 Favored 'General case' 0 C--N 1.346 0.423 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 74.8 p -118.49 -10.98 10.01 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt 61.5 12.38 4.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.406 1.082 . . . . 0.0 112.148 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -91.06 132.77 35.82 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.851 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 39.2 m -97.08 156.07 16.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.699 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -99.19 -11.12 21.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.34 43.21 4.37 Favored Glycine 0 C--N 1.339 0.708 0 O-C-N 123.351 0.407 . . . . 0.0 113.919 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -155.28 151.14 27.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.785 0.293 . . . . 0.0 111.013 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.72 -169.78 23.46 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 66' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' 1' ' 23' ' ' MET . 86.2 m-85 -138.57 158.91 43.35 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 125.084 1.353 . . . . 0.0 109.63 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 67' ' ' VAL . . . . . 0.496 HG21 ' SG ' ' 1' ' 50' ' ' CYS . 75.2 t -144.12 133.22 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 68' ' ' THR . . . . . 0.413 ' O ' HG22 ' 1' ' 47' ' ' ILE . 1.5 m -105.44 105.46 15.51 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 113.615 -1.63 . . . . 0.0 111.5 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -81.81 124.61 29.81 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.82 -1.536 . . . . 0.0 112.069 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.31 3.05 9.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 71' ' ' ASP . . . . . 0.539 ' OD1' ' HB3' ' 1' ' 73' ' ' ALA . 11.6 t0 -132.01 134.11 24.79 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.745 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -73.39 -16.51 24.57 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 121.756 1.638 . . . . 0.0 111.89 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 73' ' ' ALA . . . . . 0.539 ' HB3' ' OD1' ' 1' ' 71' ' ' ASP . . . -77.53 -30.45 52.81 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.975 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 74' ' ' SER . . . . . 0.432 ' OG ' ' HA3' ' 1' ' 45' ' ' GLY . 5.1 t -69.88 -31.59 69.48 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.27 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 75' ' ' VAL . . . . . 0.727 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 9.4 t -69.99 -32.66 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.882 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -72.06 -40.29 68.43 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.17 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 77' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' 1' ' 73' ' ' ALA . 87.0 mttt -69.19 -40.3 78.15 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.659 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 78' ' ' VAL . . . . . . . . . . . . . 87.0 t -81.97 -32.0 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.679 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 79' ' ' LEU . . . . . 0.727 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.5 OUTLIER -67.03 -35.84 80.79 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 122.504 0.322 . . . . 0.0 111.092 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 80' ' ' GLY . . . . . 0.521 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -72.59 -16.21 77.67 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.52 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -98.94 97.9 5.63 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 122.805 0.442 . . . . 0.0 110.832 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 82' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 5.3 Cg_exo -78.45 -30.66 3.09 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.721 2.28 . . . . 0.0 113.767 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -87.37 115.45 24.79 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.925 0.393 . . . . 0.0 111.521 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -140.23 123.22 16.61 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.911 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -114.23 134.92 54.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 122.006 0.908 . . . . 0.0 110.798 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 86' ' ' LEU . . . . . 0.585 HD22 ' OG1' ' 1' ' 32' ' ' THR . 6.5 tp -142.31 129.13 20.54 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.106 -1.861 . . . . 0.0 107.527 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 7.6 t70 50.17 36.95 13.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.809 1.244 . . . . 0.0 111.834 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 15.0 t 70.02 12.13 7.75 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 112.987 -1.915 . . . . 0.0 111.432 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.55 135.54 55.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.9 m -77.29 123.25 26.22 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.261 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 91' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 45.9 pt -107.88 168.59 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.427 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 92' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -115.82 93.7 38.57 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.94 124.2 3.82 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.54 2.16 . . . . 0.0 111.324 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 94' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.45 158.19 43.95 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.622 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 18.1 t -82.65 141.63 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.15 144.73 50.12 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -121.35 137.08 26.4 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.129 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -71.88 144.72 43.96 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.808 2.339 . . . . 0.0 113.07 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -115.28 -39.51 3.6 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.046 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -87.98 123.88 33.15 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.434 0.293 . . . . 0.0 111.67 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -128.55 173.15 10.5 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.299 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -107.4 108.12 61.31 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.146 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -82.35 174.24 10.04 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.517 2.145 . . . . 0.0 113.429 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -87.54 134.67 33.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.047 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 59.4 mtt -88.78 144.79 26.01 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.496 0.497 . . . . 0.0 111.502 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 45.5 t -115.7 -53.72 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.3 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 7.1 t -78.09 91.57 4.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.685 0.755 . . . . 0.0 111.949 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -118.54 -41.23 2.83 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.297 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 6.9 t -110.86 -40.97 4.37 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.412 0.445 . . . . 0.0 111.406 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -79.34 144.4 34.25 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.872 0.469 . . . . 0.0 111.794 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 14.3 tttp . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.47 -0.776 . . . . 0.0 111.289 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 54.6 mtm . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 111.47 0.174 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -129.88 140.52 50.96 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.327 0.392 . . . . 0.0 111.2 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' -1' ' ' HIS . . . . . 0.446 ' ND1' ' HD1' ' 1' ' 0' ' ' HIS . 7.1 p80 -126.7 -44.91 1.64 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.093 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 0' ' ' HIS . . . . . 0.446 ' HD1' ' ND1' ' 1' ' -1' ' ' HIS . 17.2 m80 -104.71 156.24 18.16 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.483 0.489 . . . . 0.0 110.794 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -88.06 -38.01 15.8 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.185 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -93.65 138.1 32.23 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.163 0.289 . . . . 0.0 111.258 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -114.62 136.83 52.61 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.194 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 62.7 m -101.22 126.07 47.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.127 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 7.0 t -106.16 137.85 43.37 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.267 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 49.8 p -87.84 158.73 18.65 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.405 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 t -97.97 -14.08 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.958 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.49 -51.01 4.09 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.056 0.223 . . . . 0.0 111.172 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.45 128.08 36.41 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.361 0.413 . . . . 0.0 110.892 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.42 70.93 0.23 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.98 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -151.27 -28.15 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.377 0.271 . . . . 0.0 111.658 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -95.08 -69.02 0.77 Allowed 'General case' 0 CA--C 1.534 0.352 0 O-C-N 123.38 0.425 . . . . 0.0 111.192 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -79.52 -4.83 53.16 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.575 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tp -84.37 152.05 24.31 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -89.57 140.73 29.26 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.394 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -113.14 -44.81 3.22 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.422 0.451 . . . . 0.0 111.631 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -84.84 130.23 34.69 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.25 0.344 . . . . 0.0 111.545 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m -140.6 -41.81 0.41 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.209 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -108.61 -25.79 10.71 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.401 0.438 . . . . 0.0 111.703 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.34 148.04 43.83 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.871 0.468 . . . . 0.0 111.846 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.96 -6.56 8.87 Favored Glycine 0 C--N 1.337 0.624 0 O-C-N 123.645 0.591 . . . . 0.0 113.307 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -82.24 155.4 24.9 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.172 0.511 . . . . 0.0 112.309 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 23' ' ' MET . . . . . . . . . . . . . 5.4 mtp -117.83 151.77 36.69 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.227 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 24' ' ' PHE . . . . . 0.426 ' HD2' ' O ' ' 1' ' 65' ' ' GLY . 1.7 t80 -116.96 109.91 17.62 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.906 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 25' ' ' ILE . . . . . 0.546 HD11 ' CZ ' ' 1' ' 41' ' ' PHE . 1.4 mm -95.01 123.96 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 123.668 0.787 . . . . 0.0 109.933 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 26' ' ' GLY . . . . . 0.731 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -117.75 158.89 14.41 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.274 -0.875 . . . . 0.0 114.658 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 27' ' ' GLY . . . . . 0.611 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 70.91 21.71 78.22 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 115.474 0.949 . . . . 0.0 115.474 177.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 16.2 mt -56.13 167.37 0.64 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.902 0.851 . . . . 0.0 110.687 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 29' ' ' SER . . . . . 0.686 ' H ' ' HG1' ' 1' ' 32' ' ' THR . 6.6 t -98.35 174.33 6.54 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.631 0.729 . . . . 0.0 110.574 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 30' ' ' TRP . . . . . 0.44 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.6 p-90 -71.57 -16.9 62.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.381 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -98.82 -24.43 15.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.978 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 32' ' ' THR . . . . . 0.686 ' HG1' ' H ' ' 1' ' 29' ' ' SER . 0.5 OUTLIER -69.91 114.26 7.92 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 33' ' ' SER . . . . . 0.625 ' O ' HD22 ' 1' ' 37' ' ' LEU . 9.7 t -104.92 156.54 35.87 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.446 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 34' ' ' PRO . . . . . 0.53 ' O ' ' HB2' ' 1' ' 38' ' ' ARG . 12.8 Cg_endo -53.21 -25.18 28.95 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.219 1.946 . . . . 0.0 113.611 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.54 -29.46 41.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.969 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 36' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' 1' ' 40' ' ' TYR . 16.6 t -69.67 -47.02 64.76 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.597 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 37' ' ' LEU . . . . . 0.625 HD22 ' O ' ' 1' ' 33' ' ' SER . 0.2 OUTLIER -74.25 -30.9 62.36 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 121.226 -0.189 . . . . 0.0 110.792 178.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 38' ' ' ARG . . . . . 0.571 ' HE ' ' HB3' ' 1' ' 50' ' ' CYS . 21.0 ttm180 -66.39 -43.63 85.34 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.49 -36.77 79.38 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.923 177.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 40' ' ' TYR . . . . . 0.764 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 4.2 t80 -72.04 -49.58 35.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.502 0.721 . . . . 0.0 111.75 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 41' ' ' PHE . . . . . 0.546 ' CZ ' HD11 ' 1' ' 25' ' ' ILE . 36.7 m-85 -71.48 -26.34 62.65 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.852 0.861 . . . . 0.0 112.914 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 42' ' ' SER . . . . . 0.533 ' N ' HD11 ' 1' ' 47' ' ' ILE . 35.9 p -64.58 -14.05 55.89 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 122.413 1.101 . . . . 0.0 109.541 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 43' ' ' LYS . . . . . 0.764 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 14.3 mttt -79.58 -13.08 59.77 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 112.194 -2.275 . . . . 0.0 111.78 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -102.36 -34.48 9.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.219 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 45' ' ' GLY . . . . . 0.411 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -168.25 -161.05 17.3 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -101.91 132.66 47.57 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 121.761 0.791 . . . . 0.0 110.539 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 47' ' ' ILE . . . . . 0.533 HD11 ' N ' ' 1' ' 42' ' ' SER . 5.4 mt -103.31 137.98 29.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 113.101 -1.863 . . . . 0.0 110.954 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -93.46 -40.18 10.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.751 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -156.64 157.73 35.75 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.709 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 50' ' ' CYS . . . . . 0.571 ' HB3' ' HE ' ' 1' ' 38' ' ' ARG . 10.2 t -144.88 150.27 36.78 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.692 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 24.8 ttt -154.06 134.47 13.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.516 -1.22 . . . . 0.0 112.767 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 52' ' ' VAL . . . . . 0.442 ' CG2' HD21 ' 1' ' 37' ' ' LEU . 58.7 t -127.6 124.76 64.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 113.836 -1.529 . . . . 0.0 107.21 175.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 19.0 mtp -72.12 114.81 10.62 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.616 -177.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -137.25 156.06 48.75 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.143 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.97 114.66 64.15 Favored Pre-proline 0 N--CA 1.446 -0.639 0 C-N-CA 122.703 0.401 . . . . 0.0 110.994 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.91 -8.51 3.23 Favored 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 123.047 2.498 . . . . 0.0 114.688 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 19.7 p -80.66 -44.36 18.93 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 61.1 p -129.05 -6.36 4.94 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.399 0.437 . . . . 0.0 111.987 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 5.9 mptt 56.6 53.42 8.49 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 122.758 1.266 . . . . 0.0 112.107 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -98.37 129.31 45.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 112.666 -2.061 . . . . 0.0 111.03 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 12.8 t -97.07 137.55 35.96 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.641 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -95.1 -10.7 29.93 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.428 0.455 . . . . 0.0 111.694 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.07 41.3 4.97 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 116.13 -0.486 . . . . 0.0 113.715 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -156.79 149.15 23.24 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.925 0.362 . . . . 0.0 111.386 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 65' ' ' GLY . . . . . 0.426 ' O ' ' HD2' ' 1' ' 24' ' ' PHE . . . -163.45 -169.7 27.29 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 66' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -135.74 164.88 26.88 Favored 'General case' 0 N--CA 1.427 -1.613 0 C-N-CA 125.089 1.355 . . . . 0.0 109.431 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 67' ' ' VAL . . . . . . . . . . . . . 70.3 t -150.18 133.0 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.9 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 68' ' ' THR . . . . . . . . . . . . . 1.6 m -105.68 105.04 14.9 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 113.296 -1.775 . . . . 0.0 111.343 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -83.12 123.16 29.25 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.035 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.49 1.82 13.15 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 71' ' ' ASP . . . . . 0.574 ' OD1' ' HB1' ' 1' ' 73' ' ' ALA . 15.4 t0 -129.26 132.32 24.23 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.378 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -73.41 -16.37 24.56 Favored 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 121.969 1.779 . . . . 0.0 111.666 176.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 73' ' ' ALA . . . . . 0.574 ' HB1' ' OD1' ' 1' ' 71' ' ' ASP . . . -77.3 -30.19 54.05 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.981 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 74' ' ' SER . . . . . 0.417 ' O ' HG21 ' 1' ' 78' ' ' VAL . 5.4 t -69.97 -31.8 69.7 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.327 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 75' ' ' VAL . . . . . 0.661 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 10.7 t -69.93 -32.04 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.581 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -71.32 -41.84 69.36 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.921 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 77' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' 1' ' 73' ' ' ALA . 53.5 mttm -65.88 -40.28 91.45 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.875 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 78' ' ' VAL . . . . . 0.417 HG21 ' O ' ' 1' ' 74' ' ' SER . 87.2 t -77.56 -32.41 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 79' ' ' LEU . . . . . 0.661 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.3 OUTLIER -62.67 -35.53 79.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.615 0.766 . . . . 0.0 111.95 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 80' ' ' GLY . . . . . 0.449 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -77.22 -15.37 81.62 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 115.91 -0.586 . . . . 0.0 113.4 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -98.76 99.38 7.58 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.072 0.549 . . . . 0.0 110.588 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 82' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 6.2 Cg_exo -78.32 -34.91 1.37 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.519 2.146 . . . . 0.0 113.734 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -89.98 127.21 35.99 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.748 0.309 . . . . 0.0 111.48 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -137.62 119.59 15.38 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -114.68 134.63 54.93 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 122.037 0.923 . . . . 0.0 110.771 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 86' ' ' LEU . . . . . 0.587 HD23 ' OG1' ' 1' ' 32' ' ' THR . 5.7 tp -144.25 134.55 24.41 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 113.018 -1.901 . . . . 0.0 107.244 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 9.1 t70 52.0 37.04 20.15 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.645 1.212 . . . . 0.0 111.558 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 58.2 m 68.58 11.27 8.29 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 112.805 -1.998 . . . . 0.0 112.037 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -126.58 152.13 47.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.899 0.857 . . . . 0.0 110.573 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.6 m -80.35 126.41 31.13 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.515 -1.675 . . . . 0.0 111.704 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 91' ' ' ILE . . . . . 0.731 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 43.2 pt -111.02 173.49 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.762 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -115.44 82.85 10.06 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -176.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.77 123.72 3.32 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.208 1.939 . . . . 0.0 111.443 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.95 148.54 28.53 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -80.73 141.62 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.867 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.29 159.01 31.99 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.944 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -108.39 126.48 29.51 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 122.943 0.497 . . . . 0.0 111.409 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -79.28 160.38 26.15 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.802 2.335 . . . . 0.0 113.28 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -103.38 136.97 42.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.94 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -103.21 169.17 8.71 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 123.38 0.425 . . . . 0.0 111.411 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.01 176.34 9.62 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 64.49 133.43 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 124.36 1.064 . . . . 0.0 112.76 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.8 -174.61 2.23 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.775 2.317 . . . . 0.0 113.255 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -80.45 143.62 33.25 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.717 0.407 . . . . 0.0 111.854 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 23.1 mmt -94.46 158.37 15.58 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.572 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 34.9 t -106.83 -57.0 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.6 m -99.23 94.07 6.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.862 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -92.08 145.18 24.73 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.732 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 18.5 p -95.43 143.32 26.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.318 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -140.23 -45.46 0.42 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.186 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 88.8 mttt . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.476 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 2.8 tpt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.409 0.147 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -115.81 137.41 52.12 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.813 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -114.1 146.13 40.68 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.259 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -99.95 137.88 37.8 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.656 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -98.71 138.87 35.25 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.024 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -126.56 145.26 50.6 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.65 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -95.63 143.89 26.53 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.831 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 41.9 p -108.71 -34.58 6.65 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.575 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 4.0 t -94.46 94.83 8.46 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.107 0.48 . . . . 0.0 110.789 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 47.7 p -128.49 125.78 39.12 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.302 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 13.1 t -108.49 -40.26 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.242 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -81.44 157.06 25.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.928 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 pp -78.52 157.79 28.75 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.806 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.31 71.32 0.5 Allowed Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.629 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -134.55 -4.04 2.61 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 122.448 0.299 . . . . 0.0 111.75 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -103.81 -35.04 8.33 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.75 -3.96 31.64 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 mp -92.42 -38.06 12.21 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.835 0.35 . . . . 0.0 111.42 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -80.89 132.27 35.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.33 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -140.3 0.12 1.67 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -83.96 -43.83 14.81 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 51.2 p -92.59 107.68 19.4 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.932 0.396 . . . . 0.0 111.604 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -137.46 -48.24 0.58 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.109 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.77 145.03 30.68 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.417 0.448 . . . . 0.0 112.007 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.21 -5.55 8.23 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.025 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 22' ' ' LYS . . . . . 0.727 ' HG3' HG23 ' 1' ' 68' ' ' THR . 15.1 mttp -87.35 154.67 20.49 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 122.909 0.484 . . . . 0.0 112.289 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 23' ' ' MET . . . . . 0.427 ' O ' ' HA ' ' 1' ' 66' ' ' PHE . 5.8 mtp -123.68 131.32 53.58 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.782 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -93.21 108.19 19.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.09 -1.413 . . . . 0.0 109.018 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mm -96.27 116.15 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.29 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 26' ' ' GLY . . . . . 0.717 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -108.35 158.61 14.69 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 114.99 -1.004 . . . . 0.0 115.044 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 27' ' ' GLY . . . . . 0.589 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 69.99 23.63 76.95 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 115.506 0.962 . . . . 0.0 115.506 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 18.4 mt -56.17 169.6 0.39 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 117.704 0.752 . . . . 0.0 110.918 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 29' ' ' SER . . . . . 0.407 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 4.2 t -99.5 174.42 6.27 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.659 0.742 . . . . 0.0 110.388 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 30' ' ' TRP . . . . . 0.462 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.1 p-90 -72.2 -17.21 61.94 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.333 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -97.69 -24.87 15.3 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.067 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 32' ' ' THR . . . . . 0.572 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 0.7 OUTLIER -65.26 114.3 4.63 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.813 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 33' ' ' SER . . . . . 0.512 ' OG ' ' HD2' ' 1' ' 34' ' ' PRO . 4.7 t -105.39 158.43 32.23 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.791 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 34' ' ' PRO . . . . . 0.512 ' HD2' ' OG ' ' 1' ' 33' ' ' SER . 13.0 Cg_endo -56.26 -25.86 58.36 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.242 1.961 . . . . 0.0 112.518 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.21 -33.79 37.83 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.961 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 36' ' ' SER . . . . . 0.493 ' HB3' ' H ' ' 1' ' 33' ' ' SER . 23.2 t -70.9 -35.59 72.36 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.516 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 37' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.4 mt -72.66 -39.05 67.42 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 123.742 0.817 . . . . 0.0 110.267 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 38' ' ' ARG . . . . . 0.621 ' O ' ' HB2' ' 1' ' 42' ' ' SER . 22.1 ttm180 -69.0 -42.05 77.0 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.73 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.78 -39.96 84.04 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.737 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 40' ' ' TYR . . . . . 0.699 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 6.0 t80 -72.11 -50.4 28.39 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 122.374 0.269 . . . . 0.0 111.648 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 41' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' 1' ' 37' ' ' LEU . 24.2 m-85 -71.17 -25.57 62.59 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 42' ' ' SER . . . . . 0.621 ' HB2' ' O ' ' 1' ' 38' ' ' ARG . 11.4 t -63.07 -14.05 43.44 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.444 1.116 . . . . 0.0 109.563 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 43' ' ' LYS . . . . . 0.699 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 14.7 mttt -82.67 -13.28 56.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 112.178 -2.283 . . . . 0.0 111.797 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.08 -31.48 10.15 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.98 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 45' ' ' GLY . . . . . 0.47 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -170.88 -161.99 22.46 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -102.74 133.7 47.35 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 121.823 0.821 . . . . 0.0 110.543 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 47' ' ' ILE . . . . . 0.434 HD11 ' C ' ' 1' ' 41' ' ' PHE . 4.1 mt -107.43 138.92 31.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 113.069 -1.878 . . . . 0.0 111.604 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -87.63 -42.38 12.73 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.317 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -164.01 157.86 18.9 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.596 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 50' ' ' CYS . . . . . 0.462 ' H ' HH21 ' 1' ' 38' ' ' ARG . 43.9 t -136.79 149.11 47.59 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.609 0.763 . . . . 0.0 109.443 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 26.3 ttt -145.71 133.9 21.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.653 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 57.3 t -129.23 126.76 64.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 113.859 -1.519 . . . . 0.0 108.693 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 1.3 mmt -71.72 117.28 13.1 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.205 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -131.8 159.72 37.67 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.259 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.48 118.14 55.34 Favored Pre-proline 0 N--CA 1.44 -0.937 0 C-N-CA 123.231 0.612 . . . . 0.0 110.551 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -62.41 -9.27 14.91 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 122.501 2.134 . . . . 0.0 113.845 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 18.3 p -81.74 -44.04 17.57 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 74.5 p -117.68 -9.4 10.75 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.348 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 45.3 mmtt 62.9 12.42 5.78 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.371 1.069 . . . . 0.0 111.863 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -89.78 147.47 23.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.6 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 51.1 p -87.88 156.67 19.25 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.407 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -92.62 -7.56 46.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.819 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.25 20.81 34.37 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-O 119.83 -0.428 . . . . 0.0 113.933 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -148.72 154.88 40.23 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 117.107 0.454 . . . . 0.0 111.226 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.76 -169.65 29.65 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 66' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' 1' ' 23' ' ' MET . 75.6 m-85 -136.67 163.99 29.29 Favored 'General case' 0 N--CA 1.424 -1.751 0 C-N-CA 124.719 1.208 . . . . 0.0 109.853 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 67' ' ' VAL . . . . . . . . . . . . . 69.1 t -147.38 131.86 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 68' ' ' THR . . . . . 0.727 HG23 ' HG3' ' 1' ' 22' ' ' LYS . 1.2 m -105.82 106.09 16.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.722 -1.581 . . . . 0.0 111.744 -177.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -84.09 124.97 31.67 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.677 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.17 4.46 17.36 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 71' ' ' ASP . . . . . 0.616 ' OD2' ' HB3' ' 1' ' 73' ' ' ALA . 13.6 t0 -130.16 132.35 24.02 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.525 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.6 -16.45 24.0 Favored 'Trans proline' 0 C--N 1.36 1.172 0 C-N-CA 121.971 1.78 . . . . 0.0 111.918 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 73' ' ' ALA . . . . . 0.616 ' HB3' ' OD2' ' 1' ' 71' ' ' ASP . . . -77.64 -30.79 52.37 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.929 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 74' ' ' SER . . . . . 0.479 ' O ' HG23 ' 1' ' 78' ' ' VAL . 3.6 t -70.07 -32.21 70.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.24 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 75' ' ' VAL . . . . . 0.657 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 11.5 t -70.13 -31.89 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.583 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -70.8 -41.9 71.0 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.132 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 77' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -65.82 -40.51 91.89 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.862 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 78' ' ' VAL . . . . . 0.479 HG23 ' O ' ' 1' ' 74' ' ' SER . 99.8 t -77.69 -32.28 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.117 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 79' ' ' LEU . . . . . 0.657 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.3 OUTLIER -61.95 -39.47 92.23 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.55 0.74 . . . . 0.0 111.912 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 80' ' ' GLY . . . . . 0.474 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -74.52 -22.41 77.36 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.423 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -100.62 98.18 7.76 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 123.089 0.555 . . . . 0.0 110.267 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 82' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 4.2 Cg_exo -77.65 -31.99 3.02 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.805 2.337 . . . . 0.0 114.132 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -84.82 125.27 32.45 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.871 0.367 . . . . 0.0 111.782 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -137.6 122.01 18.29 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.805 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -113.64 135.0 54.4 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 122.132 0.968 . . . . 0.0 111.162 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 86' ' ' LEU . . . . . 0.572 HD21 ' OG1' ' 1' ' 32' ' ' THR . 6.2 tp -145.25 134.16 22.47 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 112.925 -1.943 . . . . 0.0 107.26 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 10.8 t70 52.11 37.14 20.79 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 122.587 1.184 . . . . 0.0 111.832 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 66.4 m 68.96 10.22 7.81 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 112.865 -1.97 . . . . 0.0 112.03 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 10.1 pttp -126.16 152.2 46.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.044 0.926 . . . . 0.0 110.489 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.6 m -81.52 125.32 30.35 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 113.357 -1.747 . . . . 0.0 111.712 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 91' ' ' ILE . . . . . 0.717 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 49.7 pt -108.99 170.06 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 O-C-N 123.56 0.537 . . . . 0.0 110.166 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -112.32 80.7 3.55 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 93' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' 1' ' 91' ' ' ILE . 4.0 Cg_exo -83.43 122.86 3.27 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.168 1.912 . . . . 0.0 111.189 175.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 94' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -144.68 154.07 42.39 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.596 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 11.5 t -82.4 144.69 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.803 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.74 143.91 45.46 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -114.43 135.04 22.21 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.283 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -77.06 162.83 31.47 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.05 2.5 . . . . 0.0 113.311 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.76 150.7 23.42 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.585 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -109.3 160.12 16.4 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.574 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.33 176.26 9.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.136 0.574 . . . . 0.0 112.397 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -106.31 140.11 20.97 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.801 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -78.84 175.36 11.07 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.738 2.292 . . . . 0.0 113.425 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -85.78 153.75 22.07 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.699 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 20.7 mmt 57.3 135.55 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.53 1.132 . . . . 0.0 113.968 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.73 -56.37 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.529 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.6 m -103.22 106.31 16.79 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -100.84 -35.59 9.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.213 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 16.9 p -103.19 103.41 13.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.886 0.374 . . . . 0.0 111.764 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -102.92 140.64 36.92 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.023 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.561 -0.733 . . . . 0.0 111.131 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 44.1 mtt . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -136.62 -38.42 0.66 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.285 0.366 . . . . 0.0 111.982 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -88.89 -43.83 10.9 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -97.31 -40.77 8.58 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.256 0.347 . . . . 0.0 111.822 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -108.46 137.99 45.5 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.288 0.368 . . . . 0.0 111.098 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -126.43 130.8 51.4 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.936 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -118.88 117.46 28.92 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.183 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 55.0 m -130.05 157.23 42.94 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.848 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -80.63 119.2 22.95 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.851 0.46 . . . . 0.0 111.345 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -95.13 142.25 27.81 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.786 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 20.7 t -114.8 -50.44 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.277 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.32 147.87 24.56 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.132 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 9' ' ' LEU . . . . . 0.431 HD23 ' N ' ' 1' ' 10' ' ' GLY . 0.4 OUTLIER -89.76 163.67 14.98 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.148 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 10' ' ' GLY . . . . . 0.431 ' N ' HD23 ' 1' ' 9' ' ' LEU . . . -126.91 70.62 0.49 Allowed Glycine 0 C--N 1.339 0.749 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.468 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -120.27 -5.4 9.92 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.595 0.358 . . . . 0.0 111.036 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -97.0 -57.45 2.27 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.691 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.41 14.26 1.64 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.137 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 14' ' ' LEU . . . . . 0.409 HD13 ' O ' ' 1' ' 10' ' ' GLY . 4.2 tp -82.27 149.63 27.72 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.622 0.369 . . . . 0.0 111.497 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -90.56 152.53 20.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.253 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.71 -43.79 0.19 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.026 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -86.05 123.11 31.0 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.385 0.428 . . . . 0.0 110.972 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 49.0 m -100.41 124.73 46.29 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.449 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -142.74 -56.0 0.42 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.621 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -91.33 148.53 22.27 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.45 0.469 . . . . 0.0 111.32 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.86 -2.94 17.28 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.773 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 22' ' ' LYS . . . . . 0.666 ' HG3' HG23 ' 1' ' 68' ' ' THR . 43.7 mttt -85.62 152.26 23.26 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 23' ' ' MET . . . . . 0.493 ' SD ' HG11 ' 1' ' 78' ' ' VAL . 2.6 mtm -122.95 126.27 46.88 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.999 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -91.34 108.15 19.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.933 -1.485 . . . . 0.0 108.694 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -95.29 115.66 34.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.504 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 26' ' ' GLY . . . . . 0.649 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -108.86 160.41 13.63 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.7 -1.136 . . . . 0.0 114.688 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 27' ' ' GLY . . . . . 0.637 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 69.14 22.66 76.14 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 115.249 0.859 . . . . 0.0 115.249 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 22.7 mt -55.87 168.71 0.43 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 117.703 0.752 . . . . 0.0 110.781 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 29' ' ' SER . . . . . 0.429 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 4.5 t -98.83 174.24 6.48 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.577 0.703 . . . . 0.0 110.307 -178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 30' ' ' TRP . . . . . 0.46 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 0.9 OUTLIER -72.08 -15.45 62.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.466 -179.484 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -100.35 -24.91 14.4 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.111 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 32' ' ' THR . . . . . 0.647 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 0.7 OUTLIER -67.53 113.66 5.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -179.015 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 33' ' ' SER . . . . . 0.447 ' H ' ' HB3' ' 1' ' 36' ' ' SER . 57.7 m -104.89 160.3 26.45 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.98 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 34' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.06 -25.64 55.34 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.138 1.892 . . . . 0.0 112.531 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.96 -34.76 38.47 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.929 178.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 36' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' 1' ' 40' ' ' TYR . 16.9 t -70.49 -35.73 73.41 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 114.22 -1.354 . . . . 0.0 109.441 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 37' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.7 mt -73.03 -37.33 66.94 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 123.736 0.814 . . . . 0.0 110.303 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 38' ' ' ARG . . . . . 0.529 ' HE ' ' HB3' ' 1' ' 50' ' ' CYS . 14.6 ttm180 -70.54 -41.34 72.65 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.695 177.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -40.11 83.22 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.716 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 40' ' ' TYR . . . . . 0.709 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 3.3 t80 -71.89 -51.05 24.17 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 122.682 0.393 . . . . 0.0 111.645 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 41' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' 1' ' 37' ' ' LEU . 27.6 m-85 -71.42 -25.51 62.36 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 42' ' ' SER . . . . . 0.412 ' OG ' HD12 ' 1' ' 47' ' ' ILE . 3.1 m -62.75 -14.05 40.11 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 122.444 1.116 . . . . 0.0 109.621 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 43' ' ' LYS . . . . . 0.709 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 14.1 mmtt -82.04 -13.7 56.96 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 112.222 -2.263 . . . . 0.0 111.676 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.87 -32.08 10.84 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.92 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 45' ' ' GLY . . . . . 0.495 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -173.03 -159.08 19.0 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -103.22 133.03 48.99 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.713 0.768 . . . . 0.0 110.635 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 47' ' ' ILE . . . . . 0.431 HD11 ' C ' ' 1' ' 41' ' ' PHE . 4.4 mt -104.71 140.03 23.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 113.186 -1.825 . . . . 0.0 111.494 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -88.08 -43.22 11.84 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.005 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -165.6 157.5 14.67 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.265 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 50' ' ' CYS . . . . . 0.589 ' SG ' HG22 ' 1' ' 67' ' ' VAL . 53.0 t -135.78 149.86 49.28 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.261 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 26.8 ttt -146.16 133.53 20.71 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.023 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 56.3 t -129.83 125.87 61.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.148 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -69.63 122.33 18.9 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.816 -178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -136.85 154.9 50.39 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.643 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.51 115.05 65.83 Favored Pre-proline 0 N--CA 1.445 -0.725 0 C-N-CA 122.849 0.46 . . . . 0.0 111.019 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.6 -8.31 7.03 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.889 2.393 . . . . 0.0 114.573 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 19.6 p -80.82 -44.58 18.25 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 80.5 p -129.1 -8.09 4.85 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.347 0.405 . . . . 0.0 112.077 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.23 53.32 6.62 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 122.597 1.189 . . . . 0.0 112.184 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -110.64 136.35 49.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.121 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 75.1 m -89.62 150.33 22.43 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.3 0.375 . . . . 0.0 111.183 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -98.57 -10.77 22.93 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.87 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.08 32.24 8.55 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 119.812 -0.438 . . . . 0.0 113.777 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -151.82 149.37 28.93 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.983 0.391 . . . . 0.0 110.995 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.92 -169.33 27.28 Favored Glycine 0 N--CA 1.427 -1.908 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 66' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -136.5 162.5 32.9 Favored 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 125.117 1.367 . . . . 0.0 109.456 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 67' ' ' VAL . . . . . 0.589 HG22 ' SG ' ' 1' ' 50' ' ' CYS . 74.3 t -149.28 129.39 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 68' ' ' THR . . . . . 0.666 HG23 ' HG3' ' 1' ' 22' ' ' LYS . 1.5 m -104.64 107.23 18.08 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 113.353 -1.749 . . . . 0.0 111.922 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -83.44 122.08 28.03 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.867 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.98 2.85 16.29 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 71' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -129.42 134.33 26.12 Favored Pre-proline 0 C--N 1.311 -1.081 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.485 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -73.19 -16.2 25.23 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.107 1.871 . . . . 0.0 111.622 176.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 73' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' 1' ' 77' ' ' LYS . . . -75.42 -32.13 60.61 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.795 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 74' ' ' SER . . . . . 0.495 ' OG ' ' HA3' ' 1' ' 45' ' ' GLY . 4.0 t -69.86 -31.81 69.86 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.156 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 75' ' ' VAL . . . . . 0.694 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 14.2 t -69.89 -31.93 49.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.392 178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.17 -41.69 70.04 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.983 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 77' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' 1' ' 73' ' ' ALA . 87.4 mttt -65.82 -41.57 91.66 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.728 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 78' ' ' VAL . . . . . 0.493 HG11 ' SD ' ' 1' ' 23' ' ' MET . 98.8 t -75.72 -31.75 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.754 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 79' ' ' LEU . . . . . 0.694 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.2 OUTLIER -62.39 -37.29 85.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.001 0.921 . . . . 0.0 112.115 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 80' ' ' GLY . . . . . 0.569 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -76.7 -27.58 60.69 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.963 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -105.74 88.61 2.95 Favored Pre-proline 0 N--CA 1.444 -0.764 0 C-N-CA 123.212 0.605 . . . . 0.0 110.342 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 82' ' ' PRO . . . . . 0.569 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 2.9 Cg_exo -76.64 -19.91 14.16 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.719 2.28 . . . . 0.0 113.775 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -87.81 124.47 33.66 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.209 0.318 . . . . 0.0 111.046 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -135.91 122.64 21.06 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -113.19 134.39 54.6 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.762 0.792 . . . . 0.0 110.266 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 86' ' ' LEU . . . . . 0.647 HD21 ' OG1' ' 1' ' 32' ' ' THR . 8.8 tp -143.17 131.83 22.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 113.349 -1.751 . . . . 0.0 107.464 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 12.8 t70 51.77 37.1 19.49 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.632 1.205 . . . . 0.0 111.492 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 74.5 m 69.67 8.95 7.0 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 112.833 -1.985 . . . . 0.0 112.219 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -121.85 152.19 39.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 122.014 0.911 . . . . 0.0 110.38 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.3 m -82.25 124.41 29.92 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.25 -1.795 . . . . 0.0 111.744 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 91' ' ' ILE . . . . . 0.649 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 43.1 pt -109.9 170.27 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.986 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 92' ' ' ASP . . . . . 0.466 ' OD1' ' HE2' ' 1' ' 94' ' ' LYS . 8.0 t70 -116.59 83.05 13.18 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -83.0 123.46 3.58 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 121.952 1.768 . . . . 0.0 110.825 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 94' ' ' LYS . . . . . 0.466 ' HE2' ' OD1' ' 1' ' 92' ' ' ASP . 18.5 mmtt -136.53 146.81 46.62 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 t -92.62 121.95 43.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.235 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . 53.5 169.5 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -99.5 108.16 49.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.861 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -81.14 152.05 18.35 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.676 2.251 . . . . 0.0 113.55 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -110.73 131.44 55.05 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.662 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -122.67 135.29 54.55 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.391 0.432 . . . . 0.0 111.233 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -91.16 172.39 8.59 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 123.589 0.555 . . . . 0.0 111.956 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -109.61 143.84 28.64 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.211 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.93 175.83 10.69 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.695 2.263 . . . . 0.0 112.982 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -88.81 127.18 35.61 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.27 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -102.76 116.88 33.44 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.931 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 26.4 t -105.79 -57.4 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.752 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.5 m -96.09 96.06 8.59 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.579 0.549 . . . . 0.0 109.813 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -87.37 136.57 32.89 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.566 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 14.6 p -111.87 -45.74 3.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.158 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -85.16 142.17 29.66 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.39 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 56.6 pttt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.037 -0.982 . . . . 0.0 111.032 179.721 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 14.1 ttm . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -108.09 135.46 49.41 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.894 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 71.3 m80 59.29 130.14 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.281 1.032 . . . . 0.0 113.097 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -115.56 149.25 38.5 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.701 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -115.43 151.76 34.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.935 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -98.71 132.82 43.79 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.85 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -123.27 144.39 49.44 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.95 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 44.9 p -108.27 -52.38 2.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.609 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 4.3 t -105.67 103.35 12.84 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.438 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -102.33 140.74 36.21 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.857 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 10.4 t -100.09 133.14 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.203 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -84.26 121.55 27.65 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.368 0.418 . . . . 0.0 112.042 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 tp -94.98 153.8 17.48 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.491 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.31 75.37 0.3 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 121.067 -0.587 . . . . 0.0 113.1 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 5.2 t -135.96 -10.2 2.04 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.313 0.245 . . . . 0.0 111.323 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -94.75 -49.0 5.8 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.331 0.395 . . . . 0.0 111.375 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.39 20.84 0.66 Allowed 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.822 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 tp -76.84 151.46 35.87 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.819 0.448 . . . . 0.0 111.678 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -85.82 131.58 34.28 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.413 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -146.2 55.9 1.17 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.494 0.664 . . . . 0.0 109.723 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -85.3 130.89 34.5 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.082 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 75.4 m -104.01 142.61 34.15 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.82 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -107.51 -58.11 2.0 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.631 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.98 122.78 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.471 1.108 . . . . 0.0 113.511 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.73 5.64 0.12 Allowed Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.978 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 22' ' ' LYS . . . . . 0.751 ' HB3' HG23 ' 1' ' 68' ' ' THR . 28.4 pttt -91.32 174.03 7.6 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.537 0.208 . . . . 0.0 111.276 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 23' ' ' MET . . . . . 0.402 ' O ' ' HA ' ' 1' ' 66' ' ' PHE . 12.5 mtp -123.06 152.47 40.97 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.651 0.739 . . . . 0.0 110.967 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -104.91 107.1 17.89 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.403 -1.726 . . . . 0.0 107.78 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -96.03 116.31 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 123.098 0.559 . . . . 0.0 110.304 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 26' ' ' GLY . . . . . 0.695 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -108.52 161.34 13.33 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.17 -0.923 . . . . 0.0 115.039 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 27' ' ' GLY . . . . . 0.654 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 69.8 21.03 76.44 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 27.2 mt -54.46 169.05 0.21 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 117.601 0.701 . . . . 0.0 111.35 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 29' ' ' SER . . . . . 0.4 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 5.7 t -100.89 174.22 6.13 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 121.538 0.685 . . . . 0.0 110.467 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 30' ' ' TRP . . . . . 0.488 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.8 p-90 -72.34 -16.4 61.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.423 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -100.12 -24.85 14.48 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.236 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 32' ' ' THR . . . . . 0.683 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 1.2 m -68.89 113.76 6.6 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.446 0.641 . . . . 0.0 112.557 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 33' ' ' SER . . . . . . . . . . . . . 62.7 m -103.76 160.95 24.46 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.014 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 34' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' 1' ' 38' ' ' ARG . 14.1 Cg_endo -56.33 -25.41 56.7 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.077 1.851 . . . . 0.0 112.257 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.87 -33.36 40.13 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.984 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 36' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' 1' ' 40' ' ' TYR . 16.9 t -70.64 -36.79 73.62 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.078 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 37' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.8 mt -73.15 -35.67 66.52 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 124.134 0.974 . . . . 0.0 110.443 178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 38' ' ' ARG . . . . . 0.646 ' O ' ' HB2' ' 1' ' 42' ' ' SER . 10.7 ttp180 -72.88 -38.43 66.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.791 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -39.44 71.69 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.679 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 40' ' ' TYR . . . . . 0.718 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 6.0 t80 -71.7 -51.65 21.88 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 122.743 0.417 . . . . 0.0 111.673 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 41' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' 1' ' 37' ' ' LEU . 29.8 m-85 -71.15 -25.64 62.65 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 42' ' ' SER . . . . . 0.646 ' HB2' ' O ' ' 1' ' 38' ' ' ARG . 8.3 t -65.49 -14.38 60.87 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 122.481 1.134 . . . . 0.0 109.547 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 43' ' ' LYS . . . . . 0.718 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 6.2 mmtp -81.33 -12.74 58.94 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 112.339 -2.209 . . . . 0.0 111.605 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -106.02 -33.92 7.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.068 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 45' ' ' GLY . . . . . 0.448 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -164.79 -162.2 15.34 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -105.26 133.72 49.56 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.851 0.834 . . . . 0.0 110.477 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 47' ' ' ILE . . . . . 0.419 HD11 ' C ' ' 1' ' 41' ' ' PHE . 4.2 mt -106.3 139.55 27.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 113.15 -1.841 . . . . 0.0 111.498 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -87.52 -41.14 13.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.233 -1.348 . . . . 0.0 109.888 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -166.23 156.46 12.37 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.515 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 50' ' ' CYS . . . . . . . . . . . . . 40.1 t -132.72 150.63 52.13 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.296 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 60.9 ttp -144.7 134.24 23.33 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.921 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.67 126.05 62.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 113.728 -1.578 . . . . 0.0 108.285 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 1.5 mmt -70.62 111.47 6.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.949 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -137.1 154.02 50.4 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.087 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.56 113.45 65.83 Favored Pre-proline 0 N--CA 1.444 -0.744 0 C-N-CA 122.596 0.358 . . . . 0.0 110.917 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.16 -8.62 8.59 Favored 'Trans proline' 0 C--N 1.365 1.426 0 C-N-CA 122.518 2.145 . . . . 0.0 114.386 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 17.9 p -81.25 -44.09 18.25 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 73.8 p -124.7 -8.49 7.34 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.229 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 5.2 mptt 56.68 53.28 8.56 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.777 1.275 . . . . 0.0 112.216 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -104.02 136.27 43.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 112.665 -2.061 . . . . 0.0 110.872 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 61.3 m -96.56 136.77 36.6 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.97 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -93.96 -9.09 38.14 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.47 29.95 17.57 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 114.393 0.517 . . . . 0.0 114.393 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -153.65 149.67 27.8 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.193 0.496 . . . . 0.0 111.295 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.2 -167.33 21.51 Favored Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 66' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' 1' ' 23' ' ' MET . 74.6 m-85 -138.34 161.96 35.59 Favored 'General case' 0 N--CA 1.424 -1.759 0 C-N-CA 124.988 1.315 . . . . 0.0 109.703 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 67' ' ' VAL . . . . . . . . . . . . . 70.3 t -145.29 129.01 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 68' ' ' THR . . . . . 0.751 HG23 ' HB3' ' 1' ' 22' ' ' LYS . 1.1 m -103.64 106.42 16.93 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 113.493 -1.685 . . . . 0.0 111.882 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -84.75 124.11 31.17 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.679 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.98 2.07 9.49 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -129.88 135.07 26.92 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.196 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.4 -16.52 24.51 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 121.972 1.781 . . . . 0.0 111.987 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 73' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' 1' ' 77' ' ' LYS . . . -77.47 -32.19 54.22 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.596 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 74' ' ' SER . . . . . 0.448 ' OG ' ' HA3' ' 1' ' 45' ' ' GLY . 3.0 t -69.97 -32.57 70.86 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.326 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 75' ' ' VAL . . . . . 0.741 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 5.7 t -70.44 -32.5 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.658 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -72.26 -41.83 66.3 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.088 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 77' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' 1' ' 73' ' ' ALA . 45.4 mttm -68.1 -39.0 82.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 113.748 -1.569 . . . . 0.0 112.505 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 78' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.86 -32.28 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.397 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 79' ' ' LEU . . . . . 0.741 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.8 OUTLIER -66.79 -31.92 72.88 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 122.499 0.32 . . . . 0.0 110.8 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 80' ' ' GLY . . . . . 0.512 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -74.43 -14.66 80.77 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.466 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -95.44 99.93 5.31 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 122.748 0.419 . . . . 0.0 110.592 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 82' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 4.6 Cg_exo -77.25 -34.67 2.0 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.6 2.2 . . . . 0.0 113.565 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -90.91 122.1 33.32 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.282 0.364 . . . . 0.0 111.077 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -139.52 122.45 16.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.058 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -114.58 134.6 54.92 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.003 0.906 . . . . 0.0 110.886 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 86' ' ' LEU . . . . . 0.683 HD21 ' OG1' ' 1' ' 32' ' ' THR . 8.4 tp -143.75 132.93 23.06 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.043 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t70 51.46 36.84 17.76 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.683 1.23 . . . . 0.0 111.526 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 10.2 t 69.5 8.89 7.01 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 112.69 -2.05 . . . . 0.0 112.206 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 25.8 pttt -121.79 152.06 39.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.022 0.915 . . . . 0.0 110.392 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.0 m -81.06 124.03 28.86 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.26 -1.791 . . . . 0.0 111.573 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 91' ' ' ILE . . . . . 0.695 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 28.2 pt -111.1 168.85 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.032 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -117.06 86.9 21.1 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -83.43 123.96 3.53 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 122.254 1.969 . . . . 0.0 111.363 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 144.19 23.27 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.581 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 3.9 t -70.53 141.36 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.813 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.15 156.95 25.47 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.697 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -110.19 129.84 23.5 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.144 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -71.0 171.6 15.49 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.734 2.289 . . . . 0.0 113.014 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -93.61 -13.21 27.91 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -97.58 124.93 42.03 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.48 170.08 11.2 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -120.38 153.98 56.27 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.759 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.86 177.92 8.22 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.301 2.0 . . . . 0.0 113.155 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.94 140.98 32.49 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.726 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 21.5 mmt -95.97 135.11 38.15 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.198 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 27.2 t -112.12 -58.54 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.3 m -100.53 95.34 6.65 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.531 0.52 . . . . 0.0 109.846 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -94.74 147.6 23.15 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.645 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 12.3 p -95.75 146.85 24.2 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.322 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -109.07 -42.44 4.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.439 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 66.1 mttm . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.459 -0.781 . . . . 0.0 111.614 -179.891 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.485 0.184 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -98.44 153.5 18.54 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.228 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.99 136.74 43.06 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.017 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -132.97 136.94 46.37 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.613 0.57 . . . . 0.0 111.039 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -108.53 136.58 47.9 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.808 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -131.91 148.53 52.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.788 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -100.98 129.98 46.91 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.082 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 16.3 t -95.72 133.86 39.32 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.896 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 5.1 t -127.27 -50.03 1.42 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.493 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 68.6 m -96.98 130.73 44.26 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.445 0.466 . . . . 0.0 111.08 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 7.5 t -97.21 122.32 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.328 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -88.22 139.64 30.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.065 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 15.8 mt -88.87 -177.77 5.58 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.785 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.28 70.8 0.15 Allowed Glycine 0 C--N 1.34 0.785 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.199 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 61.6 p -127.91 -20.11 3.91 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.709 0.299 . . . . 0.0 111.115 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -95.16 -41.93 8.84 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.456 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -79.49 37.6 0.34 Allowed 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.915 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 tp -83.17 157.9 22.56 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.248 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -85.88 -12.19 51.32 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -77.85 -3.03 39.53 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -85.72 132.37 34.15 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.279 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 50.0 m -89.12 146.63 24.68 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.5 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -128.84 -44.37 1.33 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.95 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.5 152.63 30.1 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.991 0.516 . . . . 0.0 111.641 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.88 -1.89 17.4 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.224 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 22' ' ' LYS . . . . . 0.605 ' HG3' HG23 ' 1' ' 68' ' ' THR . 43.5 mttt -80.82 149.85 29.4 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 23' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' 1' ' 66' ' ' PHE . 5.8 mtp -120.66 127.56 52.17 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.057 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -91.52 105.92 18.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.846 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 mm -96.13 111.45 26.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.481 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 26' ' ' GLY . . . . . 0.694 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -103.35 159.16 17.15 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 115.485 0.954 . . . . 0.0 115.485 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 27' ' ' GLY . . . . . 0.67 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 70.01 26.14 74.69 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 17.0 mt -58.16 170.61 0.65 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 117.764 0.782 . . . . 0.0 111.169 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 29' ' ' SER . . . . . 0.417 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 4.5 t -99.42 174.48 6.26 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.568 0.699 . . . . 0.0 110.531 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 30' ' ' TRP . . . . . 0.472 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.5 p-90 -71.34 -16.9 62.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.515 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -99.1 -24.53 14.85 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.218 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 32' ' ' THR . . . . . 0.579 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 0.7 OUTLIER -64.74 113.95 4.12 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 33' ' ' SER . . . . . 0.459 ' H ' ' HB3' ' 1' ' 36' ' ' SER . 58.2 m -105.95 159.6 29.06 Favored Pre-proline 0 N--CA 1.467 0.378 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.977 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 34' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -56.65 -25.88 62.08 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.015 1.81 . . . . 0.0 112.557 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.29 -32.96 38.05 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.947 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 36' ' ' SER . . . . . 0.459 ' HB3' ' H ' ' 1' ' 33' ' ' SER . 16.7 t -70.69 -36.0 73.08 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.239 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 37' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.5 mt -72.96 -37.95 66.9 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 123.829 0.851 . . . . 0.0 110.148 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 38' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -68.81 -43.69 75.1 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.569 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.6 -40.15 88.74 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.871 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 40' ' ' TYR . . . . . 0.708 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 6.8 t80 -71.81 -51.0 24.73 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 122.651 0.381 . . . . 0.0 111.553 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 41' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' 1' ' 37' ' ' LEU . 23.3 m-85 -71.37 -25.7 62.48 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 42' ' ' SER . . . . . 0.471 ' OG ' HD12 ' 1' ' 47' ' ' ILE . 3.3 m -63.61 -13.96 47.09 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 122.458 1.123 . . . . 0.0 109.71 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 43' ' ' LYS . . . . . 0.708 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 6.4 mmtp -80.47 -11.89 59.62 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 112.33 -2.214 . . . . 0.0 111.625 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.84 -33.89 9.19 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.002 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 45' ' ' GLY . . . . . 0.43 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -170.59 -159.77 17.39 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -102.16 133.17 47.45 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.885 0.85 . . . . 0.0 110.571 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 47' ' ' ILE . . . . . 0.471 HD12 ' OG ' ' 1' ' 42' ' ' SER . 5.0 mt -104.99 138.94 27.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 113.017 -1.901 . . . . 0.0 111.403 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -87.96 -42.21 12.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.11 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -163.95 157.58 18.72 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.198 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 50' ' ' CYS . . . . . 0.458 ' SG ' HG22 ' 1' ' 67' ' ' VAL . 41.3 t -137.38 149.52 47.02 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 123.551 0.74 . . . . 0.0 109.287 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 61.8 ttp -146.84 136.9 23.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.138 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 91.9 t -126.27 123.87 64.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.573 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 1.2 mmt -75.4 124.33 26.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.408 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -136.61 158.4 44.54 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.277 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.15 118.21 56.55 Favored Pre-proline 0 N--CA 1.44 -0.951 0 C-N-CA 122.749 0.419 . . . . 0.0 110.826 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -64.06 -9.53 19.71 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 122.437 2.092 . . . . 0.0 113.541 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 18.7 p -81.99 -44.2 17.0 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 77.0 p -118.52 -9.18 10.35 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt 62.39 12.41 5.28 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.254 1.022 . . . . 0.0 111.927 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -92.81 143.06 26.65 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.392 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 38.1 m -94.79 154.82 17.09 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.894 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -97.87 -9.97 25.44 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.935 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.54 37.45 5.84 Favored Glycine 0 C--N 1.339 0.705 0 CA-C-O 119.766 -0.464 . . . . 0.0 114.032 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -153.47 151.94 30.42 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 117.134 0.467 . . . . 0.0 111.325 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.48 -169.69 22.26 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 66' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' 1' ' 23' ' ' MET . 83.0 m-85 -137.39 161.48 36.19 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 125.002 1.321 . . . . 0.0 109.808 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 67' ' ' VAL . . . . . 0.458 HG22 ' SG ' ' 1' ' 50' ' ' CYS . 74.0 t -147.65 132.28 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 68' ' ' THR . . . . . 0.605 HG23 ' HG3' ' 1' ' 22' ' ' LYS . 1.4 m -105.7 105.59 15.7 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.59 -1.641 . . . . 0.0 111.609 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -82.82 123.99 29.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.365 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.58 3.52 15.96 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 71' ' ' ASP . . . . . 0.606 ' OD2' ' HB3' ' 1' ' 73' ' ' ALA . 14.9 t0 -129.93 132.85 24.4 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.562 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.63 -16.3 24.01 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.04 1.827 . . . . 0.0 111.797 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 73' ' ' ALA . . . . . 0.606 ' HB3' ' OD2' ' 1' ' 71' ' ' ASP . . . -77.35 -30.9 54.1 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.83 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 74' ' ' SER . . . . . 0.493 ' O ' HG23 ' 1' ' 78' ' ' VAL . 4.1 t -70.05 -31.78 69.57 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.293 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 75' ' ' VAL . . . . . 0.644 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 6.4 t -70.09 -31.41 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.519 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -71.76 -40.79 69.09 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.985 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 77' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -66.01 -42.07 90.2 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.051 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 78' ' ' VAL . . . . . 0.493 HG23 ' O ' ' 1' ' 74' ' ' SER . 59.7 t -75.89 -32.48 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.128 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 79' ' ' LEU . . . . . 0.644 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.3 OUTLIER -64.13 -35.14 79.79 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.388 0.675 . . . . 0.0 111.726 179.143 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 80' ' ' GLY . . . . . 0.488 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -74.58 -20.31 79.59 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.253 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -99.63 98.28 6.84 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 122.961 0.504 . . . . 0.0 110.316 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 82' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 2.8 Cg_exo -76.51 -34.31 2.7 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.895 2.397 . . . . 0.0 113.979 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -88.48 125.16 34.62 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.689 0.281 . . . . 0.0 111.68 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -134.56 119.68 18.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -115.38 134.66 54.9 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.974 0.893 . . . . 0.0 110.649 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 86' ' ' LEU . . . . . 0.579 HD21 ' OG1' ' 1' ' 32' ' ' THR . 7.2 tp -145.08 134.24 22.76 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.19 -1.823 . . . . 0.0 107.199 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 10.7 t70 51.79 37.01 19.33 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.679 1.192 . . . . 0.0 111.827 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 66.3 m 68.95 9.75 7.57 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 112.914 -1.948 . . . . 0.0 111.963 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -123.99 152.14 42.89 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.995 0.902 . . . . 0.0 110.267 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.6 m -80.94 126.73 31.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.398 -1.728 . . . . 0.0 111.743 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 91' ' ' ILE . . . . . 0.694 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 43.4 pt -112.85 166.5 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 123.661 0.601 . . . . 0.0 109.612 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 92' ' ' ASP . . . . . 0.552 ' OD2' ' HD3' ' 1' ' 94' ' ' LYS . 6.1 t70 -114.92 91.46 26.55 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -175.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -82.91 124.01 3.78 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.357 2.038 . . . . 0.0 111.025 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 94' ' ' LYS . . . . . 0.552 ' HD3' ' OD2' ' 1' ' 92' ' ' ASP . 21.0 pttt -143.39 140.54 30.51 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.1 136.85 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.788 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . 51.17 164.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.31 121.6 52.89 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.657 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.14 155.48 25.78 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.625 2.217 . . . . 0.0 112.276 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -93.2 119.95 32.94 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.018 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -149.51 137.11 20.16 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.19 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.72 172.72 13.4 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.19 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -114.23 123.7 32.09 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.445 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.41 -178.59 4.57 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.508 2.139 . . . . 0.0 113.044 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.63 142.88 31.39 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.68 0.392 . . . . 0.0 111.314 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 22.5 mmt -92.1 130.96 37.71 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.575 0.547 . . . . 0.0 111.81 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.03 162.67 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.672 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.2 m -94.17 93.6 7.88 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.108 0.48 . . . . 0.0 110.758 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -101.57 132.88 46.98 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.508 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 7.4 t -101.84 144.94 29.87 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.915 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.6 -49.74 0.78 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.269 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 80.4 mttt . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.016 179.623 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 11.2 mmt . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.66 0.267 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 65.4 m80 62.79 139.6 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.285 1.034 . . . . 0.0 112.873 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -110.62 145.36 38.03 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.996 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -107.74 144.79 34.38 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.652 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -96.65 111.22 23.45 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.288 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -144.53 133.43 22.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.508 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -131.6 143.01 50.02 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.375 0.422 . . . . 0.0 111.589 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 43.3 p -133.98 -48.01 0.8 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.431 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 4.8 t -125.96 106.56 9.72 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.205 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 10.6 t -102.93 -15.32 16.19 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.109 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 t -95.21 109.12 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 123.357 0.411 . . . . 0.0 110.19 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -122.03 -47.27 2.17 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.809 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 pp -88.49 134.81 33.75 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.461 0.476 . . . . 0.0 111.138 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.55 72.84 0.29 Allowed Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.299 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 11' ' ' THR . . . . . 0.581 ' HA ' ' HB2' ' 1' ' 15' ' ' TYR . 10.0 t -144.03 8.25 1.44 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -102.77 -58.95 1.78 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.878 0.371 . . . . 0.0 111.724 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -79.51 -38.7 33.74 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.9 -46.04 9.23 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 15' ' ' TYR . . . . . 0.581 ' HB2' ' HA ' ' 1' ' 11' ' ' THR . 3.8 m-85 -88.41 132.62 34.38 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.102 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -145.2 -43.47 0.22 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.844 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -88.68 151.32 22.52 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 123.382 0.426 . . . . 0.0 111.517 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 66.7 m -89.06 156.58 18.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.493 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -100.73 -12.95 18.7 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.272 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.47 147.89 32.08 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.712 0.405 . . . . 0.0 111.97 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.79 -15.74 4.84 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.985 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 22' ' ' LYS . . . . . 0.741 ' HB3' HG23 ' 1' ' 68' ' ' THR . 13.6 pttt -100.26 173.65 6.51 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 123.561 0.212 . . . . 0.0 110.798 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 23' ' ' MET . . . . . . . . . . . . . 8.6 mtp -122.55 151.96 40.86 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 121.651 0.738 . . . . 0.0 111.178 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.55 108.29 19.73 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.471 -1.695 . . . . 0.0 107.875 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -96.58 120.21 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 123.387 0.675 . . . . 0.0 110.087 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 26' ' ' GLY . . . . . 0.739 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -113.57 160.1 13.33 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.019 -0.991 . . . . 0.0 114.876 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 27' ' ' GLY . . . . . 0.583 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 70.56 21.6 77.7 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 115.409 0.924 . . . . 0.0 115.409 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 mt -55.37 167.41 0.48 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 117.734 0.767 . . . . 0.0 111.338 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 29' ' ' SER . . . . . 0.413 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 5.8 t -100.46 174.72 5.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.448 0.642 . . . . 0.0 110.156 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 30' ' ' TRP . . . . . 0.476 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.6 p-90 -71.42 -16.85 62.41 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 124.753 1.221 . . . . 0.0 111.48 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -97.16 -24.52 15.69 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.216 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 32' ' ' THR . . . . . 0.544 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 0.4 OUTLIER -70.58 113.84 8.09 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.08 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 33' ' ' SER . . . . . 0.474 ' H ' ' HB3' ' 1' ' 36' ' ' SER . 75.3 m -105.77 160.09 27.3 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.059 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 34' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' 1' ' 38' ' ' ARG . 13.8 Cg_endo -56.38 -25.66 58.43 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.09 1.86 . . . . 0.0 112.37 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.84 -34.11 39.65 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.797 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 36' ' ' SER . . . . . 0.474 ' HB3' ' H ' ' 1' ' 33' ' ' SER . 15.1 t -71.02 -36.14 72.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.57 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 37' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.6 mt -73.01 -35.87 66.89 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 124.026 0.93 . . . . 0.0 110.254 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 38' ' ' ARG . . . . . 0.565 ' HE ' ' HB3' ' 1' ' 50' ' ' CYS . 13.2 ttm180 -72.39 -41.38 66.38 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.548 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.58 -38.74 80.92 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.756 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 40' ' ' TYR . . . . . 0.719 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 6.1 t80 -72.16 -51.82 19.48 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 122.549 0.34 . . . . 0.0 111.354 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 41' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' 1' ' 37' ' ' LEU . 37.1 m-85 -71.41 -24.98 62.14 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 42' ' ' SER . . . . . 0.412 ' OG ' HD12 ' 1' ' 47' ' ' ILE . 3.1 m -62.45 -14.24 38.81 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.483 1.135 . . . . 0.0 109.241 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 43' ' ' LYS . . . . . 0.719 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 7.0 mttm -85.03 -14.91 45.88 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 112.109 -2.314 . . . . 0.0 111.205 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.52 -31.6 11.19 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.925 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.42 -158.99 16.54 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -106.09 133.77 50.28 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.767 0.794 . . . . 0.0 110.404 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 47' ' ' ILE . . . . . 0.412 HD12 ' OG ' ' 1' ' 42' ' ' SER . 4.3 mt -107.92 140.46 26.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-N 113.217 -1.81 . . . . 0.0 111.713 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -92.82 -40.76 10.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.199 -1.364 . . . . 0.0 110.053 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -163.45 157.52 19.92 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.238 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 50' ' ' CYS . . . . . 0.594 ' SG ' HG22 ' 1' ' 67' ' ' VAL . 50.6 t -138.06 147.86 44.5 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.2 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 63.0 ttp -144.02 133.61 23.55 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.073 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.21 124.32 60.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 113.686 -1.597 . . . . 0.0 108.048 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 5.7 mmt -74.51 126.76 31.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.698 -1.137 . . . . 0.0 113.003 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 22.9 mtt180 -132.25 159.57 38.7 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.509 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.39 119.04 54.16 Favored Pre-proline 0 N--CA 1.441 -0.886 0 C-N-CA 122.885 0.474 . . . . 0.0 110.77 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.51 -10.25 23.53 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 122.353 2.035 . . . . 0.0 113.436 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 20.4 p -82.13 -44.34 16.6 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 74.0 p -116.29 -9.98 11.47 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt 62.54 11.89 5.05 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.416 1.086 . . . . 0.0 111.98 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 7.5 mmt85 -94.32 146.07 24.3 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.968 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 58.3 p -86.83 155.66 20.19 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.519 0.512 . . . . 0.0 111.465 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -94.87 -10.93 29.77 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.364 0.415 . . . . 0.0 111.959 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.7 32.98 8.17 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 116.387 -0.369 . . . . 0.0 113.518 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -150.94 152.61 33.85 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.753 0.277 . . . . 0.0 111.103 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.83 -169.5 30.51 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 66' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -137.52 161.81 35.41 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 125.19 1.396 . . . . 0.0 109.484 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 67' ' ' VAL . . . . . 0.594 HG22 ' SG ' ' 1' ' 50' ' ' CYS . 90.8 t -146.81 127.82 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 68' ' ' THR . . . . . 0.741 HG23 ' HB3' ' 1' ' 22' ' ' LYS . 0.8 OUTLIER -101.6 107.96 19.37 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 113.468 -1.696 . . . . 0.0 111.513 -177.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -83.72 122.85 29.19 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.074 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.47 3.34 9.47 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -131.34 134.84 26.18 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.135 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -72.93 -16.07 26.05 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 122.013 1.809 . . . . 0.0 111.792 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 73' ' ' ALA . . . . . 0.428 ' O ' ' HG3' ' 1' ' 77' ' ' LYS . . . -76.7 -28.8 56.02 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.103 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 74' ' ' SER . . . . . 0.571 ' O ' HG23 ' 1' ' 78' ' ' VAL . 5.9 t -69.69 -31.9 70.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.169 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 75' ' ' VAL . . . . . 0.695 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 13.8 t -70.44 -32.0 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.576 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -71.54 -40.82 69.79 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.037 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 77' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' 1' ' 73' ' ' ALA . 81.3 mttt -65.53 -42.16 92.3 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 113.825 -1.534 . . . . 0.0 112.134 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 78' ' ' VAL . . . . . 0.571 HG23 ' O ' ' 1' ' 74' ' ' SER . 32.6 t -77.28 -31.48 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.052 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 79' ' ' LEU . . . . . 0.695 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.2 OUTLIER -63.28 -35.96 82.1 Favored 'General case' 0 C--N 1.346 0.438 0 C-N-CA 123.915 0.886 . . . . 0.0 112.016 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 80' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -74.87 -27.75 64.09 Favored Glycine 0 C--N 1.346 1.087 0 O-C-N 123.62 0.575 . . . . 0.0 113.091 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -104.01 96.03 8.81 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.14 0.576 . . . . 0.0 110.064 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 82' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 3.8 Cg_exo -76.7 -31.55 4.09 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.781 2.321 . . . . 0.0 114.292 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -84.82 127.37 34.1 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.703 0.287 . . . . 0.0 111.464 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -138.65 125.65 21.25 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -113.06 134.59 54.46 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 121.946 0.879 . . . . 0.0 110.622 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 86' ' ' LEU . . . . . 0.544 HD21 ' OG1' ' 1' ' 32' ' ' THR . 7.6 tp -144.03 132.67 22.34 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.154 -1.839 . . . . 0.0 107.208 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t70 52.13 36.98 20.43 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 122.712 1.244 . . . . 0.0 111.529 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 62.6 m 68.49 9.68 7.42 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.747 -2.024 . . . . 0.0 112.122 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -122.87 152.42 40.78 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.071 0.939 . . . . 0.0 110.49 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.4 m -82.17 122.46 27.91 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.45 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 91' ' ' ILE . . . . . 0.739 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 21.3 pt -109.38 171.55 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.372 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 92' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -114.04 81.35 6.11 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 93' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' 1' ' 91' ' ' ILE . 4.5 Cg_exo -83.48 123.66 3.43 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 121.988 1.792 . . . . 0.0 110.987 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.56 150.72 31.59 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.24 141.69 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.118 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.98 150.98 40.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.255 0.622 . . . . 0.0 112.641 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -106.0 115.64 60.95 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.306 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.31 175.16 11.7 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.716 2.277 . . . . 0.0 112.93 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -99.34 -37.79 9.1 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.442 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -95.79 153.84 17.53 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.222 0.326 . . . . 0.0 110.96 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.37 170.79 14.17 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 123.535 0.522 . . . . 0.0 112.253 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -123.77 139.79 33.03 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.982 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.69 178.03 7.93 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.461 2.107 . . . . 0.0 113.0 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -82.03 127.33 32.97 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.585 0.354 . . . . 0.0 111.304 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 82.5 mtp -93.87 146.66 23.74 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.341 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 2.7 t -97.36 161.48 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.554 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.3 m -97.03 97.22 9.05 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.117 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -91.08 149.21 21.91 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.953 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 16.1 p -143.5 -34.74 0.4 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.431 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -80.21 -32.29 38.56 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.858 0.463 . . . . 0.0 112.16 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 96.2 mttt . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.066 -0.969 . . . . 0.0 111.487 179.959 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 48.6 mtt . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -96.75 136.62 37.03 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.342 0.401 . . . . 0.0 111.34 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -127.47 -41.7 1.7 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.842 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -112.38 139.76 47.67 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.729 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -101.77 139.2 37.73 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.048 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -118.85 141.58 48.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.599 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -107.01 141.95 37.41 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.579 0.549 . . . . 0.0 111.188 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 52.0 m -95.68 145.25 25.42 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.017 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 6.9 t -96.55 125.63 41.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.117 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 60.5 m -113.45 -18.23 12.04 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.963 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 t -92.94 107.39 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 123.434 0.459 . . . . 0.0 109.991 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -88.5 149.89 23.4 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.351 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 tp -89.15 153.41 20.97 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.986 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.19 71.84 0.38 Allowed Glycine 0 C--N 1.339 0.745 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.616 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 64.0 p -114.36 -21.57 10.32 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.384 0.274 . . . . 0.0 111.367 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -108.71 -41.85 4.67 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.867 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.79 9.39 2.88 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.11 156.65 24.41 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.57 0.224 . . . . 0.0 111.551 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -84.18 161.48 20.55 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.581 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -142.62 -42.81 0.32 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.075 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -83.76 155.49 23.02 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.18 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -114.23 -9.01 12.9 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.22 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -98.11 -16.43 19.55 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.02 150.38 27.62 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.662 0.385 . . . . 0.0 111.645 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.1 1.4 29.98 Favored Glycine 0 C--N 1.34 0.797 0 O-C-N 123.569 0.543 . . . . 0.0 113.816 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 22' ' ' LYS . . . . . 0.772 ' HG3' HG23 ' 1' ' 68' ' ' THR . 39.2 mttt -78.4 162.84 26.13 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 23' ' ' MET . . . . . 0.448 ' SD ' HG11 ' 1' ' 78' ' ' VAL . 2.4 ttm -128.98 151.4 49.73 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.166 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -120.18 109.61 15.63 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 125.159 1.384 . . . . 0.0 108.295 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 25' ' ' ILE . . . . . 0.408 HD12 ' CZ ' ' 1' ' 41' ' ' PHE . 0.9 OUTLIER -98.51 116.44 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.444 -178.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 26' ' ' GLY . . . . . 0.684 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -105.21 157.57 16.36 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.741 -1.118 . . . . 0.0 114.612 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 27' ' ' GLY . . . . . 0.654 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 72.0 21.17 79.18 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 177.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 25.7 mt -54.94 168.42 0.3 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.895 0.847 . . . . 0.0 111.101 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 29' ' ' SER . . . . . 0.401 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 4.1 t -100.25 174.4 6.15 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.684 0.754 . . . . 0.0 110.381 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 30' ' ' TRP . . . . . 0.474 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.7 p-90 -72.22 -16.08 61.94 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.532 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -98.41 -25.06 14.93 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.22 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 32' ' ' THR . . . . . 0.628 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 0.6 OUTLIER -68.45 113.63 6.17 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.514 0.673 . . . . 0.0 112.686 -179.03 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 33' ' ' SER . . . . . 0.453 ' H ' ' HB3' ' 1' ' 36' ' ' SER . 25.3 p -103.4 159.82 28.1 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.253 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 34' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.44 -25.7 49.95 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.061 1.841 . . . . 0.0 112.54 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.19 -33.94 37.84 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.068 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 36' ' ' SER . . . . . 0.453 ' HB3' ' H ' ' 1' ' 33' ' ' SER . 19.4 t -70.49 -35.23 73.13 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.04 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 37' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.5 mt -72.57 -40.37 66.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.176 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 38' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -67.2 -42.54 83.97 Favored 'General case' 0 C--N 1.347 0.457 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.92 -40.28 87.61 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.791 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 40' ' ' TYR . . . . . 0.736 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 5.8 t80 -72.01 -50.69 26.51 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-O 120.802 0.334 . . . . 0.0 111.446 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 41' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' 1' ' 37' ' ' LEU . 20.0 m-85 -71.4 -25.66 62.44 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -178.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 42' ' ' SER . . . . . . . . . . . . . 36.7 p -62.88 -14.18 43.2 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.496 1.141 . . . . 0.0 109.565 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 43' ' ' LYS . . . . . 0.736 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 13.7 mmtt -79.44 -12.8 59.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 112.238 -2.255 . . . . 0.0 111.534 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -101.53 -34.63 9.46 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.083 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 45' ' ' GLY . . . . . 0.404 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -171.19 -160.29 19.37 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -101.52 132.14 47.3 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-O 121.884 0.85 . . . . 0.0 110.308 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 47' ' ' ILE . . . . . 0.429 HD11 ' C ' ' 1' ' 41' ' ' PHE . 5.0 mt -103.08 138.27 28.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 112.97 -1.923 . . . . 0.0 111.667 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -86.13 -43.42 13.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.314 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -162.97 157.71 21.35 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.296 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 50' ' ' CYS . . . . . . . . . . . . . 44.5 t -138.19 148.7 45.1 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.268 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 64.0 ttp -146.96 135.41 21.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.161 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 70.4 t -127.43 125.1 65.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 113.639 -1.618 . . . . 0.0 108.48 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 11.5 mmt -77.2 116.98 18.28 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.219 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -136.37 155.06 50.57 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.554 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.33 116.18 65.21 Favored Pre-proline 0 N--CA 1.437 -1.081 0 C-N-CA 122.837 0.455 . . . . 0.0 110.84 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.99 -10.17 21.97 Favored 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 122.258 1.972 . . . . 0.0 113.188 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 19.1 p -82.08 -44.21 16.84 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 58' ' ' THR . . . . . 0.528 ' OG1' ' HG2' ' 1' ' 60' ' ' ARG . 46.9 p -114.48 -12.64 12.29 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.344 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt 61.2 11.97 3.84 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.646 1.178 . . . . 0.0 112.633 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 60' ' ' ARG . . . . . 0.528 ' HG2' ' OG1' ' 1' ' 58' ' ' THR . 19.1 ptp180 -99.05 132.41 44.38 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.382 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 8.7 t -87.09 157.8 19.33 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.165 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -97.66 -9.26 27.11 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.172 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.1 42.85 4.55 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.663 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -152.87 144.14 23.21 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.765 0.282 . . . . 0.0 110.951 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.22 -170.5 25.95 Favored Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 66' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -135.2 168.35 19.32 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 124.798 1.239 . . . . 0.0 110.092 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 67' ' ' VAL . . . . . . . . . . . . . 79.2 t -153.23 132.78 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 68' ' ' THR . . . . . 0.772 HG23 ' HG3' ' 1' ' 22' ' ' LYS . 1.3 m -107.2 105.32 15.25 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 113.956 -1.475 . . . . 0.0 111.624 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -83.13 124.41 30.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.458 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.82 2.29 27.0 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 71' ' ' ASP . . . . . 0.589 ' OD1' ' HB3' ' 1' ' 73' ' ' ALA . 15.5 t0 -126.97 132.53 24.36 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.458 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -73.57 -16.18 24.22 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 122.023 1.816 . . . . 0.0 111.682 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 73' ' ' ALA . . . . . 0.589 ' HB3' ' OD1' ' 1' ' 71' ' ' ASP . . . -77.33 -30.97 54.23 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.867 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 74' ' ' SER . . . . . 0.458 ' O ' HG23 ' 1' ' 78' ' ' VAL . 3.1 t -70.16 -31.86 69.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.316 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 75' ' ' VAL . . . . . 0.682 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 5.6 t -69.02 -31.93 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.392 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -71.84 -41.94 67.56 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.869 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 77' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' 1' ' 73' ' ' ALA . 90.3 mttt -64.56 -42.79 95.44 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 113.868 -1.514 . . . . 0.0 112.091 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 78' ' ' VAL . . . . . 0.458 HG23 ' O ' ' 1' ' 74' ' ' SER . 95.2 t -74.92 -31.97 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.792 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 79' ' ' LEU . . . . . 0.682 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.2 OUTLIER -65.24 -32.91 74.82 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.877 0.871 . . . . 0.0 112.207 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 80' ' ' GLY . . . . . 0.416 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -79.14 -19.16 72.91 Favored Glycine 0 C--N 1.343 0.955 0 O-C-N 123.697 0.623 . . . . 0.0 113.47 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -98.65 100.74 10.07 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 122.881 0.472 . . . . 0.0 110.835 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 82' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 4.7 Cg_exo -79.23 -35.33 0.9 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.44 2.093 . . . . 0.0 113.676 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -91.16 128.79 37.12 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.767 0.317 . . . . 0.0 111.252 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -139.65 123.71 17.77 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.021 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -117.35 134.67 54.55 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.845 0.831 . . . . 0.0 110.861 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 86' ' ' LEU . . . . . 0.628 HD21 ' OG1' ' 1' ' 32' ' ' THR . 9.2 tp -143.25 133.35 24.34 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 113.331 -1.759 . . . . 0.0 107.492 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 11.8 t70 51.92 37.31 20.59 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 122.591 1.186 . . . . 0.0 111.78 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 12.6 t 69.88 9.62 7.19 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 112.842 -1.981 . . . . 0.0 112.063 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -124.14 152.39 42.85 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.902 0.858 . . . . 0.0 110.529 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.3 m -80.87 127.45 32.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.542 -1.663 . . . . 0.0 111.817 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 91' ' ' ILE . . . . . 0.684 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 44.6 pt -115.26 168.71 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.896 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 92' ' ' ASP . . . . . 0.408 ' OD2' ' HD3' ' 1' ' 94' ' ' LYS . 5.7 t70 -116.64 90.42 31.2 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.5 124.12 3.54 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.347 2.031 . . . . 0.0 111.44 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 94' ' ' LYS . . . . . 0.408 ' HD3' ' OD2' ' 1' ' 92' ' ' ASP . 2.0 pttp -149.4 154.07 38.34 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 6.4 t -76.85 129.85 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.777 0.431 . . . . 0.0 111.501 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.54 156.26 17.14 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -114.02 124.25 31.3 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.377 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.63 137.07 26.92 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.584 2.19 . . . . 0.0 113.016 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -134.6 142.51 46.94 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.964 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -125.6 131.0 52.78 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.259 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -154.85 168.35 27.2 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.771 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 60.11 148.66 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 124.601 1.16 . . . . 0.0 113.465 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.26 176.58 9.78 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.74 2.294 . . . . 0.0 113.557 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -85.52 154.72 21.58 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.331 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 26.2 mmt -90.53 160.91 15.72 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.478 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 2.7 t -94.41 165.27 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.098 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.6 m -101.02 -44.5 5.7 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.082 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -95.53 124.75 39.71 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.287 0.367 . . . . 0.0 111.137 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 19.7 p -100.49 122.36 43.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.264 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -91.03 145.5 24.64 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.269 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 84.4 mttt . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.503 179.92 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.535 0.207 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -117.35 148.18 41.96 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.081 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -116.83 -42.96 2.91 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.149 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -104.0 145.41 30.2 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.378 0.424 . . . . 0.0 110.958 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -104.72 -40.24 6.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.47 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -97.66 142.42 29.49 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 123.276 0.36 . . . . 0.0 111.44 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -130.02 138.07 50.59 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.553 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 55.9 m -94.11 128.81 40.73 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.508 0.505 . . . . 0.0 111.891 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 6.0 t -103.77 138.43 40.4 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.78 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 50.6 m -93.1 146.6 23.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.684 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 13.0 t -98.1 126.23 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.941 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.69 150.4 23.64 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.61 0.569 . . . . 0.0 111.716 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.23 -38.62 3.55 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.524 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.9 70.33 0.84 Allowed Glycine 0 CA--C 1.517 0.177 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.324 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 11' ' ' THR . . . . . 0.513 ' O ' HD11 ' 1' ' 14' ' ' LEU . 71.0 p -121.87 -22.94 5.59 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.616 0.366 . . . . 0.0 110.602 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 12' ' ' GLU . . . . . 0.519 ' O ' HD12 ' 1' ' 14' ' ' LEU . 38.7 tt0 -116.83 -52.79 2.52 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.467 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -80.07 51.67 1.4 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.381 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 14' ' ' LEU . . . . . 0.519 HD12 ' O ' ' 1' ' 12' ' ' GLU . 1.7 mp -80.48 -30.93 37.38 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.578 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -82.09 120.41 25.25 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.064 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -84.14 -15.91 45.47 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -93.59 108.26 20.0 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.199 0.312 . . . . 0.0 110.659 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 13.8 t -120.11 137.2 54.28 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.367 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -116.87 -44.96 2.79 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.613 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.92 146.48 24.89 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.02 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.92 -2.73 6.88 Favored Glycine 0 C--N 1.335 0.51 0 O-C-N 123.578 0.549 . . . . 0.0 113.023 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 22' ' ' LYS . . . . . 0.753 ' HB3' HG23 ' 1' ' 68' ' ' THR . 24.8 pttt -87.17 174.66 8.48 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.544 0.338 . . . . 0.0 111.005 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 23' ' ' MET . . . . . 0.406 ' O ' ' HA ' ' 1' ' 66' ' ' PHE . 10.8 mtp -121.7 152.47 39.36 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.887 0.851 . . . . 0.0 111.554 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -103.98 106.88 17.53 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.014 -1.903 . . . . 0.0 107.988 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 25' ' ' ILE . . . . . 0.421 HD12 ' CZ ' ' 1' ' 41' ' ' PHE . 1.1 mm -96.75 110.39 24.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 122.882 0.473 . . . . 0.0 110.618 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 26' ' ' GLY . . . . . 0.673 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -101.38 160.34 18.36 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.906 -1.043 . . . . 0.0 115.243 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 27' ' ' GLY . . . . . 0.62 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 73.54 20.92 79.91 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 115.195 0.838 . . . . 0.0 115.195 177.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 18.1 mt -58.27 168.33 1.1 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 117.875 0.838 . . . . 0.0 110.818 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 29' ' ' SER . . . . . 0.426 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 5.7 t -101.66 174.53 5.92 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.502 0.668 . . . . 0.0 110.01 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 30' ' ' TRP . . . . . 0.471 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.4 p-90 -71.64 -16.0 62.25 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.782 1.233 . . . . 0.0 111.481 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -97.99 -24.97 15.14 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.977 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 32' ' ' THR . . . . . 0.648 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 0.7 OUTLIER -65.4 113.73 4.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.456 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 33' ' ' SER . . . . . 0.417 ' H ' ' HB3' ' 1' ' 36' ' ' SER . 71.6 m -103.03 159.21 30.0 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.938 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 34' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.53 -25.71 60.04 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.11 1.873 . . . . 0.0 112.271 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.13 -32.26 39.01 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.927 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 36' ' ' SER . . . . . 0.417 ' HB3' ' H ' ' 1' ' 33' ' ' SER . 21.7 t -70.96 -36.43 72.55 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.218 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 37' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.7 mt -72.9 -37.96 67.09 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 123.933 0.893 . . . . 0.0 110.038 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 38' ' ' ARG . . . . . 0.43 ' HE ' ' HB3' ' 1' ' 50' ' ' CYS . 7.8 ttm180 -69.08 -42.6 75.98 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.609 178.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -38.98 91.79 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 123.866 0.729 . . . . 0.0 111.161 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 40' ' ' TYR . . . . . 0.701 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 0.3 OUTLIER -71.51 -52.96 15.5 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 122.941 0.496 . . . . 0.0 111.649 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 41' ' ' PHE . . . . . 0.445 ' C ' HD11 ' 1' ' 47' ' ' ILE . 21.7 m-85 -71.28 -25.42 62.44 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 42' ' ' SER . . . . . . . . . . . . . 25.2 p -63.53 -14.18 48.62 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.418 1.104 . . . . 0.0 109.619 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 43' ' ' LYS . . . . . 0.701 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 6.0 mmtp -80.42 -12.09 59.61 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 112.333 -2.212 . . . . 0.0 112.148 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.57 -32.79 7.9 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.922 0.489 . . . . 0.0 110.405 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.88 -161.06 16.71 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -103.0 133.32 48.33 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.697 0.76 . . . . 0.0 110.429 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 47' ' ' ILE . . . . . 0.445 HD11 ' C ' ' 1' ' 41' ' ' PHE . 4.6 mt -105.78 136.86 38.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 113.263 -1.789 . . . . 0.0 111.498 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -86.57 -41.37 14.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.306 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -163.96 157.63 18.76 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.954 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 50' ' ' CYS . . . . . 0.43 ' HB3' ' HE ' ' 1' ' 38' ' ' ARG . 40.5 t -135.54 150.48 49.75 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.06 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 27.6 ttt -145.17 133.41 21.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.424 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 82.2 t -127.5 124.28 63.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 113.448 -1.705 . . . . 0.0 108.221 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 1.2 mmt -76.52 133.68 39.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.919 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 54' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' 1' ' 59' ' ' LYS . 7.9 ttm180 -131.3 160.69 34.22 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.986 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.41 118.78 51.38 Favored Pre-proline 0 N--CA 1.441 -0.923 0 C-N-CA 122.575 0.35 . . . . 0.0 110.509 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.33 -10.71 19.55 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.484 2.122 . . . . 0.0 113.539 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 19.0 p -82.03 -44.25 16.89 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 72.5 p -117.01 -6.81 11.4 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.408 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 59' ' ' LYS . . . . . 0.475 ' O ' ' HD3' ' 1' ' 54' ' ' ARG . 17.6 mmtp 61.57 11.63 3.98 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.435 1.094 . . . . 0.0 111.723 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -100.64 154.5 18.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.261 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 49.9 m -92.36 154.24 18.68 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.557 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -91.73 -5.81 53.0 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.638 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.06 38.6 5.97 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.454 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -154.86 144.41 21.38 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.402 0.281 . . . . 0.0 111.167 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.2 -168.83 18.96 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 66' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' 1' ' 23' ' ' MET . 75.2 m-85 -138.92 161.38 37.45 Favored 'General case' 0 N--CA 1.423 -1.794 0 C-N-CA 124.948 1.299 . . . . 0.0 109.537 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 67' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' 1' ' 22' ' ' LYS . 73.5 t -145.1 132.13 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 68' ' ' THR . . . . . 0.753 HG23 ' HB3' ' 1' ' 22' ' ' LYS . 0.9 OUTLIER -105.54 107.06 17.85 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.935 -177.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -86.07 125.56 33.54 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.925 -1.488 . . . . 0.0 111.937 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.05 2.18 9.38 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -129.55 134.6 26.41 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.999 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -73.43 -16.31 24.55 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.1 1.867 . . . . 0.0 112.173 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 73' ' ' ALA . . . . . 0.473 ' O ' ' HG3' ' 1' ' 77' ' ' LYS . . . -77.31 -31.28 54.56 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.763 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 74' ' ' SER . . . . . . . . . . . . . 2.2 t -70.1 -31.94 69.74 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.281 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 75' ' ' VAL . . . . . 0.73 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 11.3 t -69.98 -33.12 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.652 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -72.02 -40.79 68.19 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.008 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 77' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' 1' ' 73' ' ' ALA . 43.5 mttp -66.61 -41.34 88.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.518 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 78' ' ' VAL . . . . . . . . . . . . . 88.4 t -81.33 -31.85 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.646 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 79' ' ' LEU . . . . . 0.73 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.8 OUTLIER -65.94 -35.16 79.84 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 122.775 0.43 . . . . 0.0 111.439 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 80' ' ' GLY . . . . . 0.468 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -77.49 -15.24 81.63 Favored Glycine 0 C--N 1.343 0.936 0 O-C-N 123.575 0.547 . . . . 0.0 113.877 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -98.53 99.96 8.44 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 122.69 0.396 . . . . 0.0 111.286 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 82' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 5.3 Cg_exo -78.36 -21.31 10.45 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.578 2.186 . . . . 0.0 113.819 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -89.04 115.26 26.45 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.027 0.442 . . . . 0.0 111.482 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -139.76 119.95 13.76 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.838 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -116.89 134.6 54.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.997 0.903 . . . . 0.0 111.094 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 86' ' ' LEU . . . . . 0.648 HD21 ' OG1' ' 1' ' 32' ' ' THR . 6.3 tp -145.66 133.34 21.03 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.273 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 11.5 t70 52.0 36.95 19.9 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 122.646 1.212 . . . . 0.0 111.721 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 67.8 m 69.23 9.64 7.44 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 112.856 -1.975 . . . . 0.0 112.076 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -123.87 152.46 42.32 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 122.108 0.956 . . . . 0.0 110.697 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.5 m -80.41 124.8 29.21 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.177 -1.829 . . . . 0.0 112.211 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 91' ' ' ILE . . . . . 0.673 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 43.7 pt -112.03 167.34 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.794 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 92' ' ' ASP . . . . . 0.59 ' OD1' ' HD3' ' 1' ' 94' ' ' LYS . 4.9 t70 -117.71 96.18 49.03 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -175.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -83.07 124.24 3.76 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.129 1.886 . . . . 0.0 111.017 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 94' ' ' LYS . . . . . 0.59 ' HD3' ' OD1' ' 1' ' 92' ' ' ASP . 23.5 pttt -147.54 139.9 24.52 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 t -74.39 125.19 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 122.715 0.406 . . . . 0.0 111.157 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.42 149.88 25.7 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 97' ' ' PHE . . . . . 0.423 ' HA ' ' HD3' ' 1' ' 98' ' ' PRO . 2.8 m-85 -109.82 130.62 22.6 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.886 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 98' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' 1' ' 97' ' ' PHE . 12.4 Cg_exo -73.19 139.98 30.22 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.64 2.227 . . . . 0.0 113.179 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -149.43 118.85 6.88 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.025 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -99.89 128.16 46.0 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.337 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.74 170.9 10.04 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -116.63 144.6 33.58 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.666 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.45 174.62 12.26 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.555 2.17 . . . . 0.0 113.603 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -88.07 158.13 18.67 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.461 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 62.0 mtt -95.13 -6.01 42.85 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.034 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 2.7 t -91.01 162.21 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.507 0.323 . . . . 0.0 110.239 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 9.7 t -92.35 -47.61 7.09 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 -100.48 132.6 45.78 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.205 0.315 . . . . 0.0 111.113 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 17.0 p -94.11 136.86 33.95 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.333 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -87.81 128.31 35.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.561 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.398 -0.811 . . . . 0.0 111.397 179.966 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 31.7 mtm . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.6 0.238 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -121.78 -40.79 2.51 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.24 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -96.25 154.91 17.0 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.427 0.454 . . . . 0.0 111.098 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -95.72 141.65 28.94 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.252 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -117.09 139.75 50.35 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.443 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -127.64 142.07 51.45 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.322 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -102.74 154.15 19.44 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.884 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 60.2 m -112.54 -32.46 6.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.937 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 4.8 p -82.87 117.03 22.44 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 122.936 0.495 . . . . 0.0 111.873 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 50.3 m -135.66 137.91 42.31 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.197 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 t -89.43 143.68 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.879 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -106.86 -44.46 4.42 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.411 0.445 . . . . 0.0 111.645 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.18 148.69 26.61 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.226 0.329 . . . . 0.0 111.401 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 10' ' ' GLY . . . . . 0.415 ' O ' HD21 ' 1' ' 14' ' ' LEU . . . -149.18 72.09 0.3 Allowed Glycine 0 C--N 1.336 0.569 0 O-C-N 123.619 0.574 . . . . 0.0 112.552 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -148.54 13.35 0.94 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.625 0.37 . . . . 0.0 111.378 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -102.95 -55.71 2.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.261 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -77.25 -44.06 31.21 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.934 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 14' ' ' LEU . . . . . 0.415 HD21 ' O ' ' 1' ' 10' ' ' GLY . 3.4 pp -82.98 157.64 22.88 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.43 0.456 . . . . 0.0 111.328 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -76.35 153.08 36.11 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.335 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -140.22 -6.3 1.23 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.54 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -87.4 -5.34 58.9 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 51.8 p -83.79 152.21 24.76 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.488 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -118.84 -30.49 5.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.585 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.55 149.3 33.07 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 122.895 0.478 . . . . 0.0 111.643 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.37 -16.85 3.82 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.46 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 22' ' ' LYS . . . . . 0.691 ' HB3' HG23 ' 1' ' 68' ' ' THR . 8.0 pttp -98.84 173.65 6.76 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 123.795 0.35 . . . . 0.0 110.911 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 23' ' ' MET . . . . . . . . . . . . . 14.5 mtp -117.3 152.57 34.6 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 122.005 0.907 . . . . 0.0 111.039 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -105.86 105.2 15.13 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 112.944 -1.934 . . . . 0.0 107.716 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mm -94.82 116.97 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.131 0.572 . . . . 0.0 110.102 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 26' ' ' GLY . . . . . 0.744 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -108.32 159.79 14.1 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.086 -0.961 . . . . 0.0 115.044 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 27' ' ' GLY . . . . . 0.625 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 71.9 21.32 79.05 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 115.372 0.909 . . . . 0.0 115.372 177.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 16.2 mt -57.17 169.62 0.55 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 117.858 0.829 . . . . 0.0 110.902 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 29' ' ' SER . . . . . 0.421 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 5.4 t -100.99 174.45 6.0 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.483 0.659 . . . . 0.0 110.181 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 30' ' ' TRP . . . . . 0.457 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.2 p-90 -72.02 -16.64 62.06 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.424 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -97.65 -24.93 15.29 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.006 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 32' ' ' THR . . . . . 0.592 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 0.6 OUTLIER -65.83 114.04 4.78 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.637 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 33' ' ' SER . . . . . 0.419 ' H ' ' HB3' ' 1' ' 36' ' ' SER . 71.5 m -103.72 158.53 31.66 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.977 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 34' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.26 -25.83 58.22 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.136 1.89 . . . . 0.0 112.468 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 35' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' 1' ' 39' ' ' ASP . 0.4 OUTLIER -80.23 -33.35 38.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.113 177.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 36' ' ' SER . . . . . 0.419 ' HB3' ' H ' ' 1' ' 33' ' ' SER . 22.7 t -70.5 -35.82 73.44 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.044 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 37' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.6 mt -72.91 -38.81 66.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.19 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 38' ' ' ARG . . . . . 0.568 ' O ' ' HB2' ' 1' ' 42' ' ' SER . 12.5 ttm180 -68.01 -42.76 80.19 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.792 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 39' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' 1' ' 35' ' ' ASP . 0.1 OUTLIER -67.0 -40.19 87.29 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.582 178.04 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 40' ' ' TYR . . . . . 0.694 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 5.6 t80 -72.09 -50.05 31.29 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 122.609 0.364 . . . . 0.0 111.556 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 41' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' 1' ' 37' ' ' LEU . 17.5 m-85 -71.47 -25.18 62.18 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 42' ' ' SER . . . . . 0.568 ' HB2' ' O ' ' 1' ' 38' ' ' ARG . 16.9 t -61.53 -14.08 26.61 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.51 1.147 . . . . 0.0 109.526 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 43' ' ' LYS . . . . . 0.694 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 13.1 mmtt -82.97 -14.83 53.31 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 112.191 -2.277 . . . . 0.0 111.537 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 44' ' ' PHE . . . . . 0.444 ' CD1' HG22 ' 1' ' 78' ' ' VAL . 0.3 OUTLIER -97.63 -33.2 11.41 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.105 178.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.05 -160.44 22.29 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -100.09 132.72 45.29 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.839 0.828 . . . . 0.0 110.357 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 47' ' ' ILE . . . . . 0.445 HD11 ' C ' ' 1' ' 41' ' ' PHE . 4.9 mt -107.68 137.79 37.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 113.037 -1.892 . . . . 0.0 111.549 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -88.02 -41.35 13.16 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.971 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -166.45 157.22 12.55 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.421 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 50' ' ' CYS . . . . . . . . . . . . . 42.3 t -133.71 151.42 51.62 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.329 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 57.3 ttp -146.54 133.67 20.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.032 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 64.8 t -126.51 124.79 66.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.197 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.99 117.27 12.27 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.178 -177.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -137.36 155.9 48.85 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.566 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.84 115.59 65.75 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 122.814 0.446 . . . . 0.0 110.777 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.74 -8.34 4.23 Favored 'Trans proline' 0 C--N 1.364 1.355 0 C-N-CA 122.963 2.442 . . . . 0.0 115.054 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 20.1 p -81.01 -45.31 16.76 Favored 'General case' 0 C--N 1.347 0.46 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 61.9 p -130.02 -5.92 4.45 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 mptt 58.56 53.07 6.37 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 122.722 1.249 . . . . 0.0 111.434 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -98.89 130.66 45.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.664 -2.062 . . . . 0.0 110.845 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 49.1 m -92.82 142.05 27.76 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.412 0.445 . . . . 0.0 111.201 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -96.09 -10.1 29.19 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.457 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.98 33.07 8.45 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 116.015 -0.539 . . . . 0.0 113.755 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -153.5 151.4 29.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 117.162 0.481 . . . . 0.0 111.514 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.06 -168.2 23.62 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 66' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -138.08 163.07 32.53 Favored 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 124.729 1.211 . . . . 0.0 109.855 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 67' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' 1' ' 22' ' ' LYS . 58.9 t -144.53 133.12 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 68' ' ' THR . . . . . 0.691 HG23 ' HB3' ' 1' ' 22' ' ' LYS . 1.1 m -106.91 105.97 16.26 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.743 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -83.73 126.81 33.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.051 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.03 2.66 6.58 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 71' ' ' ASP . . . . . 0.6 ' OD1' ' HB3' ' 1' ' 73' ' ' ALA . 11.6 t0 -131.7 133.0 23.69 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.825 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -73.42 -16.11 24.65 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 122.014 1.809 . . . . 0.0 111.934 176.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 73' ' ' ALA . . . . . 0.6 ' HB3' ' OD1' ' 1' ' 71' ' ' ASP . . . -77.48 -28.84 52.38 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.124 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 74' ' ' SER . . . . . 0.482 ' O ' HG23 ' 1' ' 78' ' ' VAL . 3.8 t -69.42 -31.73 70.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.215 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 75' ' ' VAL . . . . . 0.725 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 16.7 t -67.26 -32.68 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.655 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.21 -37.8 69.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.772 -1.103 . . . . 0.0 110.178 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 77' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -69.5 -43.13 73.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 113.815 -1.539 . . . . 0.0 112.209 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 78' ' ' VAL . . . . . 0.482 HG23 ' O ' ' 1' ' 74' ' ' SER . 53.0 t -77.16 -31.81 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.343 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 79' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.4 OUTLIER -71.09 -29.35 65.17 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 122.683 0.393 . . . . 0.0 110.79 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 80' ' ' GLY . . . . . 0.548 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -74.33 -28.83 63.11 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.046 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -98.61 97.64 5.05 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 122.821 0.449 . . . . 0.0 110.413 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 82' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 2.6 Cg_exo -76.1 -27.93 7.88 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.021 2.481 . . . . 0.0 114.293 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -81.94 116.15 21.44 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.962 0.411 . . . . 0.0 111.304 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -136.16 121.63 19.41 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.08 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -115.36 134.65 54.91 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.801 0.81 . . . . 0.0 110.464 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 86' ' ' LEU . . . . . 0.592 HD21 ' OG1' ' 1' ' 32' ' ' THR . 6.4 tp -145.67 133.95 21.74 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 113.349 -1.751 . . . . 0.0 107.555 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 12.8 t70 51.69 37.15 19.38 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.628 1.171 . . . . 0.0 111.844 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 53.4 m 68.97 10.19 7.79 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 112.953 -1.93 . . . . 0.0 111.852 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -124.61 151.64 44.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.974 0.893 . . . . 0.0 110.302 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.9 m -81.99 126.87 32.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.536 -1.665 . . . . 0.0 111.83 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 91' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 44.4 pt -110.51 169.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.339 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 92' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -113.16 93.87 27.82 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.15 124.37 3.76 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.46 2.107 . . . . 0.0 111.513 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 94' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -143.26 163.45 32.93 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.139 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -95.28 147.4 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 120.71 0.29 . . . . 0.0 110.773 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.98 165.91 10.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.848 0.859 . . . . 0.0 112.674 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 97' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' 1' ' 98' ' ' PRO . 25.6 m-85 -103.36 144.14 28.04 Favored Pre-proline 0 N--CA 1.446 -0.671 0 C-N-CA 123.446 0.698 . . . . 0.0 110.773 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 98' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' 1' ' 97' ' ' PHE . 15.0 Cg_exo -74.33 -175.95 2.48 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 123.197 2.598 . . . . 0.0 113.367 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -73.88 156.75 37.37 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.315 0.646 . . . . 0.0 112.659 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 51.85 92.02 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.451 1.101 . . . . 0.0 113.345 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -112.28 -175.91 2.79 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.823 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -110.03 126.03 29.86 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 119.621 -0.228 . . . . 0.0 110.639 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.49 173.62 14.18 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.485 2.123 . . . . 0.0 113.236 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -84.66 150.32 25.23 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.964 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 19.6 ptm -129.67 -14.99 4.03 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.963 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 2.6 t -98.99 160.61 3.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 O-C-N 123.46 0.475 . . . . 0.0 110.067 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 3.0 m -109.73 -55.29 2.45 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.638 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -98.1 142.24 30.04 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.476 0.485 . . . . 0.0 111.274 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 17.7 p -100.91 121.25 41.41 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.334 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -91.2 147.48 23.03 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.384 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 22.5 mttm . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.423 179.681 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 17.5 mmt . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.522 0.201 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -128.74 133.54 48.15 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.984 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -103.83 -35.52 8.15 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.714 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -88.81 -36.28 16.14 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -94.08 131.0 40.03 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 123.305 0.378 . . . . 0.0 111.34 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -108.26 149.07 29.1 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -123.34 -43.96 2.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.649 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 57.9 m -90.97 123.52 34.52 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 123.208 0.317 . . . . 0.0 111.7 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 9.7 p -91.51 159.21 16.05 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.677 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 42.2 p -87.5 130.72 34.6 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.39 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 15.0 t -108.87 -49.11 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.51 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.47 128.72 34.75 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.32 0.387 . . . . 0.0 111.713 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.96 163.56 14.9 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.72 70.43 0.5 Allowed Glycine 0 C--N 1.341 0.844 0 C-N-CA 121.41 -0.424 . . . . 0.0 112.521 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 9.1 t -138.73 13.89 2.71 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 123.769 0.335 . . . . 0.0 111.596 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -121.37 -46.41 2.28 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.534 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.11 8.64 2.46 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.449 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 pp -79.71 164.79 23.44 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -78.5 122.92 26.48 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.479 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -104.78 -15.46 15.21 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.316 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -82.25 148.78 28.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 55.0 m -93.07 160.61 14.78 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.542 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -137.04 79.93 1.78 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.366 0.603 . . . . 0.0 110.43 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.71 136.68 39.26 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.291 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.54 -1.39 2.09 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.741 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 22' ' ' LYS . . . . . 0.586 ' HG3' HG23 ' 1' ' 68' ' ' THR . 27.4 mttt -81.09 147.73 29.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 23' ' ' MET . . . . . 0.484 ' O ' ' HA ' ' 1' ' 66' ' ' PHE . 5.8 mtp -117.23 129.62 56.04 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.662 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -91.26 103.78 16.41 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 126.093 1.757 . . . . 0.0 109.088 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mm -92.28 109.88 22.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.291 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 26' ' ' GLY . . . . . 0.643 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -99.56 154.45 19.71 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 116.077 1.191 . . . . 0.0 116.077 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 27' ' ' GLY . . . . . 0.642 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 72.53 27.0 70.34 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 113.996 -1.102 . . . . 0.0 115.717 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 18.9 mt -58.11 170.88 0.61 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 117.964 0.882 . . . . 0.0 111.149 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 29' ' ' SER . . . . . 0.424 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 5.7 t -100.25 174.31 6.2 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.456 0.646 . . . . 0.0 110.388 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 30' ' ' TRP . . . . . 0.479 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.3 p-90 -72.75 -16.78 61.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.197 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -98.62 -24.98 14.87 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.995 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 32' ' ' THR . . . . . 0.593 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 1.0 OUTLIER -66.78 114.08 5.38 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.599 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 33' ' ' SER . . . . . 0.411 ' H ' ' HB3' ' 1' ' 36' ' ' SER . 57.8 m -104.22 160.21 26.78 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.287 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 34' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -56.45 -25.69 59.29 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.167 1.911 . . . . 0.0 112.374 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.9 -33.32 39.98 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.913 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 36' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' 1' ' 40' ' ' TYR . 19.9 t -70.81 -35.92 72.72 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.383 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 37' ' ' LEU . . . . . 0.453 ' HB3' ' SG ' ' 1' ' 50' ' ' CYS . 1.9 mt -72.77 -37.16 67.71 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.396 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 38' ' ' ARG . . . . . 0.621 ' O ' ' HB2' ' 1' ' 42' ' ' SER . 6.0 ttm180 -71.19 -42.05 69.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.664 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.44 -39.58 85.39 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.868 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 40' ' ' TYR . . . . . 0.712 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 2.5 t80 -71.91 -52.04 19.23 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-O 120.851 0.358 . . . . 0.0 111.641 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 41' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' 1' ' 37' ' ' LEU . 33.9 m-85 -71.5 -25.69 62.37 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 42' ' ' SER . . . . . 0.621 ' HB2' ' O ' ' 1' ' 38' ' ' ARG . 9.4 t -63.0 -14.04 42.81 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.5 1.143 . . . . 0.0 109.465 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 43' ' ' LYS . . . . . 0.712 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 14.8 mttt -82.48 -13.5 56.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 112.15 -2.295 . . . . 0.0 111.82 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -104.69 -31.15 9.5 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.305 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 45' ' ' GLY . . . . . 0.439 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -168.2 -163.26 21.85 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -102.82 132.77 48.77 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.826 0.822 . . . . 0.0 110.744 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 47' ' ' ILE . . . . . . . . . . . . . 4.9 mt -107.41 137.85 36.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 113.029 -1.896 . . . . 0.0 111.44 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -87.66 -41.7 13.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.974 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -164.7 157.38 16.62 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.251 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 50' ' ' CYS . . . . . 0.502 ' SG ' HG22 ' 1' ' 67' ' ' VAL . 43.4 t -135.36 150.58 49.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.286 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 27.4 ttt -145.42 135.92 24.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.919 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.47 125.19 63.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 113.659 -1.609 . . . . 0.0 107.653 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -69.53 117.02 10.62 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.141 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 38.7 mtt-85 -137.27 150.92 48.15 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.625 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.34 115.6 60.65 Favored Pre-proline 0 N--CA 1.44 -0.947 0 C-N-CA 122.918 0.487 . . . . 0.0 110.594 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -63.9 -8.97 17.25 Favored 'Trans proline' 0 C--N 1.363 1.313 0 C-N-CA 122.297 1.998 . . . . 0.0 113.36 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 19.9 p -82.18 -44.23 16.68 Favored 'General case' 0 C--N 1.346 0.423 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 74.8 p -118.49 -10.98 10.01 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt 61.5 12.38 4.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.406 1.082 . . . . 0.0 112.148 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -91.06 132.77 35.82 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.851 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 39.2 m -97.08 156.07 16.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.699 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -99.19 -11.12 21.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.34 43.21 4.37 Favored Glycine 0 C--N 1.339 0.708 0 O-C-N 123.351 0.407 . . . . 0.0 113.919 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -155.28 151.14 27.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.785 0.293 . . . . 0.0 111.013 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.72 -169.78 23.46 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 66' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' 1' ' 23' ' ' MET . 86.2 m-85 -138.57 158.91 43.35 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 125.084 1.353 . . . . 0.0 109.63 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 67' ' ' VAL . . . . . 0.502 HG22 ' SG ' ' 1' ' 50' ' ' CYS . 75.2 t -144.12 133.22 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 68' ' ' THR . . . . . 0.586 HG23 ' HG3' ' 1' ' 22' ' ' LYS . 1.5 m -105.44 105.46 15.51 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 113.615 -1.63 . . . . 0.0 111.5 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -81.81 124.61 29.81 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.82 -1.536 . . . . 0.0 112.069 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.31 3.05 9.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 71' ' ' ASP . . . . . 0.585 ' OD1' ' HB3' ' 1' ' 73' ' ' ALA . 11.6 t0 -132.01 134.11 24.79 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.745 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -73.39 -16.51 24.57 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 121.756 1.638 . . . . 0.0 111.89 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 73' ' ' ALA . . . . . 0.585 ' HB3' ' OD1' ' 1' ' 71' ' ' ASP . . . -77.53 -30.45 52.81 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.975 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 74' ' ' SER . . . . . 0.439 ' OG ' ' HA3' ' 1' ' 45' ' ' GLY . 5.1 t -69.88 -31.59 69.48 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.27 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 75' ' ' VAL . . . . . 0.739 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 9.4 t -69.99 -32.66 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.882 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -72.06 -40.29 68.43 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.17 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 77' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' 1' ' 73' ' ' ALA . 87.0 mttt -69.19 -40.3 78.15 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.659 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 78' ' ' VAL . . . . . . . . . . . . . 87.0 t -81.97 -32.0 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.679 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 79' ' ' LEU . . . . . 0.739 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.5 OUTLIER -67.03 -35.84 80.79 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 122.504 0.322 . . . . 0.0 111.092 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 80' ' ' GLY . . . . . 0.525 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -72.59 -16.21 77.67 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.52 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -98.94 97.9 5.63 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 122.805 0.442 . . . . 0.0 110.832 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 82' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 5.3 Cg_exo -78.45 -30.66 3.09 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.721 2.28 . . . . 0.0 113.767 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -87.37 115.45 24.79 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.925 0.393 . . . . 0.0 111.521 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -140.23 123.22 16.61 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.911 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -114.23 134.92 54.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 122.006 0.908 . . . . 0.0 110.798 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 86' ' ' LEU . . . . . 0.593 HD21 ' OG1' ' 1' ' 32' ' ' THR . 6.5 tp -142.31 129.13 20.54 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.106 -1.861 . . . . 0.0 107.527 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 7.6 t70 50.17 36.95 13.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.809 1.244 . . . . 0.0 111.834 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 15.0 t 70.02 12.13 7.75 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 112.987 -1.915 . . . . 0.0 111.432 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.55 135.54 55.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.9 m -77.29 123.25 26.22 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.261 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 91' ' ' ILE . . . . . 0.643 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 45.9 pt -107.88 168.59 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.427 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 92' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -115.82 93.7 38.57 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.94 124.2 3.82 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.54 2.16 . . . . 0.0 111.324 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 94' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.45 158.19 43.95 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.622 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 95' ' ' VAL . . . . . 0.422 HG23 ' HG ' ' 1' ' 79' ' ' LEU . 18.1 t -82.65 141.63 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.15 144.73 50.12 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -121.35 137.08 26.4 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.129 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -71.88 144.72 43.96 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.808 2.339 . . . . 0.0 113.07 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -115.28 -39.51 3.6 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.046 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -87.98 123.88 33.15 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.434 0.293 . . . . 0.0 111.67 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -128.55 173.15 10.5 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.299 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -107.4 108.12 61.31 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.146 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -82.35 174.24 10.04 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.517 2.145 . . . . 0.0 113.429 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -87.54 134.67 33.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.047 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 59.4 mtt -88.78 144.79 26.01 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.496 0.497 . . . . 0.0 111.502 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 45.5 t -115.7 -53.72 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.3 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 7.1 t -78.09 91.57 4.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.685 0.755 . . . . 0.0 111.949 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -118.54 -41.23 2.83 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.297 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 6.9 t -110.86 -40.97 4.37 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.412 0.445 . . . . 0.0 111.406 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -79.34 144.4 34.25 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.872 0.469 . . . . 0.0 111.794 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 14.3 tttp . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.47 -0.776 . . . . 0.0 111.289 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 54.6 mtm . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 111.47 0.174 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -129.88 140.52 50.96 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.327 0.392 . . . . 0.0 111.2 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -126.7 -44.91 1.64 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.093 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -104.71 156.24 18.16 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.483 0.489 . . . . 0.0 110.794 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -88.06 -38.01 15.8 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.185 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -93.65 138.1 32.23 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.163 0.289 . . . . 0.0 111.258 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -114.62 136.83 52.61 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.194 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 62.7 m -101.22 126.07 47.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.127 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 7.0 t -106.16 137.85 43.37 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.267 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 49.8 p -87.84 158.73 18.65 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.405 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 t -97.97 -14.08 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.958 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.49 -51.01 4.09 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.056 0.223 . . . . 0.0 111.172 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.45 128.08 36.41 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.361 0.413 . . . . 0.0 110.892 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.42 70.93 0.23 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.98 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -151.27 -28.15 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.377 0.271 . . . . 0.0 111.658 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -95.08 -69.02 0.77 Allowed 'General case' 0 CA--C 1.534 0.352 0 O-C-N 123.38 0.425 . . . . 0.0 111.192 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.52 -4.83 53.16 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.575 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tp -84.37 152.05 24.31 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -89.57 140.73 29.26 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.394 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -113.14 -44.81 3.22 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.422 0.451 . . . . 0.0 111.631 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -84.84 130.23 34.69 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.25 0.344 . . . . 0.0 111.545 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m -140.6 -41.81 0.41 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.209 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -108.61 -25.79 10.71 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.401 0.438 . . . . 0.0 111.703 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.34 148.04 43.83 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.871 0.468 . . . . 0.0 111.846 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.96 -6.56 8.87 Favored Glycine 0 C--N 1.337 0.624 0 O-C-N 123.645 0.591 . . . . 0.0 113.307 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 22' ' ' LYS . . . . . 0.636 ' HG3' HG23 ' 1' ' 68' ' ' THR . 42.5 mttt -82.24 155.4 24.9 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.172 0.511 . . . . 0.0 112.309 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 23' ' ' MET . . . . . . . . . . . . . 5.4 mtp -117.83 151.77 36.69 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.227 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 24' ' ' PHE . . . . . 0.427 ' HD2' ' O ' ' 1' ' 65' ' ' GLY . 1.7 t80 -116.96 109.91 17.62 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.906 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 25' ' ' ILE . . . . . 0.51 HD12 ' CZ ' ' 1' ' 41' ' ' PHE . 1.4 mm -95.01 123.96 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 123.668 0.787 . . . . 0.0 109.933 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 26' ' ' GLY . . . . . 0.748 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -117.75 158.89 14.41 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.274 -0.875 . . . . 0.0 114.658 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 27' ' ' GLY . . . . . 0.62 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 70.91 21.71 78.22 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 115.474 0.949 . . . . 0.0 115.474 177.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 16.2 mt -56.13 167.37 0.64 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.902 0.851 . . . . 0.0 110.687 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 29' ' ' SER . . . . . 0.434 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 6.6 t -98.35 174.33 6.54 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.631 0.729 . . . . 0.0 110.574 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 30' ' ' TRP . . . . . 0.488 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.6 p-90 -71.57 -16.9 62.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.381 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -98.82 -24.43 15.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.978 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 32' ' ' THR . . . . . 0.614 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 0.5 OUTLIER -69.91 114.26 7.92 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.075 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 33' ' ' SER . . . . . 0.503 ' OG ' ' HD2' ' 1' ' 34' ' ' PRO . 9.7 t -104.92 156.54 35.87 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.446 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 34' ' ' PRO . . . . . 0.546 ' O ' ' HB2' ' 1' ' 38' ' ' ARG . 12.8 Cg_endo -53.21 -25.18 28.95 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.219 1.946 . . . . 0.0 113.611 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.54 -29.46 41.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.969 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 36' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' 1' ' 40' ' ' TYR . 16.6 t -69.67 -47.02 64.76 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.597 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 37' ' ' LEU . . . . . 0.56 HD21 HG21 ' 1' ' 52' ' ' VAL . 0.2 OUTLIER -74.25 -30.9 62.36 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 121.226 -0.189 . . . . 0.0 110.792 178.505 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 38' ' ' ARG . . . . . 0.631 ' HE ' ' HB3' ' 1' ' 50' ' ' CYS . 21.0 ttm180 -66.39 -43.63 85.34 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.49 -36.77 79.38 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.923 177.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 40' ' ' TYR . . . . . 0.77 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 4.2 t80 -72.04 -49.58 35.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.502 0.721 . . . . 0.0 111.75 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 41' ' ' PHE . . . . . 0.51 ' CZ ' HD12 ' 1' ' 25' ' ' ILE . 36.7 m-85 -71.48 -26.34 62.65 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.852 0.861 . . . . 0.0 112.914 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 42' ' ' SER . . . . . . . . . . . . . 35.9 p -64.58 -14.05 55.89 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 122.413 1.101 . . . . 0.0 109.541 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 43' ' ' LYS . . . . . 0.77 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 14.3 mttt -79.58 -13.08 59.77 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 112.194 -2.275 . . . . 0.0 111.78 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -102.36 -34.48 9.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.219 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 45' ' ' GLY . . . . . 0.412 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -168.25 -161.05 17.3 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -101.91 132.66 47.57 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 121.761 0.791 . . . . 0.0 110.539 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 47' ' ' ILE . . . . . . . . . . . . . 5.4 mt -103.31 137.98 29.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 113.101 -1.863 . . . . 0.0 110.954 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -93.46 -40.18 10.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.751 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -156.64 157.73 35.75 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.709 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 50' ' ' CYS . . . . . 0.631 ' HB3' ' HE ' ' 1' ' 38' ' ' ARG . 10.2 t -144.88 150.27 36.78 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.692 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 24.8 ttt -154.06 134.47 13.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.516 -1.22 . . . . 0.0 112.767 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 52' ' ' VAL . . . . . 0.56 HG21 HD21 ' 1' ' 37' ' ' LEU . 58.7 t -127.6 124.76 64.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 113.836 -1.529 . . . . 0.0 107.21 175.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 19.0 mtp -72.12 114.81 10.62 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.616 -177.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -137.25 156.06 48.75 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.143 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.97 114.66 64.15 Favored Pre-proline 0 N--CA 1.446 -0.639 0 C-N-CA 122.703 0.401 . . . . 0.0 110.994 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.91 -8.51 3.23 Favored 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 123.047 2.498 . . . . 0.0 114.688 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 19.7 p -80.66 -44.36 18.93 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 61.1 p -129.05 -6.36 4.94 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.399 0.437 . . . . 0.0 111.987 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 5.9 mptt 56.6 53.42 8.49 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 122.758 1.266 . . . . 0.0 112.107 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -98.37 129.31 45.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 112.666 -2.061 . . . . 0.0 111.03 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 12.8 t -97.07 137.55 35.96 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.641 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -95.1 -10.7 29.93 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.428 0.455 . . . . 0.0 111.694 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.07 41.3 4.97 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 116.13 -0.486 . . . . 0.0 113.715 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -156.79 149.15 23.24 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.925 0.362 . . . . 0.0 111.386 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 65' ' ' GLY . . . . . 0.427 ' O ' ' HD2' ' 1' ' 24' ' ' PHE . . . -163.45 -169.7 27.29 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 66' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -135.74 164.88 26.88 Favored 'General case' 0 N--CA 1.427 -1.613 0 C-N-CA 125.089 1.355 . . . . 0.0 109.431 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 67' ' ' VAL . . . . . . . . . . . . . 70.3 t -150.18 133.0 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.9 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 68' ' ' THR . . . . . 0.636 HG23 ' HG3' ' 1' ' 22' ' ' LYS . 1.6 m -105.68 105.04 14.9 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 113.296 -1.775 . . . . 0.0 111.343 -178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -83.12 123.16 29.25 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.035 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.49 1.82 13.15 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 71' ' ' ASP . . . . . 0.597 ' OD1' ' HB3' ' 1' ' 73' ' ' ALA . 15.4 t0 -129.26 132.32 24.23 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.378 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -73.41 -16.37 24.56 Favored 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 121.969 1.779 . . . . 0.0 111.666 176.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 73' ' ' ALA . . . . . 0.597 ' HB3' ' OD1' ' 1' ' 71' ' ' ASP . . . -77.3 -30.19 54.05 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.981 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 74' ' ' SER . . . . . 0.438 ' O ' HG23 ' 1' ' 78' ' ' VAL . 5.4 t -69.97 -31.8 69.7 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.327 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 75' ' ' VAL . . . . . 0.669 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 10.7 t -69.93 -32.04 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.581 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -71.32 -41.84 69.36 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.921 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 77' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' 1' ' 73' ' ' ALA . 53.5 mttm -65.88 -40.28 91.45 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.875 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 78' ' ' VAL . . . . . 0.438 HG23 ' O ' ' 1' ' 74' ' ' SER . 87.2 t -77.56 -32.41 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 79' ' ' LEU . . . . . 0.669 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.3 OUTLIER -62.67 -35.53 79.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.615 0.766 . . . . 0.0 111.95 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 80' ' ' GLY . . . . . 0.455 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -77.22 -15.37 81.62 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 115.91 -0.586 . . . . 0.0 113.4 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -98.76 99.38 7.58 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.072 0.549 . . . . 0.0 110.588 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 82' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 6.2 Cg_exo -78.32 -34.91 1.37 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.519 2.146 . . . . 0.0 113.734 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -89.98 127.21 35.99 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.748 0.309 . . . . 0.0 111.48 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -137.62 119.59 15.38 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -114.68 134.63 54.93 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 122.037 0.923 . . . . 0.0 110.771 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 86' ' ' LEU . . . . . 0.614 HD21 ' OG1' ' 1' ' 32' ' ' THR . 5.7 tp -144.25 134.55 24.41 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 113.018 -1.901 . . . . 0.0 107.244 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 9.1 t70 52.0 37.04 20.15 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.645 1.212 . . . . 0.0 111.558 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 58.2 m 68.58 11.27 8.29 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 112.805 -1.998 . . . . 0.0 112.037 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -126.58 152.13 47.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.899 0.857 . . . . 0.0 110.573 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.6 m -80.35 126.41 31.13 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.515 -1.675 . . . . 0.0 111.704 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 91' ' ' ILE . . . . . 0.748 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 43.2 pt -111.02 173.49 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.762 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -115.44 82.85 10.06 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -176.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.77 123.72 3.32 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.208 1.939 . . . . 0.0 111.443 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.95 148.54 28.53 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -80.73 141.62 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.867 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.29 159.01 31.99 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.944 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -108.39 126.48 29.51 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 122.943 0.497 . . . . 0.0 111.409 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -79.28 160.38 26.15 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.802 2.335 . . . . 0.0 113.28 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -103.38 136.97 42.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.94 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -103.21 169.17 8.71 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 123.38 0.425 . . . . 0.0 111.411 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.01 176.34 9.62 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 64.49 133.43 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 124.36 1.064 . . . . 0.0 112.76 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.8 -174.61 2.23 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.775 2.317 . . . . 0.0 113.255 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -80.45 143.62 33.25 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.717 0.407 . . . . 0.0 111.854 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 23.1 mmt -94.46 158.37 15.58 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.572 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 34.9 t -106.83 -57.0 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.6 m -99.23 94.07 6.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.862 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -92.08 145.18 24.73 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.732 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 18.5 p -95.43 143.32 26.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.318 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -140.23 -45.46 0.42 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.186 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 88.8 mttt . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.476 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 2.8 tpt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.409 0.147 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -115.81 137.41 52.12 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.813 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -114.1 146.13 40.68 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.259 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -99.95 137.88 37.8 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.656 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -98.71 138.87 35.25 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.024 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -126.56 145.26 50.6 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.65 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -95.63 143.89 26.53 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.831 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 41.9 p -108.71 -34.58 6.65 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.575 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 4.0 t -94.46 94.83 8.46 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.107 0.48 . . . . 0.0 110.789 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 47.7 p -128.49 125.78 39.12 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.302 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 13.1 t -108.49 -40.26 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.242 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -81.44 157.06 25.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.928 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 pp -78.52 157.79 28.75 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.806 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.31 71.32 0.5 Allowed Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.629 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -134.55 -4.04 2.61 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 122.448 0.299 . . . . 0.0 111.75 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -103.81 -35.04 8.33 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -73.75 -3.96 31.64 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 mp -92.42 -38.06 12.21 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.835 0.35 . . . . 0.0 111.42 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -80.89 132.27 35.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.33 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -140.3 0.12 1.67 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -83.96 -43.83 14.81 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 51.2 p -92.59 107.68 19.4 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.932 0.396 . . . . 0.0 111.604 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -137.46 -48.24 0.58 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.109 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.77 145.03 30.68 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.417 0.448 . . . . 0.0 112.007 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.21 -5.55 8.23 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.025 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 22' ' ' LYS . . . . . 0.727 ' HG3' HG23 ' 1' ' 68' ' ' THR . 15.1 mttp -87.35 154.67 20.49 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 122.909 0.484 . . . . 0.0 112.289 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 23' ' ' MET . . . . . 0.427 ' O ' ' HA ' ' 1' ' 66' ' ' PHE . 5.8 mtp -123.68 131.32 53.58 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.782 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -93.21 108.19 19.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.09 -1.413 . . . . 0.0 109.018 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mm -96.27 116.15 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.29 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 26' ' ' GLY . . . . . 0.717 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -108.35 158.61 14.69 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 114.99 -1.004 . . . . 0.0 115.044 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 27' ' ' GLY . . . . . 0.589 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 69.99 23.63 76.95 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 115.506 0.962 . . . . 0.0 115.506 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 18.4 mt -56.17 169.6 0.39 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 117.704 0.752 . . . . 0.0 110.918 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 29' ' ' SER . . . . . 0.407 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 4.2 t -99.5 174.42 6.27 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.659 0.742 . . . . 0.0 110.388 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 30' ' ' TRP . . . . . 0.462 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.1 p-90 -72.2 -17.21 61.94 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.333 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -97.69 -24.87 15.3 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.067 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 32' ' ' THR . . . . . 0.572 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 0.7 OUTLIER -65.26 114.3 4.63 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 33' ' ' SER . . . . . 0.512 ' OG ' ' HD2' ' 1' ' 34' ' ' PRO . 4.7 t -105.39 158.43 32.23 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.791 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 34' ' ' PRO . . . . . 0.512 ' HD2' ' OG ' ' 1' ' 33' ' ' SER . 13.0 Cg_endo -56.26 -25.86 58.36 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.242 1.961 . . . . 0.0 112.518 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.21 -33.79 37.83 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.961 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 36' ' ' SER . . . . . 0.493 ' HB3' ' H ' ' 1' ' 33' ' ' SER . 23.2 t -70.9 -35.59 72.36 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.516 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 37' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.4 mt -72.66 -39.05 67.42 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 123.742 0.817 . . . . 0.0 110.267 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 38' ' ' ARG . . . . . 0.621 ' O ' ' HB2' ' 1' ' 42' ' ' SER . 22.1 ttm180 -69.0 -42.05 77.0 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.73 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.78 -39.96 84.04 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.737 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 40' ' ' TYR . . . . . 0.699 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 6.0 t80 -72.11 -50.4 28.39 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 122.374 0.269 . . . . 0.0 111.648 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 41' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' 1' ' 37' ' ' LEU . 24.2 m-85 -71.17 -25.57 62.59 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 42' ' ' SER . . . . . 0.621 ' HB2' ' O ' ' 1' ' 38' ' ' ARG . 11.4 t -63.07 -14.05 43.44 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.444 1.116 . . . . 0.0 109.563 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 43' ' ' LYS . . . . . 0.699 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 14.7 mttt -82.67 -13.28 56.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 112.178 -2.283 . . . . 0.0 111.797 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.08 -31.48 10.15 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.98 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 45' ' ' GLY . . . . . 0.47 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -170.88 -161.99 22.46 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -102.74 133.7 47.35 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 121.823 0.821 . . . . 0.0 110.543 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 47' ' ' ILE . . . . . 0.434 HD11 ' C ' ' 1' ' 41' ' ' PHE . 4.1 mt -107.43 138.92 31.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 113.069 -1.878 . . . . 0.0 111.604 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -87.63 -42.38 12.73 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.317 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -164.01 157.86 18.9 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.596 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 50' ' ' CYS . . . . . 0.462 ' H ' HH21 ' 1' ' 38' ' ' ARG . 43.9 t -136.79 149.11 47.59 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.609 0.763 . . . . 0.0 109.443 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 26.3 ttt -145.71 133.9 21.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.653 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 57.3 t -129.23 126.76 64.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 113.859 -1.519 . . . . 0.0 108.693 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 1.3 mmt -71.72 117.28 13.1 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.205 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -131.8 159.72 37.67 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.259 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.48 118.14 55.34 Favored Pre-proline 0 N--CA 1.44 -0.937 0 C-N-CA 123.231 0.612 . . . . 0.0 110.551 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -62.41 -9.27 14.91 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 122.501 2.134 . . . . 0.0 113.845 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 18.3 p -81.74 -44.04 17.57 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 74.5 p -117.68 -9.4 10.75 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.348 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 45.3 mmtt 62.9 12.42 5.78 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.371 1.069 . . . . 0.0 111.863 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -89.78 147.47 23.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.6 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 51.1 p -87.88 156.67 19.25 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.407 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -92.62 -7.56 46.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.819 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.25 20.81 34.37 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-O 119.83 -0.428 . . . . 0.0 113.933 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -148.72 154.88 40.23 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 117.107 0.454 . . . . 0.0 111.226 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.76 -169.65 29.65 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 66' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' 1' ' 23' ' ' MET . 75.6 m-85 -136.67 163.99 29.29 Favored 'General case' 0 N--CA 1.424 -1.751 0 C-N-CA 124.719 1.208 . . . . 0.0 109.853 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 67' ' ' VAL . . . . . . . . . . . . . 69.1 t -147.38 131.86 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 68' ' ' THR . . . . . 0.727 HG23 ' HG3' ' 1' ' 22' ' ' LYS . 1.2 m -105.82 106.09 16.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.722 -1.581 . . . . 0.0 111.744 -177.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -84.09 124.97 31.67 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.677 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.17 4.46 17.36 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 71' ' ' ASP . . . . . 0.616 ' OD2' ' HB3' ' 1' ' 73' ' ' ALA . 13.6 t0 -130.16 132.35 24.02 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.525 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.6 -16.45 24.0 Favored 'Trans proline' 0 C--N 1.36 1.172 0 C-N-CA 121.971 1.78 . . . . 0.0 111.918 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 73' ' ' ALA . . . . . 0.616 ' HB3' ' OD2' ' 1' ' 71' ' ' ASP . . . -77.64 -30.79 52.37 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.929 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 74' ' ' SER . . . . . 0.479 ' O ' HG23 ' 1' ' 78' ' ' VAL . 3.6 t -70.07 -32.21 70.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.24 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 75' ' ' VAL . . . . . 0.657 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 11.5 t -70.13 -31.89 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.583 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -70.8 -41.9 71.0 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.132 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 77' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -65.82 -40.51 91.89 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.862 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 78' ' ' VAL . . . . . 0.479 HG23 ' O ' ' 1' ' 74' ' ' SER . 99.8 t -77.69 -32.28 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.117 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 79' ' ' LEU . . . . . 0.657 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.3 OUTLIER -61.95 -39.47 92.23 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.55 0.74 . . . . 0.0 111.912 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 80' ' ' GLY . . . . . 0.474 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -74.52 -22.41 77.36 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.423 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -100.62 98.18 7.76 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 123.089 0.555 . . . . 0.0 110.267 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 82' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 4.2 Cg_exo -77.65 -31.99 3.02 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.805 2.337 . . . . 0.0 114.132 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -84.82 125.27 32.45 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.871 0.367 . . . . 0.0 111.782 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -137.6 122.01 18.29 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.805 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -113.64 135.0 54.4 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 122.132 0.968 . . . . 0.0 111.162 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 86' ' ' LEU . . . . . 0.572 HD21 ' OG1' ' 1' ' 32' ' ' THR . 6.2 tp -145.25 134.16 22.47 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 112.925 -1.943 . . . . 0.0 107.26 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 10.8 t70 52.11 37.14 20.79 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 122.587 1.184 . . . . 0.0 111.832 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 66.4 m 68.96 10.22 7.81 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 112.865 -1.97 . . . . 0.0 112.03 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 10.1 pttp -126.16 152.2 46.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.044 0.926 . . . . 0.0 110.489 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.6 m -81.52 125.32 30.35 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 113.357 -1.747 . . . . 0.0 111.712 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 91' ' ' ILE . . . . . 0.717 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 49.7 pt -108.99 170.06 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 O-C-N 123.56 0.537 . . . . 0.0 110.166 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -112.32 80.7 3.55 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 93' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' 1' ' 91' ' ' ILE . 4.0 Cg_exo -83.43 122.86 3.27 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.168 1.912 . . . . 0.0 111.189 175.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 94' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -144.68 154.07 42.39 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.596 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 11.5 t -82.4 144.69 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.803 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.74 143.91 45.46 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -114.43 135.04 22.21 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.283 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -77.06 162.83 31.47 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.05 2.5 . . . . 0.0 113.311 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.76 150.7 23.42 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.585 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -109.3 160.12 16.4 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.574 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.33 176.26 9.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.136 0.574 . . . . 0.0 112.397 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -106.31 140.11 20.97 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.801 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -78.84 175.36 11.07 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.738 2.292 . . . . 0.0 113.425 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -85.78 153.75 22.07 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.699 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 20.7 mmt 57.3 135.55 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.53 1.132 . . . . 0.0 113.968 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.73 -56.37 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.529 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.6 m -103.22 106.31 16.79 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -100.84 -35.59 9.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.213 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 16.9 p -103.19 103.41 13.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.886 0.374 . . . . 0.0 111.764 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -102.92 140.64 36.92 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.023 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.561 -0.733 . . . . 0.0 111.131 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 44.1 mtt . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -136.62 -38.42 0.66 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.285 0.366 . . . . 0.0 111.982 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -88.89 -43.83 10.9 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -97.31 -40.77 8.58 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.256 0.347 . . . . 0.0 111.822 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -108.46 137.99 45.5 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.288 0.368 . . . . 0.0 111.098 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -126.43 130.8 51.4 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.936 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -118.88 117.46 28.92 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.183 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 55.0 m -130.05 157.23 42.94 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.848 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -80.63 119.2 22.95 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.851 0.46 . . . . 0.0 111.345 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -95.13 142.25 27.81 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.786 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 20.7 t -114.8 -50.44 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.277 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.32 147.87 24.56 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.132 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 9' ' ' LEU . . . . . 0.431 HD23 ' N ' ' 1' ' 10' ' ' GLY . 0.4 OUTLIER -89.76 163.67 14.98 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.148 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 10' ' ' GLY . . . . . 0.431 ' N ' HD23 ' 1' ' 9' ' ' LEU . . . -126.91 70.62 0.49 Allowed Glycine 0 C--N 1.339 0.749 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.468 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -120.27 -5.4 9.92 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.595 0.358 . . . . 0.0 111.036 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -97.0 -57.45 2.27 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.691 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -79.41 14.26 1.64 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.137 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 14' ' ' LEU . . . . . 0.409 HD13 ' O ' ' 1' ' 10' ' ' GLY . 4.2 tp -82.27 149.63 27.72 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.622 0.369 . . . . 0.0 111.497 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -90.56 152.53 20.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.253 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.71 -43.79 0.19 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.026 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -86.05 123.11 31.0 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.385 0.428 . . . . 0.0 110.972 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 49.0 m -100.41 124.73 46.29 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.449 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -142.74 -56.0 0.42 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.621 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -91.33 148.53 22.27 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.45 0.469 . . . . 0.0 111.32 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.86 -2.94 17.28 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.773 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 22' ' ' LYS . . . . . 0.666 ' HG3' HG23 ' 1' ' 68' ' ' THR . 43.7 mttt -85.62 152.26 23.26 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 23' ' ' MET . . . . . 0.493 ' SD ' HG11 ' 1' ' 78' ' ' VAL . 2.6 mtm -122.95 126.27 46.88 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.999 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -91.34 108.15 19.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.933 -1.485 . . . . 0.0 108.694 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -95.29 115.66 34.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.504 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 26' ' ' GLY . . . . . 0.649 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -108.86 160.41 13.63 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.7 -1.136 . . . . 0.0 114.688 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 27' ' ' GLY . . . . . 0.637 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 69.14 22.66 76.14 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 115.249 0.859 . . . . 0.0 115.249 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 22.7 mt -55.87 168.71 0.43 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 117.703 0.752 . . . . 0.0 110.781 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 29' ' ' SER . . . . . 0.429 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 4.5 t -98.83 174.24 6.48 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.577 0.703 . . . . 0.0 110.307 -178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 30' ' ' TRP . . . . . 0.46 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 0.9 OUTLIER -72.08 -15.45 62.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.466 -179.484 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -100.35 -24.91 14.4 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.111 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 32' ' ' THR . . . . . 0.647 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 0.7 OUTLIER -67.53 113.66 5.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -179.015 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 33' ' ' SER . . . . . 0.447 ' H ' ' HB3' ' 1' ' 36' ' ' SER . 57.7 m -104.89 160.3 26.45 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.98 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 34' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.06 -25.64 55.34 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.138 1.892 . . . . 0.0 112.531 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.96 -34.76 38.47 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.929 178.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 36' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' 1' ' 40' ' ' TYR . 16.9 t -70.49 -35.73 73.41 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 114.22 -1.354 . . . . 0.0 109.441 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 37' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.7 mt -73.03 -37.33 66.94 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 123.736 0.814 . . . . 0.0 110.303 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 38' ' ' ARG . . . . . 0.529 ' HE ' ' HB3' ' 1' ' 50' ' ' CYS . 14.6 ttm180 -70.54 -41.34 72.65 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.695 177.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -40.11 83.22 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.716 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 40' ' ' TYR . . . . . 0.709 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 3.3 t80 -71.89 -51.05 24.17 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 122.682 0.393 . . . . 0.0 111.645 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 41' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' 1' ' 37' ' ' LEU . 27.6 m-85 -71.42 -25.51 62.36 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 42' ' ' SER . . . . . 0.412 ' OG ' HD12 ' 1' ' 47' ' ' ILE . 3.1 m -62.75 -14.05 40.11 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 122.444 1.116 . . . . 0.0 109.621 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 43' ' ' LYS . . . . . 0.709 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 14.1 mmtt -82.04 -13.7 56.96 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 112.222 -2.263 . . . . 0.0 111.676 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.87 -32.08 10.84 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.92 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 45' ' ' GLY . . . . . 0.495 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -173.03 -159.08 19.0 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -103.22 133.03 48.99 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.713 0.768 . . . . 0.0 110.635 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 47' ' ' ILE . . . . . 0.431 HD11 ' C ' ' 1' ' 41' ' ' PHE . 4.4 mt -104.71 140.03 23.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 113.186 -1.825 . . . . 0.0 111.494 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -88.08 -43.22 11.84 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.005 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -165.6 157.5 14.67 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.265 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 50' ' ' CYS . . . . . 0.589 ' SG ' HG22 ' 1' ' 67' ' ' VAL . 53.0 t -135.78 149.86 49.28 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.261 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 26.8 ttt -146.16 133.53 20.71 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.023 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 56.3 t -129.83 125.87 61.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.148 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -69.63 122.33 18.9 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.816 -178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -136.85 154.9 50.39 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.643 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.51 115.05 65.83 Favored Pre-proline 0 N--CA 1.445 -0.725 0 C-N-CA 122.849 0.46 . . . . 0.0 111.019 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.6 -8.31 7.03 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.889 2.393 . . . . 0.0 114.573 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 19.6 p -80.82 -44.58 18.25 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 80.5 p -129.1 -8.09 4.85 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.347 0.405 . . . . 0.0 112.077 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.23 53.32 6.62 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 122.597 1.189 . . . . 0.0 112.184 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -110.64 136.35 49.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.121 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 75.1 m -89.62 150.33 22.43 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.3 0.375 . . . . 0.0 111.183 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -98.57 -10.77 22.93 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.87 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.08 32.24 8.55 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 119.812 -0.438 . . . . 0.0 113.777 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -151.82 149.37 28.93 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.983 0.391 . . . . 0.0 110.995 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.92 -169.33 27.28 Favored Glycine 0 N--CA 1.427 -1.908 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 66' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -136.5 162.5 32.9 Favored 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 125.117 1.367 . . . . 0.0 109.456 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 67' ' ' VAL . . . . . 0.589 HG22 ' SG ' ' 1' ' 50' ' ' CYS . 74.3 t -149.28 129.39 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 68' ' ' THR . . . . . 0.666 HG23 ' HG3' ' 1' ' 22' ' ' LYS . 1.5 m -104.64 107.23 18.08 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 113.353 -1.749 . . . . 0.0 111.922 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -83.44 122.08 28.03 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.867 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.98 2.85 16.29 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 71' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -129.42 134.33 26.12 Favored Pre-proline 0 C--N 1.311 -1.081 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.485 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -73.19 -16.2 25.23 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.107 1.871 . . . . 0.0 111.622 176.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 73' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' 1' ' 77' ' ' LYS . . . -75.42 -32.13 60.61 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.795 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 74' ' ' SER . . . . . 0.495 ' OG ' ' HA3' ' 1' ' 45' ' ' GLY . 4.0 t -69.86 -31.81 69.86 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.156 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 75' ' ' VAL . . . . . 0.694 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 14.2 t -69.89 -31.93 49.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.392 178.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.17 -41.69 70.04 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.983 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 77' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' 1' ' 73' ' ' ALA . 87.4 mttt -65.82 -41.57 91.66 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.728 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 78' ' ' VAL . . . . . 0.493 HG11 ' SD ' ' 1' ' 23' ' ' MET . 98.8 t -75.72 -31.75 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.754 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 79' ' ' LEU . . . . . 0.694 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.2 OUTLIER -62.39 -37.29 85.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.001 0.921 . . . . 0.0 112.115 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 80' ' ' GLY . . . . . 0.569 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -76.7 -27.58 60.69 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.963 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -105.74 88.61 2.95 Favored Pre-proline 0 N--CA 1.444 -0.764 0 C-N-CA 123.212 0.605 . . . . 0.0 110.342 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 82' ' ' PRO . . . . . 0.569 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 2.9 Cg_exo -76.64 -19.91 14.16 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.719 2.28 . . . . 0.0 113.775 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -87.81 124.47 33.66 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.209 0.318 . . . . 0.0 111.046 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -135.91 122.64 21.06 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -113.19 134.39 54.6 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.762 0.792 . . . . 0.0 110.266 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 86' ' ' LEU . . . . . 0.647 HD21 ' OG1' ' 1' ' 32' ' ' THR . 8.8 tp -143.17 131.83 22.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 113.349 -1.751 . . . . 0.0 107.464 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 12.8 t70 51.77 37.1 19.49 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.632 1.205 . . . . 0.0 111.492 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 74.5 m 69.67 8.95 7.0 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 112.833 -1.985 . . . . 0.0 112.219 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -121.85 152.19 39.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 122.014 0.911 . . . . 0.0 110.38 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.3 m -82.25 124.41 29.92 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.25 -1.795 . . . . 0.0 111.744 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 91' ' ' ILE . . . . . 0.649 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 43.1 pt -109.9 170.27 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.986 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 92' ' ' ASP . . . . . 0.466 ' OD1' ' HE2' ' 1' ' 94' ' ' LYS . 8.0 t70 -116.59 83.05 13.18 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -83.0 123.46 3.58 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 121.952 1.768 . . . . 0.0 110.825 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 94' ' ' LYS . . . . . 0.466 ' HE2' ' OD1' ' 1' ' 92' ' ' ASP . 18.5 mmtt -136.53 146.81 46.62 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 t -92.62 121.95 43.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.235 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . 53.5 169.5 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -99.5 108.16 49.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.861 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -81.14 152.05 18.35 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.676 2.251 . . . . 0.0 113.55 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -110.73 131.44 55.05 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.662 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -122.67 135.29 54.55 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.391 0.432 . . . . 0.0 111.233 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -91.16 172.39 8.59 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 123.589 0.555 . . . . 0.0 111.956 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -109.61 143.84 28.64 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.211 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.93 175.83 10.69 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.695 2.263 . . . . 0.0 112.982 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -88.81 127.18 35.61 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.27 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -102.76 116.88 33.44 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.931 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 26.4 t -105.79 -57.4 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.752 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.5 m -96.09 96.06 8.59 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.579 0.549 . . . . 0.0 109.813 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -87.37 136.57 32.89 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.566 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 14.6 p -111.87 -45.74 3.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.158 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -85.16 142.17 29.66 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.39 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 56.6 pttt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.037 -0.982 . . . . 0.0 111.032 179.721 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 14.1 ttm . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -108.09 135.46 49.41 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.894 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 71.3 m80 59.29 130.14 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.281 1.032 . . . . 0.0 113.097 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -115.56 149.25 38.5 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.701 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -115.43 151.76 34.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.935 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -98.71 132.82 43.79 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.85 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -123.27 144.39 49.44 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.95 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 44.9 p -108.27 -52.38 2.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.609 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 4.3 t -105.67 103.35 12.84 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.438 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -102.33 140.74 36.21 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.857 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 10.4 t -100.09 133.14 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.203 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -84.26 121.55 27.65 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.368 0.418 . . . . 0.0 112.042 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 tp -94.98 153.8 17.48 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.491 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.31 75.37 0.3 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 121.067 -0.587 . . . . 0.0 113.1 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 5.2 t -135.96 -10.2 2.04 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.313 0.245 . . . . 0.0 111.323 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -94.75 -49.0 5.8 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.331 0.395 . . . . 0.0 111.375 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -80.39 20.84 0.66 Allowed 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.822 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 tp -76.84 151.46 35.87 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.819 0.448 . . . . 0.0 111.678 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -85.82 131.58 34.28 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.413 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -146.2 55.9 1.17 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.494 0.664 . . . . 0.0 109.723 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -85.3 130.89 34.5 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.082 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 75.4 m -104.01 142.61 34.15 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.82 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -107.51 -58.11 2.0 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.631 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.98 122.78 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.471 1.108 . . . . 0.0 113.511 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.73 5.64 0.12 Allowed Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.978 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 22' ' ' LYS . . . . . 0.751 ' HB3' HG23 ' 1' ' 68' ' ' THR . 28.4 pttt -91.32 174.03 7.6 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.537 0.208 . . . . 0.0 111.276 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 23' ' ' MET . . . . . 0.402 ' O ' ' HA ' ' 1' ' 66' ' ' PHE . 12.5 mtp -123.06 152.47 40.97 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.651 0.739 . . . . 0.0 110.967 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -104.91 107.1 17.89 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.403 -1.726 . . . . 0.0 107.78 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -96.03 116.31 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 123.098 0.559 . . . . 0.0 110.304 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 26' ' ' GLY . . . . . 0.695 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -108.52 161.34 13.33 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.17 -0.923 . . . . 0.0 115.039 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 27' ' ' GLY . . . . . 0.654 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 69.8 21.03 76.44 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 27.2 mt -54.46 169.05 0.21 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 117.601 0.701 . . . . 0.0 111.35 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 29' ' ' SER . . . . . 0.4 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 5.7 t -100.89 174.22 6.13 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 121.538 0.685 . . . . 0.0 110.467 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 30' ' ' TRP . . . . . 0.488 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.8 p-90 -72.34 -16.4 61.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.423 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -100.12 -24.85 14.48 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.236 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 32' ' ' THR . . . . . 0.683 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 1.2 m -68.89 113.76 6.6 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.446 0.641 . . . . 0.0 112.557 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 33' ' ' SER . . . . . . . . . . . . . 62.7 m -103.76 160.95 24.46 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.014 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 34' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' 1' ' 38' ' ' ARG . 14.1 Cg_endo -56.33 -25.41 56.7 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.077 1.851 . . . . 0.0 112.257 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.87 -33.36 40.13 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.984 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 36' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' 1' ' 40' ' ' TYR . 16.9 t -70.64 -36.79 73.62 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.078 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 37' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.8 mt -73.15 -35.67 66.52 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 124.134 0.974 . . . . 0.0 110.443 178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 38' ' ' ARG . . . . . 0.646 ' O ' ' HB2' ' 1' ' 42' ' ' SER . 10.7 ttp180 -72.88 -38.43 66.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.791 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -39.44 71.69 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.679 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 40' ' ' TYR . . . . . 0.718 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 6.0 t80 -71.7 -51.65 21.88 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 122.743 0.417 . . . . 0.0 111.673 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 41' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' 1' ' 37' ' ' LEU . 29.8 m-85 -71.15 -25.64 62.65 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 42' ' ' SER . . . . . 0.646 ' HB2' ' O ' ' 1' ' 38' ' ' ARG . 8.3 t -65.49 -14.38 60.87 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 122.481 1.134 . . . . 0.0 109.547 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 43' ' ' LYS . . . . . 0.718 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 6.2 mmtp -81.33 -12.74 58.94 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 112.339 -2.209 . . . . 0.0 111.605 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -106.02 -33.92 7.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.068 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 45' ' ' GLY . . . . . 0.448 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -164.79 -162.2 15.34 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -105.26 133.72 49.56 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.851 0.834 . . . . 0.0 110.477 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 47' ' ' ILE . . . . . 0.419 HD11 ' C ' ' 1' ' 41' ' ' PHE . 4.2 mt -106.3 139.55 27.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 113.15 -1.841 . . . . 0.0 111.498 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -87.52 -41.14 13.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.233 -1.348 . . . . 0.0 109.888 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -166.23 156.46 12.37 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.515 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 50' ' ' CYS . . . . . . . . . . . . . 40.1 t -132.72 150.63 52.13 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.296 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 60.9 ttp -144.7 134.24 23.33 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.921 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.67 126.05 62.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 113.728 -1.578 . . . . 0.0 108.285 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 1.5 mmt -70.62 111.47 6.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.949 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -137.1 154.02 50.4 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.087 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.56 113.45 65.83 Favored Pre-proline 0 N--CA 1.444 -0.744 0 C-N-CA 122.596 0.358 . . . . 0.0 110.917 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.16 -8.62 8.59 Favored 'Trans proline' 0 C--N 1.365 1.426 0 C-N-CA 122.518 2.145 . . . . 0.0 114.386 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 17.9 p -81.25 -44.09 18.25 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 73.8 p -124.7 -8.49 7.34 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.229 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 5.2 mptt 56.68 53.28 8.56 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.777 1.275 . . . . 0.0 112.216 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -104.02 136.27 43.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 112.665 -2.061 . . . . 0.0 110.872 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 61.3 m -96.56 136.77 36.6 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.97 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -93.96 -9.09 38.14 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.47 29.95 17.57 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 114.393 0.517 . . . . 0.0 114.393 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -153.65 149.67 27.8 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.193 0.496 . . . . 0.0 111.295 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.2 -167.33 21.51 Favored Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 66' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' 1' ' 23' ' ' MET . 74.6 m-85 -138.34 161.96 35.59 Favored 'General case' 0 N--CA 1.424 -1.759 0 C-N-CA 124.988 1.315 . . . . 0.0 109.703 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 67' ' ' VAL . . . . . . . . . . . . . 70.3 t -145.29 129.01 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 68' ' ' THR . . . . . 0.751 HG23 ' HB3' ' 1' ' 22' ' ' LYS . 1.1 m -103.64 106.42 16.93 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 113.493 -1.685 . . . . 0.0 111.882 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -84.75 124.11 31.17 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.679 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.98 2.07 9.49 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -129.88 135.07 26.92 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.196 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.4 -16.52 24.51 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 121.972 1.781 . . . . 0.0 111.987 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 73' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' 1' ' 77' ' ' LYS . . . -77.47 -32.19 54.22 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.596 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 74' ' ' SER . . . . . 0.448 ' OG ' ' HA3' ' 1' ' 45' ' ' GLY . 3.0 t -69.97 -32.57 70.86 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.326 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 75' ' ' VAL . . . . . 0.741 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 5.7 t -70.44 -32.5 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.658 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -72.26 -41.83 66.3 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.088 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 77' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' 1' ' 73' ' ' ALA . 45.4 mttm -68.1 -39.0 82.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 113.748 -1.569 . . . . 0.0 112.505 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 78' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.86 -32.28 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.397 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 79' ' ' LEU . . . . . 0.741 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.8 OUTLIER -66.79 -31.92 72.88 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 122.499 0.32 . . . . 0.0 110.8 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 80' ' ' GLY . . . . . 0.512 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -74.43 -14.66 80.77 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.466 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -95.44 99.93 5.31 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 122.748 0.419 . . . . 0.0 110.592 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 82' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 4.6 Cg_exo -77.25 -34.67 2.0 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.6 2.2 . . . . 0.0 113.565 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -90.91 122.1 33.32 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.282 0.364 . . . . 0.0 111.077 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -139.52 122.45 16.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.058 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -114.58 134.6 54.92 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.003 0.906 . . . . 0.0 110.886 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 86' ' ' LEU . . . . . 0.683 HD21 ' OG1' ' 1' ' 32' ' ' THR . 8.4 tp -143.75 132.93 23.06 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.043 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t70 51.46 36.84 17.76 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.683 1.23 . . . . 0.0 111.526 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 10.2 t 69.5 8.89 7.01 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 112.69 -2.05 . . . . 0.0 112.206 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 25.8 pttt -121.79 152.06 39.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.022 0.915 . . . . 0.0 110.392 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.0 m -81.06 124.03 28.86 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.26 -1.791 . . . . 0.0 111.573 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 91' ' ' ILE . . . . . 0.695 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 28.2 pt -111.1 168.85 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.032 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -117.06 86.9 21.1 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -83.43 123.96 3.53 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 122.254 1.969 . . . . 0.0 111.363 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 144.19 23.27 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.581 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 3.9 t -70.53 141.36 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.813 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.15 156.95 25.47 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.697 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -110.19 129.84 23.5 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.144 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -71.0 171.6 15.49 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.734 2.289 . . . . 0.0 113.014 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -93.61 -13.21 27.91 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -97.58 124.93 42.03 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.48 170.08 11.2 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -120.38 153.98 56.27 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.759 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.86 177.92 8.22 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.301 2.0 . . . . 0.0 113.155 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.94 140.98 32.49 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.726 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 21.5 mmt -95.97 135.11 38.15 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.198 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 27.2 t -112.12 -58.54 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.3 m -100.53 95.34 6.65 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.531 0.52 . . . . 0.0 109.846 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -94.74 147.6 23.15 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.645 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 12.3 p -95.75 146.85 24.2 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.322 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -109.07 -42.44 4.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.439 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 66.1 mttm . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.459 -0.781 . . . . 0.0 111.614 -179.891 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.485 0.184 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -98.44 153.5 18.54 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.228 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.99 136.74 43.06 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.017 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -132.97 136.94 46.37 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.613 0.57 . . . . 0.0 111.039 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -108.53 136.58 47.9 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.808 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -131.91 148.53 52.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.788 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -100.98 129.98 46.91 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.082 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 16.3 t -95.72 133.86 39.32 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.896 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 5.1 t -127.27 -50.03 1.42 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.493 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 68.6 m -96.98 130.73 44.26 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.445 0.466 . . . . 0.0 111.08 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 7.5 t -97.21 122.32 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.328 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -88.22 139.64 30.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.065 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 15.8 mt -88.87 -177.77 5.58 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.785 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.28 70.8 0.15 Allowed Glycine 0 C--N 1.34 0.785 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.199 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 61.6 p -127.91 -20.11 3.91 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.709 0.299 . . . . 0.0 111.115 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -95.16 -41.93 8.84 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.456 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -79.49 37.6 0.34 Allowed 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.915 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 tp -83.17 157.9 22.56 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.248 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -85.88 -12.19 51.32 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -77.85 -3.03 39.53 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -85.72 132.37 34.15 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.279 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 50.0 m -89.12 146.63 24.68 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.5 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -128.84 -44.37 1.33 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.95 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.5 152.63 30.1 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.991 0.516 . . . . 0.0 111.641 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.88 -1.89 17.4 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.224 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 22' ' ' LYS . . . . . 0.605 ' HG3' HG23 ' 1' ' 68' ' ' THR . 43.5 mttt -80.82 149.85 29.4 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 23' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' 1' ' 66' ' ' PHE . 5.8 mtp -120.66 127.56 52.17 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.057 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -91.52 105.92 18.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.846 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 mm -96.13 111.45 26.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.481 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 26' ' ' GLY . . . . . 0.694 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -103.35 159.16 17.15 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 115.485 0.954 . . . . 0.0 115.485 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 27' ' ' GLY . . . . . 0.67 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 70.01 26.14 74.69 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 17.0 mt -58.16 170.61 0.65 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 117.764 0.782 . . . . 0.0 111.169 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 29' ' ' SER . . . . . 0.417 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 4.5 t -99.42 174.48 6.26 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.568 0.699 . . . . 0.0 110.531 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 30' ' ' TRP . . . . . 0.472 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.5 p-90 -71.34 -16.9 62.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.515 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -99.1 -24.53 14.85 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.218 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 32' ' ' THR . . . . . 0.579 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 0.7 OUTLIER -64.74 113.95 4.12 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 33' ' ' SER . . . . . 0.459 ' H ' ' HB3' ' 1' ' 36' ' ' SER . 58.2 m -105.95 159.6 29.06 Favored Pre-proline 0 N--CA 1.467 0.378 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.977 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 34' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -56.65 -25.88 62.08 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.015 1.81 . . . . 0.0 112.557 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.29 -32.96 38.05 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.947 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 36' ' ' SER . . . . . 0.459 ' HB3' ' H ' ' 1' ' 33' ' ' SER . 16.7 t -70.69 -36.0 73.08 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.239 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 37' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.5 mt -72.96 -37.95 66.9 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 123.829 0.851 . . . . 0.0 110.148 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 38' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -68.81 -43.69 75.1 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.569 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.6 -40.15 88.74 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.871 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 40' ' ' TYR . . . . . 0.708 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 6.8 t80 -71.81 -51.0 24.73 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 122.651 0.381 . . . . 0.0 111.553 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 41' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' 1' ' 37' ' ' LEU . 23.3 m-85 -71.37 -25.7 62.48 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 42' ' ' SER . . . . . 0.471 ' OG ' HD12 ' 1' ' 47' ' ' ILE . 3.3 m -63.61 -13.96 47.09 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 122.458 1.123 . . . . 0.0 109.71 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 43' ' ' LYS . . . . . 0.708 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 6.4 mmtp -80.47 -11.89 59.62 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 112.33 -2.214 . . . . 0.0 111.625 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.84 -33.89 9.19 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.002 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 45' ' ' GLY . . . . . 0.43 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -170.59 -159.77 17.39 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -102.16 133.17 47.45 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.885 0.85 . . . . 0.0 110.571 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 47' ' ' ILE . . . . . 0.471 HD12 ' OG ' ' 1' ' 42' ' ' SER . 5.0 mt -104.99 138.94 27.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 113.017 -1.901 . . . . 0.0 111.403 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -87.96 -42.21 12.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.11 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -163.95 157.58 18.72 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.198 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 50' ' ' CYS . . . . . 0.458 ' SG ' HG22 ' 1' ' 67' ' ' VAL . 41.3 t -137.38 149.52 47.02 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 123.551 0.74 . . . . 0.0 109.287 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 61.8 ttp -146.84 136.9 23.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.138 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 91.9 t -126.27 123.87 64.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.573 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 1.2 mmt -75.4 124.33 26.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.408 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -136.61 158.4 44.54 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.277 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.15 118.21 56.55 Favored Pre-proline 0 N--CA 1.44 -0.951 0 C-N-CA 122.749 0.419 . . . . 0.0 110.826 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -64.06 -9.53 19.71 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 122.437 2.092 . . . . 0.0 113.541 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 18.7 p -81.99 -44.2 17.0 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 77.0 p -118.52 -9.18 10.35 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt 62.39 12.41 5.28 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.254 1.022 . . . . 0.0 111.927 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -92.81 143.06 26.65 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.392 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 38.1 m -94.79 154.82 17.09 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.894 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -97.87 -9.97 25.44 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.935 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.54 37.45 5.84 Favored Glycine 0 C--N 1.339 0.705 0 CA-C-O 119.766 -0.464 . . . . 0.0 114.032 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -153.47 151.94 30.42 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 117.134 0.467 . . . . 0.0 111.325 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.48 -169.69 22.26 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 66' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' 1' ' 23' ' ' MET . 83.0 m-85 -137.39 161.48 36.19 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 125.002 1.321 . . . . 0.0 109.808 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 67' ' ' VAL . . . . . 0.458 HG22 ' SG ' ' 1' ' 50' ' ' CYS . 74.0 t -147.65 132.28 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 68' ' ' THR . . . . . 0.605 HG23 ' HG3' ' 1' ' 22' ' ' LYS . 1.4 m -105.7 105.59 15.7 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.59 -1.641 . . . . 0.0 111.609 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -82.82 123.99 29.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.365 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.58 3.52 15.96 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 71' ' ' ASP . . . . . 0.606 ' OD2' ' HB3' ' 1' ' 73' ' ' ALA . 14.9 t0 -129.93 132.85 24.4 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.562 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.63 -16.3 24.01 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.04 1.827 . . . . 0.0 111.797 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 73' ' ' ALA . . . . . 0.606 ' HB3' ' OD2' ' 1' ' 71' ' ' ASP . . . -77.35 -30.9 54.1 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.83 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 74' ' ' SER . . . . . 0.493 ' O ' HG23 ' 1' ' 78' ' ' VAL . 4.1 t -70.05 -31.78 69.57 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.293 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 75' ' ' VAL . . . . . 0.644 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 6.4 t -70.09 -31.41 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.519 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -71.76 -40.79 69.09 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.985 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 77' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -66.01 -42.07 90.2 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.051 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 78' ' ' VAL . . . . . 0.493 HG23 ' O ' ' 1' ' 74' ' ' SER . 59.7 t -75.89 -32.48 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.128 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 79' ' ' LEU . . . . . 0.644 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.3 OUTLIER -64.13 -35.14 79.79 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.388 0.675 . . . . 0.0 111.726 179.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 80' ' ' GLY . . . . . 0.488 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -74.58 -20.31 79.59 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.253 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -99.63 98.28 6.84 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 122.961 0.504 . . . . 0.0 110.316 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 82' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 2.8 Cg_exo -76.51 -34.31 2.7 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.895 2.397 . . . . 0.0 113.979 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -88.48 125.16 34.62 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.689 0.281 . . . . 0.0 111.68 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -134.56 119.68 18.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -115.38 134.66 54.9 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.974 0.893 . . . . 0.0 110.649 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 86' ' ' LEU . . . . . 0.579 HD21 ' OG1' ' 1' ' 32' ' ' THR . 7.2 tp -145.08 134.24 22.76 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.19 -1.823 . . . . 0.0 107.199 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 10.7 t70 51.79 37.01 19.33 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.679 1.192 . . . . 0.0 111.827 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 66.3 m 68.95 9.75 7.57 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 112.914 -1.948 . . . . 0.0 111.963 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -123.99 152.14 42.89 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.995 0.902 . . . . 0.0 110.267 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.6 m -80.94 126.73 31.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.398 -1.728 . . . . 0.0 111.743 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 91' ' ' ILE . . . . . 0.694 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 43.4 pt -112.85 166.5 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 123.661 0.601 . . . . 0.0 109.612 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 92' ' ' ASP . . . . . 0.552 ' OD2' ' HD3' ' 1' ' 94' ' ' LYS . 6.1 t70 -114.92 91.46 26.55 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -175.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -82.91 124.01 3.78 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.357 2.038 . . . . 0.0 111.025 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 94' ' ' LYS . . . . . 0.552 ' HD3' ' OD2' ' 1' ' 92' ' ' ASP . 21.0 pttt -143.39 140.54 30.51 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.1 136.85 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.788 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . 51.17 164.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.31 121.6 52.89 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.657 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.14 155.48 25.78 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.625 2.217 . . . . 0.0 112.276 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -93.2 119.95 32.94 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.018 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -149.51 137.11 20.16 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.19 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.72 172.72 13.4 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.19 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -114.23 123.7 32.09 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.445 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.41 -178.59 4.57 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.508 2.139 . . . . 0.0 113.044 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.63 142.88 31.39 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.68 0.392 . . . . 0.0 111.314 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 22.5 mmt -92.1 130.96 37.71 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.575 0.547 . . . . 0.0 111.81 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.03 162.67 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.672 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.2 m -94.17 93.6 7.88 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.108 0.48 . . . . 0.0 110.758 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -101.57 132.88 46.98 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.508 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 7.4 t -101.84 144.94 29.87 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.915 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.6 -49.74 0.78 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.269 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 80.4 mttt . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.016 179.623 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 11.2 mmt . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.66 0.267 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 65.4 m80 62.79 139.6 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.285 1.034 . . . . 0.0 112.873 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -110.62 145.36 38.03 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.996 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -107.74 144.79 34.38 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.652 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -96.65 111.22 23.45 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.288 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -144.53 133.43 22.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.508 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -131.6 143.01 50.02 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.375 0.422 . . . . 0.0 111.589 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 43.3 p -133.98 -48.01 0.8 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.431 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 4.8 t -125.96 106.56 9.72 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.205 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 10.6 t -102.93 -15.32 16.19 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.109 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 t -95.21 109.12 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 123.357 0.411 . . . . 0.0 110.19 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -122.03 -47.27 2.17 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.809 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 pp -88.49 134.81 33.75 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.461 0.476 . . . . 0.0 111.138 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.55 72.84 0.29 Allowed Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.299 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 11' ' ' THR . . . . . 0.581 ' HA ' ' HB2' ' 1' ' 15' ' ' TYR . 10.0 t -144.03 8.25 1.44 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -102.77 -58.95 1.78 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.878 0.371 . . . . 0.0 111.724 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -79.51 -38.7 33.74 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.9 -46.04 9.23 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 15' ' ' TYR . . . . . 0.581 ' HB2' ' HA ' ' 1' ' 11' ' ' THR . 3.8 m-85 -88.41 132.62 34.38 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.102 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -145.2 -43.47 0.22 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.844 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -88.68 151.32 22.52 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 123.382 0.426 . . . . 0.0 111.517 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 66.7 m -89.06 156.58 18.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.493 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -100.73 -12.95 18.7 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.272 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.47 147.89 32.08 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.712 0.405 . . . . 0.0 111.97 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.79 -15.74 4.84 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.985 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 22' ' ' LYS . . . . . 0.741 ' HB3' HG23 ' 1' ' 68' ' ' THR . 13.6 pttt -100.26 173.65 6.51 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 123.561 0.212 . . . . 0.0 110.798 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 23' ' ' MET . . . . . . . . . . . . . 8.6 mtp -122.55 151.96 40.86 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 121.651 0.738 . . . . 0.0 111.178 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.55 108.29 19.73 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.471 -1.695 . . . . 0.0 107.875 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -96.58 120.21 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 123.387 0.675 . . . . 0.0 110.087 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 26' ' ' GLY . . . . . 0.739 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -113.57 160.1 13.33 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.019 -0.991 . . . . 0.0 114.876 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 27' ' ' GLY . . . . . 0.583 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 70.56 21.6 77.7 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 115.409 0.924 . . . . 0.0 115.409 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 mt -55.37 167.41 0.48 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 117.734 0.767 . . . . 0.0 111.338 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 29' ' ' SER . . . . . 0.413 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 5.8 t -100.46 174.72 5.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.448 0.642 . . . . 0.0 110.156 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 30' ' ' TRP . . . . . 0.476 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.6 p-90 -71.42 -16.85 62.41 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 124.753 1.221 . . . . 0.0 111.48 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -97.16 -24.52 15.69 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.216 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 32' ' ' THR . . . . . 0.544 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 0.4 OUTLIER -70.58 113.84 8.09 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.08 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 33' ' ' SER . . . . . 0.474 ' H ' ' HB3' ' 1' ' 36' ' ' SER . 75.3 m -105.77 160.09 27.3 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.059 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 34' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' 1' ' 38' ' ' ARG . 13.8 Cg_endo -56.38 -25.66 58.43 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.09 1.86 . . . . 0.0 112.37 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.84 -34.11 39.65 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.797 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 36' ' ' SER . . . . . 0.474 ' HB3' ' H ' ' 1' ' 33' ' ' SER . 15.1 t -71.02 -36.14 72.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.57 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 37' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.6 mt -73.01 -35.87 66.89 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 124.026 0.93 . . . . 0.0 110.254 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 38' ' ' ARG . . . . . 0.565 ' HE ' ' HB3' ' 1' ' 50' ' ' CYS . 13.2 ttm180 -72.39 -41.38 66.38 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.548 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.58 -38.74 80.92 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.756 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 40' ' ' TYR . . . . . 0.719 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 6.1 t80 -72.16 -51.82 19.48 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 122.549 0.34 . . . . 0.0 111.354 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 41' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' 1' ' 37' ' ' LEU . 37.1 m-85 -71.41 -24.98 62.14 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 42' ' ' SER . . . . . 0.412 ' OG ' HD12 ' 1' ' 47' ' ' ILE . 3.1 m -62.45 -14.24 38.81 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.483 1.135 . . . . 0.0 109.241 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 43' ' ' LYS . . . . . 0.719 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 7.0 mttm -85.03 -14.91 45.88 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 112.109 -2.314 . . . . 0.0 111.205 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.52 -31.6 11.19 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.925 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.42 -158.99 16.54 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -106.09 133.77 50.28 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.767 0.794 . . . . 0.0 110.404 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 47' ' ' ILE . . . . . 0.412 HD12 ' OG ' ' 1' ' 42' ' ' SER . 4.3 mt -107.92 140.46 26.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-N 113.217 -1.81 . . . . 0.0 111.713 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -92.82 -40.76 10.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.199 -1.364 . . . . 0.0 110.053 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -163.45 157.52 19.92 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.238 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 50' ' ' CYS . . . . . 0.594 ' SG ' HG22 ' 1' ' 67' ' ' VAL . 50.6 t -138.06 147.86 44.5 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.2 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 63.0 ttp -144.02 133.61 23.55 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.073 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.21 124.32 60.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 113.686 -1.597 . . . . 0.0 108.048 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 5.7 mmt -74.51 126.76 31.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.698 -1.137 . . . . 0.0 113.003 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 22.9 mtt180 -132.25 159.57 38.7 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.509 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.39 119.04 54.16 Favored Pre-proline 0 N--CA 1.441 -0.886 0 C-N-CA 122.885 0.474 . . . . 0.0 110.77 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.51 -10.25 23.53 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 122.353 2.035 . . . . 0.0 113.436 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 20.4 p -82.13 -44.34 16.6 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 74.0 p -116.29 -9.98 11.47 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt 62.54 11.89 5.05 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.416 1.086 . . . . 0.0 111.98 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 7.5 mmt85 -94.32 146.07 24.3 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.968 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 58.3 p -86.83 155.66 20.19 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.519 0.512 . . . . 0.0 111.465 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -94.87 -10.93 29.77 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.364 0.415 . . . . 0.0 111.959 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.7 32.98 8.17 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 116.387 -0.369 . . . . 0.0 113.518 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -150.94 152.61 33.85 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.753 0.277 . . . . 0.0 111.103 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.83 -169.5 30.51 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 66' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -137.52 161.81 35.41 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 125.19 1.396 . . . . 0.0 109.484 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 67' ' ' VAL . . . . . 0.594 HG22 ' SG ' ' 1' ' 50' ' ' CYS . 90.8 t -146.81 127.82 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 68' ' ' THR . . . . . 0.741 HG23 ' HB3' ' 1' ' 22' ' ' LYS . 0.8 OUTLIER -101.6 107.96 19.37 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 113.468 -1.696 . . . . 0.0 111.513 -177.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -83.72 122.85 29.19 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.074 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.47 3.34 9.47 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -131.34 134.84 26.18 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.135 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -72.93 -16.07 26.05 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 122.013 1.809 . . . . 0.0 111.792 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 73' ' ' ALA . . . . . 0.428 ' O ' ' HG3' ' 1' ' 77' ' ' LYS . . . -76.7 -28.8 56.02 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.103 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 74' ' ' SER . . . . . 0.571 ' O ' HG23 ' 1' ' 78' ' ' VAL . 5.9 t -69.69 -31.9 70.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.169 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 75' ' ' VAL . . . . . 0.695 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 13.8 t -70.44 -32.0 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.576 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -71.54 -40.82 69.79 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.037 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 77' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' 1' ' 73' ' ' ALA . 81.3 mttt -65.53 -42.16 92.3 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 113.825 -1.534 . . . . 0.0 112.134 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 78' ' ' VAL . . . . . 0.571 HG23 ' O ' ' 1' ' 74' ' ' SER . 32.6 t -77.28 -31.48 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.052 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 79' ' ' LEU . . . . . 0.695 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.2 OUTLIER -63.28 -35.96 82.1 Favored 'General case' 0 C--N 1.346 0.438 0 C-N-CA 123.915 0.886 . . . . 0.0 112.016 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 80' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -74.87 -27.75 64.09 Favored Glycine 0 C--N 1.346 1.087 0 O-C-N 123.62 0.575 . . . . 0.0 113.091 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -104.01 96.03 8.81 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.14 0.576 . . . . 0.0 110.064 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 82' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 3.8 Cg_exo -76.7 -31.55 4.09 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.781 2.321 . . . . 0.0 114.292 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -84.82 127.37 34.1 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.703 0.287 . . . . 0.0 111.464 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -138.65 125.65 21.25 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -113.06 134.59 54.46 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 121.946 0.879 . . . . 0.0 110.622 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 86' ' ' LEU . . . . . 0.544 HD21 ' OG1' ' 1' ' 32' ' ' THR . 7.6 tp -144.03 132.67 22.34 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.154 -1.839 . . . . 0.0 107.208 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t70 52.13 36.98 20.43 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 122.712 1.244 . . . . 0.0 111.529 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 62.6 m 68.49 9.68 7.42 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.747 -2.024 . . . . 0.0 112.122 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -122.87 152.42 40.78 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.071 0.939 . . . . 0.0 110.49 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.4 m -82.17 122.46 27.91 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.45 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 91' ' ' ILE . . . . . 0.739 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 21.3 pt -109.38 171.55 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.372 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 92' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -114.04 81.35 6.11 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 93' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' 1' ' 91' ' ' ILE . 4.5 Cg_exo -83.48 123.66 3.43 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 121.988 1.792 . . . . 0.0 110.987 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.56 150.72 31.59 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.24 141.69 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.118 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.98 150.98 40.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.255 0.622 . . . . 0.0 112.641 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -106.0 115.64 60.95 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.306 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.31 175.16 11.7 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.716 2.277 . . . . 0.0 112.93 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -99.34 -37.79 9.1 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.442 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -95.79 153.84 17.53 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.222 0.326 . . . . 0.0 110.96 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.37 170.79 14.17 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 123.535 0.522 . . . . 0.0 112.253 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -123.77 139.79 33.03 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.982 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.69 178.03 7.93 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.461 2.107 . . . . 0.0 113.0 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -82.03 127.33 32.97 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.585 0.354 . . . . 0.0 111.304 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 82.5 mtp -93.87 146.66 23.74 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.341 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 2.7 t -97.36 161.48 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.554 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.3 m -97.03 97.22 9.05 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.117 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -91.08 149.21 21.91 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.953 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 16.1 p -143.5 -34.74 0.4 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.431 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -80.21 -32.29 38.56 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.858 0.463 . . . . 0.0 112.16 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 96.2 mttt . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.066 -0.969 . . . . 0.0 111.487 179.959 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 48.6 mtt . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -96.75 136.62 37.03 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.342 0.401 . . . . 0.0 111.34 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -127.47 -41.7 1.7 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.842 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -112.38 139.76 47.67 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.729 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -101.77 139.2 37.73 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.048 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -118.85 141.58 48.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.599 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -107.01 141.95 37.41 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.579 0.549 . . . . 0.0 111.188 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 52.0 m -95.68 145.25 25.42 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.017 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 6.9 t -96.55 125.63 41.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.117 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 60.5 m -113.45 -18.23 12.04 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.963 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 t -92.94 107.39 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 123.434 0.459 . . . . 0.0 109.991 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -88.5 149.89 23.4 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.351 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 tp -89.15 153.41 20.97 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.986 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.19 71.84 0.38 Allowed Glycine 0 C--N 1.339 0.745 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.616 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 64.0 p -114.36 -21.57 10.32 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.384 0.274 . . . . 0.0 111.367 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -108.71 -41.85 4.67 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.867 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -76.79 9.39 2.88 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.11 156.65 24.41 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.57 0.224 . . . . 0.0 111.551 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -84.18 161.48 20.55 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.581 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -142.62 -42.81 0.32 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.075 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -83.76 155.49 23.02 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.18 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -114.23 -9.01 12.9 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.22 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -98.11 -16.43 19.55 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.02 150.38 27.62 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.662 0.385 . . . . 0.0 111.645 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.1 1.4 29.98 Favored Glycine 0 C--N 1.34 0.797 0 O-C-N 123.569 0.543 . . . . 0.0 113.816 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 22' ' ' LYS . . . . . 0.772 ' HG3' HG23 ' 1' ' 68' ' ' THR . 39.2 mttt -78.4 162.84 26.13 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 23' ' ' MET . . . . . 0.448 ' SD ' HG11 ' 1' ' 78' ' ' VAL . 2.4 ttm -128.98 151.4 49.73 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.166 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -120.18 109.61 15.63 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 125.159 1.384 . . . . 0.0 108.295 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 25' ' ' ILE . . . . . 0.408 HD12 ' CZ ' ' 1' ' 41' ' ' PHE . 0.9 OUTLIER -98.51 116.44 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.444 -178.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 26' ' ' GLY . . . . . 0.684 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -105.21 157.57 16.36 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.741 -1.118 . . . . 0.0 114.612 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 27' ' ' GLY . . . . . 0.654 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 72.0 21.17 79.18 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 177.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 25.7 mt -54.94 168.42 0.3 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.895 0.847 . . . . 0.0 111.101 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 29' ' ' SER . . . . . 0.401 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 4.1 t -100.25 174.4 6.15 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.684 0.754 . . . . 0.0 110.381 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 30' ' ' TRP . . . . . 0.474 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.7 p-90 -72.22 -16.08 61.94 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.532 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -98.41 -25.06 14.93 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.22 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 32' ' ' THR . . . . . 0.628 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 0.6 OUTLIER -68.45 113.63 6.17 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.514 0.673 . . . . 0.0 112.686 -179.03 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 33' ' ' SER . . . . . 0.453 ' H ' ' HB3' ' 1' ' 36' ' ' SER . 25.3 p -103.4 159.82 28.1 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.253 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 34' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.44 -25.7 49.95 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.061 1.841 . . . . 0.0 112.54 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.19 -33.94 37.84 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.068 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 36' ' ' SER . . . . . 0.453 ' HB3' ' H ' ' 1' ' 33' ' ' SER . 19.4 t -70.49 -35.23 73.13 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.04 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 37' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.5 mt -72.57 -40.37 66.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.176 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 38' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -67.2 -42.54 83.97 Favored 'General case' 0 C--N 1.347 0.457 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.92 -40.28 87.61 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.791 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 40' ' ' TYR . . . . . 0.736 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 5.8 t80 -72.01 -50.69 26.51 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-O 120.802 0.334 . . . . 0.0 111.446 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 41' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' 1' ' 37' ' ' LEU . 20.0 m-85 -71.4 -25.66 62.44 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -178.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 42' ' ' SER . . . . . . . . . . . . . 36.7 p -62.88 -14.18 43.2 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.496 1.141 . . . . 0.0 109.565 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 43' ' ' LYS . . . . . 0.736 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 13.7 mmtt -79.44 -12.8 59.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 112.238 -2.255 . . . . 0.0 111.534 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -101.53 -34.63 9.46 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.083 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 45' ' ' GLY . . . . . 0.404 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -171.19 -160.29 19.37 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -101.52 132.14 47.3 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-O 121.884 0.85 . . . . 0.0 110.308 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 47' ' ' ILE . . . . . 0.429 HD11 ' C ' ' 1' ' 41' ' ' PHE . 5.0 mt -103.08 138.27 28.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 112.97 -1.923 . . . . 0.0 111.667 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -86.13 -43.42 13.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.314 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -162.97 157.71 21.35 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.296 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 50' ' ' CYS . . . . . . . . . . . . . 44.5 t -138.19 148.7 45.1 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.268 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 64.0 ttp -146.96 135.41 21.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.161 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 70.4 t -127.43 125.1 65.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 113.639 -1.618 . . . . 0.0 108.48 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 11.5 mmt -77.2 116.98 18.28 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.219 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -136.37 155.06 50.57 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.554 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.33 116.18 65.21 Favored Pre-proline 0 N--CA 1.437 -1.081 0 C-N-CA 122.837 0.455 . . . . 0.0 110.84 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.99 -10.17 21.97 Favored 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 122.258 1.972 . . . . 0.0 113.188 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 19.1 p -82.08 -44.21 16.84 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 58' ' ' THR . . . . . 0.528 ' OG1' ' HG2' ' 1' ' 60' ' ' ARG . 46.9 p -114.48 -12.64 12.29 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.344 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt 61.2 11.97 3.84 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.646 1.178 . . . . 0.0 112.633 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 60' ' ' ARG . . . . . 0.528 ' HG2' ' OG1' ' 1' ' 58' ' ' THR . 19.1 ptp180 -99.05 132.41 44.38 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.382 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 8.7 t -87.09 157.8 19.33 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.165 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -97.66 -9.26 27.11 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.172 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.1 42.85 4.55 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.663 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -152.87 144.14 23.21 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.765 0.282 . . . . 0.0 110.951 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.22 -170.5 25.95 Favored Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 66' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -135.2 168.35 19.32 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 124.798 1.239 . . . . 0.0 110.092 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 67' ' ' VAL . . . . . . . . . . . . . 79.2 t -153.23 132.78 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 68' ' ' THR . . . . . 0.772 HG23 ' HG3' ' 1' ' 22' ' ' LYS . 1.3 m -107.2 105.32 15.25 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 113.956 -1.475 . . . . 0.0 111.624 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -83.13 124.41 30.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.458 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.82 2.29 27.0 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 71' ' ' ASP . . . . . 0.589 ' OD1' ' HB3' ' 1' ' 73' ' ' ALA . 15.5 t0 -126.97 132.53 24.36 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.458 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -73.57 -16.18 24.22 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 122.023 1.816 . . . . 0.0 111.682 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 73' ' ' ALA . . . . . 0.589 ' HB3' ' OD1' ' 1' ' 71' ' ' ASP . . . -77.33 -30.97 54.23 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.867 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 74' ' ' SER . . . . . 0.458 ' O ' HG23 ' 1' ' 78' ' ' VAL . 3.1 t -70.16 -31.86 69.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.316 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 75' ' ' VAL . . . . . 0.682 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 5.6 t -69.02 -31.93 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.392 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -71.84 -41.94 67.56 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.869 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 77' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' 1' ' 73' ' ' ALA . 90.3 mttt -64.56 -42.79 95.44 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 113.868 -1.514 . . . . 0.0 112.091 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 78' ' ' VAL . . . . . 0.458 HG23 ' O ' ' 1' ' 74' ' ' SER . 95.2 t -74.92 -31.97 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.792 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 79' ' ' LEU . . . . . 0.682 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.2 OUTLIER -65.24 -32.91 74.82 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.877 0.871 . . . . 0.0 112.207 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 80' ' ' GLY . . . . . 0.416 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -79.14 -19.16 72.91 Favored Glycine 0 C--N 1.343 0.955 0 O-C-N 123.697 0.623 . . . . 0.0 113.47 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -98.65 100.74 10.07 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 122.881 0.472 . . . . 0.0 110.835 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 82' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 4.7 Cg_exo -79.23 -35.33 0.9 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.44 2.093 . . . . 0.0 113.676 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -91.16 128.79 37.12 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.767 0.317 . . . . 0.0 111.252 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -139.65 123.71 17.77 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.021 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -117.35 134.67 54.55 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.845 0.831 . . . . 0.0 110.861 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 86' ' ' LEU . . . . . 0.628 HD21 ' OG1' ' 1' ' 32' ' ' THR . 9.2 tp -143.25 133.35 24.34 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 113.331 -1.759 . . . . 0.0 107.492 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 11.8 t70 51.92 37.31 20.59 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 122.591 1.186 . . . . 0.0 111.78 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 12.6 t 69.88 9.62 7.19 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 112.842 -1.981 . . . . 0.0 112.063 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -124.14 152.39 42.85 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.902 0.858 . . . . 0.0 110.529 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.3 m -80.87 127.45 32.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.542 -1.663 . . . . 0.0 111.817 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 91' ' ' ILE . . . . . 0.684 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 44.6 pt -115.26 168.71 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.896 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 92' ' ' ASP . . . . . 0.408 ' OD2' ' HD3' ' 1' ' 94' ' ' LYS . 5.7 t70 -116.64 90.42 31.2 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.5 124.12 3.54 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.347 2.031 . . . . 0.0 111.44 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 94' ' ' LYS . . . . . 0.408 ' HD3' ' OD2' ' 1' ' 92' ' ' ASP . 2.0 pttp -149.4 154.07 38.34 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 6.4 t -76.85 129.85 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.777 0.431 . . . . 0.0 111.501 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.54 156.26 17.14 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -114.02 124.25 31.3 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.377 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.63 137.07 26.92 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.584 2.19 . . . . 0.0 113.016 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -134.6 142.51 46.94 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.964 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -125.6 131.0 52.78 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.259 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -154.85 168.35 27.2 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.771 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 60.11 148.66 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 124.601 1.16 . . . . 0.0 113.465 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.26 176.58 9.78 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.74 2.294 . . . . 0.0 113.557 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -85.52 154.72 21.58 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.331 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 26.2 mmt -90.53 160.91 15.72 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.478 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 2.7 t -94.41 165.27 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.098 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.6 m -101.02 -44.5 5.7 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.082 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -95.53 124.75 39.71 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.287 0.367 . . . . 0.0 111.137 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 19.7 p -100.49 122.36 43.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.264 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -91.03 145.5 24.64 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.269 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 84.4 mttt . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.503 179.92 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.535 0.207 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -117.35 148.18 41.96 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.081 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -116.83 -42.96 2.91 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.149 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -104.0 145.41 30.2 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.378 0.424 . . . . 0.0 110.958 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -104.72 -40.24 6.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.47 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -97.66 142.42 29.49 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 123.276 0.36 . . . . 0.0 111.44 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -130.02 138.07 50.59 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.553 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 55.9 m -94.11 128.81 40.73 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.508 0.505 . . . . 0.0 111.891 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 6.0 t -103.77 138.43 40.4 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.78 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 50.6 m -93.1 146.6 23.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.684 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 13.0 t -98.1 126.23 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.941 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.69 150.4 23.64 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.61 0.569 . . . . 0.0 111.716 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.23 -38.62 3.55 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.524 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.9 70.33 0.84 Allowed Glycine 0 CA--C 1.517 0.177 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.324 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 11' ' ' THR . . . . . 0.513 ' O ' HD11 ' 1' ' 14' ' ' LEU . 71.0 p -121.87 -22.94 5.59 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.616 0.366 . . . . 0.0 110.602 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 12' ' ' GLU . . . . . 0.519 ' O ' HD12 ' 1' ' 14' ' ' LEU . 38.7 tt0 -116.83 -52.79 2.52 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.467 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -80.07 51.67 1.4 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.381 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 14' ' ' LEU . . . . . 0.519 HD12 ' O ' ' 1' ' 12' ' ' GLU . 1.7 mp -80.48 -30.93 37.38 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.578 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -82.09 120.41 25.25 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.064 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -84.14 -15.91 45.47 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -93.59 108.26 20.0 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.199 0.312 . . . . 0.0 110.659 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 13.8 t -120.11 137.2 54.28 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.367 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -116.87 -44.96 2.79 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.613 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.92 146.48 24.89 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.02 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.92 -2.73 6.88 Favored Glycine 0 C--N 1.335 0.51 0 O-C-N 123.578 0.549 . . . . 0.0 113.023 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 22' ' ' LYS . . . . . 0.753 ' HB3' HG23 ' 1' ' 68' ' ' THR . 24.8 pttt -87.17 174.66 8.48 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.544 0.338 . . . . 0.0 111.005 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 23' ' ' MET . . . . . 0.406 ' O ' ' HA ' ' 1' ' 66' ' ' PHE . 10.8 mtp -121.7 152.47 39.36 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.887 0.851 . . . . 0.0 111.554 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -103.98 106.88 17.53 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.014 -1.903 . . . . 0.0 107.988 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 25' ' ' ILE . . . . . 0.421 HD12 ' CZ ' ' 1' ' 41' ' ' PHE . 1.1 mm -96.75 110.39 24.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 122.882 0.473 . . . . 0.0 110.618 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 26' ' ' GLY . . . . . 0.673 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -101.38 160.34 18.36 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.906 -1.043 . . . . 0.0 115.243 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 27' ' ' GLY . . . . . 0.62 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 73.54 20.92 79.91 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 115.195 0.838 . . . . 0.0 115.195 177.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 18.1 mt -58.27 168.33 1.1 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 117.875 0.838 . . . . 0.0 110.818 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 29' ' ' SER . . . . . 0.426 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 5.7 t -101.66 174.53 5.92 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.502 0.668 . . . . 0.0 110.01 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 30' ' ' TRP . . . . . 0.471 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.4 p-90 -71.64 -16.0 62.25 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.782 1.233 . . . . 0.0 111.481 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -97.99 -24.97 15.14 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.977 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 32' ' ' THR . . . . . 0.648 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 0.7 OUTLIER -65.4 113.73 4.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.456 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 33' ' ' SER . . . . . 0.417 ' H ' ' HB3' ' 1' ' 36' ' ' SER . 71.6 m -103.03 159.21 30.0 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.938 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 34' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.53 -25.71 60.04 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.11 1.873 . . . . 0.0 112.271 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.13 -32.26 39.01 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.927 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 36' ' ' SER . . . . . 0.417 ' HB3' ' H ' ' 1' ' 33' ' ' SER . 21.7 t -70.96 -36.43 72.55 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.218 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 37' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.7 mt -72.9 -37.96 67.09 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 123.933 0.893 . . . . 0.0 110.038 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 38' ' ' ARG . . . . . 0.43 ' HE ' ' HB3' ' 1' ' 50' ' ' CYS . 7.8 ttm180 -69.08 -42.6 75.98 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.609 178.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -38.98 91.79 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 123.866 0.729 . . . . 0.0 111.161 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 40' ' ' TYR . . . . . 0.701 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 0.3 OUTLIER -71.51 -52.96 15.5 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 122.941 0.496 . . . . 0.0 111.649 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 41' ' ' PHE . . . . . 0.445 ' C ' HD11 ' 1' ' 47' ' ' ILE . 21.7 m-85 -71.28 -25.42 62.44 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 42' ' ' SER . . . . . . . . . . . . . 25.2 p -63.53 -14.18 48.62 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.418 1.104 . . . . 0.0 109.619 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 43' ' ' LYS . . . . . 0.701 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 6.0 mmtp -80.42 -12.09 59.61 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 112.333 -2.212 . . . . 0.0 112.148 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.57 -32.79 7.9 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.922 0.489 . . . . 0.0 110.405 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.88 -161.06 16.71 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -103.0 133.32 48.33 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.697 0.76 . . . . 0.0 110.429 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 47' ' ' ILE . . . . . 0.445 HD11 ' C ' ' 1' ' 41' ' ' PHE . 4.6 mt -105.78 136.86 38.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 113.263 -1.789 . . . . 0.0 111.498 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -86.57 -41.37 14.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.306 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -163.96 157.63 18.76 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.954 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 50' ' ' CYS . . . . . 0.43 ' HB3' ' HE ' ' 1' ' 38' ' ' ARG . 40.5 t -135.54 150.48 49.75 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.06 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 27.6 ttt -145.17 133.41 21.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.424 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 82.2 t -127.5 124.28 63.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 113.448 -1.705 . . . . 0.0 108.221 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 1.2 mmt -76.52 133.68 39.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.919 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 54' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' 1' ' 59' ' ' LYS . 7.9 ttm180 -131.3 160.69 34.22 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.986 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.41 118.78 51.38 Favored Pre-proline 0 N--CA 1.441 -0.923 0 C-N-CA 122.575 0.35 . . . . 0.0 110.509 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.33 -10.71 19.55 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.484 2.122 . . . . 0.0 113.539 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 19.0 p -82.03 -44.25 16.89 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 72.5 p -117.01 -6.81 11.4 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.408 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 59' ' ' LYS . . . . . 0.475 ' O ' ' HD3' ' 1' ' 54' ' ' ARG . 17.6 mmtp 61.57 11.63 3.98 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.435 1.094 . . . . 0.0 111.723 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -100.64 154.5 18.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.261 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 49.9 m -92.36 154.24 18.68 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.557 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -91.73 -5.81 53.0 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.638 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.06 38.6 5.97 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.454 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -154.86 144.41 21.38 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.402 0.281 . . . . 0.0 111.167 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.2 -168.83 18.96 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 66' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' 1' ' 23' ' ' MET . 75.2 m-85 -138.92 161.38 37.45 Favored 'General case' 0 N--CA 1.423 -1.794 0 C-N-CA 124.948 1.299 . . . . 0.0 109.537 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 67' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' 1' ' 22' ' ' LYS . 73.5 t -145.1 132.13 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 68' ' ' THR . . . . . 0.753 HG23 ' HB3' ' 1' ' 22' ' ' LYS . 0.9 OUTLIER -105.54 107.06 17.85 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.935 -177.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -86.07 125.56 33.54 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.925 -1.488 . . . . 0.0 111.937 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.05 2.18 9.38 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -129.55 134.6 26.41 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.999 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -73.43 -16.31 24.55 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.1 1.867 . . . . 0.0 112.173 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 73' ' ' ALA . . . . . 0.473 ' O ' ' HG3' ' 1' ' 77' ' ' LYS . . . -77.31 -31.28 54.56 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.763 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 74' ' ' SER . . . . . . . . . . . . . 2.2 t -70.1 -31.94 69.74 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.281 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 75' ' ' VAL . . . . . 0.73 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 11.3 t -69.98 -33.12 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.652 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -72.02 -40.79 68.19 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.008 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 77' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' 1' ' 73' ' ' ALA . 43.5 mttp -66.61 -41.34 88.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.518 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 78' ' ' VAL . . . . . . . . . . . . . 88.4 t -81.33 -31.85 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.646 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 79' ' ' LEU . . . . . 0.73 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.8 OUTLIER -65.94 -35.16 79.84 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 122.775 0.43 . . . . 0.0 111.439 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 80' ' ' GLY . . . . . 0.468 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -77.49 -15.24 81.63 Favored Glycine 0 C--N 1.343 0.936 0 O-C-N 123.575 0.547 . . . . 0.0 113.877 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -98.53 99.96 8.44 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 122.69 0.396 . . . . 0.0 111.286 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 82' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 5.3 Cg_exo -78.36 -21.31 10.45 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.578 2.186 . . . . 0.0 113.819 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -89.04 115.26 26.45 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.027 0.442 . . . . 0.0 111.482 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -139.76 119.95 13.76 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.838 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -116.89 134.6 54.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.997 0.903 . . . . 0.0 111.094 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 86' ' ' LEU . . . . . 0.648 HD21 ' OG1' ' 1' ' 32' ' ' THR . 6.3 tp -145.66 133.34 21.03 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.273 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 11.5 t70 52.0 36.95 19.9 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 122.646 1.212 . . . . 0.0 111.721 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 67.8 m 69.23 9.64 7.44 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 112.856 -1.975 . . . . 0.0 112.076 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -123.87 152.46 42.32 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 122.108 0.956 . . . . 0.0 110.697 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.5 m -80.41 124.8 29.21 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.177 -1.829 . . . . 0.0 112.211 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 91' ' ' ILE . . . . . 0.673 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 43.7 pt -112.03 167.34 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.794 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 92' ' ' ASP . . . . . 0.59 ' OD1' ' HD3' ' 1' ' 94' ' ' LYS . 4.9 t70 -117.71 96.18 49.03 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -175.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -83.07 124.24 3.76 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.129 1.886 . . . . 0.0 111.017 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 94' ' ' LYS . . . . . 0.59 ' HD3' ' OD1' ' 1' ' 92' ' ' ASP . 23.5 pttt -147.54 139.9 24.52 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 t -74.39 125.19 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 122.715 0.406 . . . . 0.0 111.157 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.42 149.88 25.7 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 97' ' ' PHE . . . . . 0.423 ' HA ' ' HD3' ' 1' ' 98' ' ' PRO . 2.8 m-85 -109.82 130.62 22.6 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.886 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 98' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' 1' ' 97' ' ' PHE . 12.4 Cg_exo -73.19 139.98 30.22 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.64 2.227 . . . . 0.0 113.179 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -149.43 118.85 6.88 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.025 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -99.89 128.16 46.0 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.337 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.74 170.9 10.04 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -116.63 144.6 33.58 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.666 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.45 174.62 12.26 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.555 2.17 . . . . 0.0 113.603 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -88.07 158.13 18.67 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.461 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 62.0 mtt -95.13 -6.01 42.85 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.034 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 2.7 t -91.01 162.21 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.507 0.323 . . . . 0.0 110.239 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 9.7 t -92.35 -47.61 7.09 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 -100.48 132.6 45.78 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.205 0.315 . . . . 0.0 111.113 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 17.0 p -94.11 136.86 33.95 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.333 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -87.81 128.31 35.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.561 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.398 -0.811 . . . . 0.0 111.397 179.966 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 31.7 mtm . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.6 0.238 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -121.78 -40.79 2.51 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.24 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -96.25 154.91 17.0 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.427 0.454 . . . . 0.0 111.098 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -95.72 141.65 28.94 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.252 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -117.09 139.75 50.35 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.443 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -127.64 142.07 51.45 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.322 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -102.74 154.15 19.44 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.884 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 60.2 m -112.54 -32.46 6.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.937 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 4.8 p -82.87 117.03 22.44 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 122.936 0.495 . . . . 0.0 111.873 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 50.3 m -135.66 137.91 42.31 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.197 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 t -89.43 143.68 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.879 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -106.86 -44.46 4.42 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.411 0.445 . . . . 0.0 111.645 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.18 148.69 26.61 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.226 0.329 . . . . 0.0 111.401 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 10' ' ' GLY . . . . . 0.415 ' O ' HD21 ' 1' ' 14' ' ' LEU . . . -149.18 72.09 0.3 Allowed Glycine 0 C--N 1.336 0.569 0 O-C-N 123.619 0.574 . . . . 0.0 112.552 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -148.54 13.35 0.94 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.625 0.37 . . . . 0.0 111.378 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -102.95 -55.71 2.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.261 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -77.25 -44.06 31.21 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.934 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 14' ' ' LEU . . . . . 0.415 HD21 ' O ' ' 1' ' 10' ' ' GLY . 3.4 pp -82.98 157.64 22.88 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.43 0.456 . . . . 0.0 111.328 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -76.35 153.08 36.11 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.335 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -140.22 -6.3 1.23 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.54 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -87.4 -5.34 58.9 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 51.8 p -83.79 152.21 24.76 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.488 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -118.84 -30.49 5.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.585 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.55 149.3 33.07 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 122.895 0.478 . . . . 0.0 111.643 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.37 -16.85 3.82 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.46 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 22' ' ' LYS . . . . . 0.691 ' HB3' HG23 ' 1' ' 68' ' ' THR . 8.0 pttp -98.84 173.65 6.76 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 123.795 0.35 . . . . 0.0 110.911 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 23' ' ' MET . . . . . . . . . . . . . 14.5 mtp -117.3 152.57 34.6 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 122.005 0.907 . . . . 0.0 111.039 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -105.86 105.2 15.13 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 112.944 -1.934 . . . . 0.0 107.716 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mm -94.82 116.97 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.131 0.572 . . . . 0.0 110.102 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 26' ' ' GLY . . . . . 0.744 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -108.32 159.79 14.1 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.086 -0.961 . . . . 0.0 115.044 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 27' ' ' GLY . . . . . 0.625 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 71.9 21.32 79.05 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 115.372 0.909 . . . . 0.0 115.372 177.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 16.2 mt -57.17 169.62 0.55 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 117.858 0.829 . . . . 0.0 110.902 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 29' ' ' SER . . . . . 0.421 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 5.4 t -100.99 174.45 6.0 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.483 0.659 . . . . 0.0 110.181 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 30' ' ' TRP . . . . . 0.457 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.2 p-90 -72.02 -16.64 62.06 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.424 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -97.65 -24.93 15.29 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.006 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 32' ' ' THR . . . . . 0.592 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 0.6 OUTLIER -65.83 114.04 4.78 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.637 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 33' ' ' SER . . . . . 0.419 ' H ' ' HB3' ' 1' ' 36' ' ' SER . 71.5 m -103.72 158.53 31.66 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.977 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 34' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.26 -25.83 58.22 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.136 1.89 . . . . 0.0 112.468 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 35' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' 1' ' 39' ' ' ASP . 0.4 OUTLIER -80.23 -33.35 38.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.113 177.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 36' ' ' SER . . . . . 0.419 ' HB3' ' H ' ' 1' ' 33' ' ' SER . 22.7 t -70.5 -35.82 73.44 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.044 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 37' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' 1' ' 41' ' ' PHE . 1.6 mt -72.91 -38.81 66.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.19 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 38' ' ' ARG . . . . . 0.568 ' O ' ' HB2' ' 1' ' 42' ' ' SER . 12.5 ttm180 -68.01 -42.76 80.19 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.792 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 39' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' 1' ' 35' ' ' ASP . 0.1 OUTLIER -67.0 -40.19 87.29 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.582 178.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 40' ' ' TYR . . . . . 0.694 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 5.6 t80 -72.09 -50.05 31.29 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 122.609 0.364 . . . . 0.0 111.556 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 41' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' 1' ' 37' ' ' LEU . 17.5 m-85 -71.47 -25.18 62.18 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 42' ' ' SER . . . . . 0.568 ' HB2' ' O ' ' 1' ' 38' ' ' ARG . 16.9 t -61.53 -14.08 26.61 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.51 1.147 . . . . 0.0 109.526 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 43' ' ' LYS . . . . . 0.694 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 13.1 mmtt -82.97 -14.83 53.31 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 112.191 -2.277 . . . . 0.0 111.537 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 44' ' ' PHE . . . . . 0.444 ' CD1' HG22 ' 1' ' 78' ' ' VAL . 0.3 OUTLIER -97.63 -33.2 11.41 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.105 178.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.05 -160.44 22.29 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -100.09 132.72 45.29 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.839 0.828 . . . . 0.0 110.357 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 47' ' ' ILE . . . . . 0.445 HD11 ' C ' ' 1' ' 41' ' ' PHE . 4.9 mt -107.68 137.79 37.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 113.037 -1.892 . . . . 0.0 111.549 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -88.02 -41.35 13.16 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.971 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -166.45 157.22 12.55 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.421 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 50' ' ' CYS . . . . . . . . . . . . . 42.3 t -133.71 151.42 51.62 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.329 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 57.3 ttp -146.54 133.67 20.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.032 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 64.8 t -126.51 124.79 66.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.197 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.99 117.27 12.27 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.178 -177.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -137.36 155.9 48.85 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.566 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.84 115.59 65.75 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 122.814 0.446 . . . . 0.0 110.777 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.74 -8.34 4.23 Favored 'Trans proline' 0 C--N 1.364 1.355 0 C-N-CA 122.963 2.442 . . . . 0.0 115.054 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 20.1 p -81.01 -45.31 16.76 Favored 'General case' 0 C--N 1.347 0.46 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 61.9 p -130.02 -5.92 4.45 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 mptt 58.56 53.07 6.37 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 122.722 1.249 . . . . 0.0 111.434 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -98.89 130.66 45.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.664 -2.062 . . . . 0.0 110.845 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 49.1 m -92.82 142.05 27.76 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.412 0.445 . . . . 0.0 111.201 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -96.09 -10.1 29.19 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.457 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.98 33.07 8.45 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 116.015 -0.539 . . . . 0.0 113.755 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -153.5 151.4 29.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 117.162 0.481 . . . . 0.0 111.514 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.06 -168.2 23.62 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 66' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -138.08 163.07 32.53 Favored 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 124.729 1.211 . . . . 0.0 109.855 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 67' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' 1' ' 22' ' ' LYS . 58.9 t -144.53 133.12 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 68' ' ' THR . . . . . 0.691 HG23 ' HB3' ' 1' ' 22' ' ' LYS . 1.1 m -106.91 105.97 16.26 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.743 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -83.73 126.81 33.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.051 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.03 2.66 6.58 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 71' ' ' ASP . . . . . 0.6 ' OD1' ' HB3' ' 1' ' 73' ' ' ALA . 11.6 t0 -131.7 133.0 23.69 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.825 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -73.42 -16.11 24.65 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 122.014 1.809 . . . . 0.0 111.934 176.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 73' ' ' ALA . . . . . 0.6 ' HB3' ' OD1' ' 1' ' 71' ' ' ASP . . . -77.48 -28.84 52.38 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.124 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 74' ' ' SER . . . . . 0.482 ' O ' HG23 ' 1' ' 78' ' ' VAL . 3.8 t -69.42 -31.73 70.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.215 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 75' ' ' VAL . . . . . 0.725 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 16.7 t -67.26 -32.68 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.655 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.21 -37.8 69.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.772 -1.103 . . . . 0.0 110.178 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 77' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -69.5 -43.13 73.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 113.815 -1.539 . . . . 0.0 112.209 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 78' ' ' VAL . . . . . 0.482 HG23 ' O ' ' 1' ' 74' ' ' SER . 53.0 t -77.16 -31.81 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.343 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 79' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.4 OUTLIER -71.09 -29.35 65.17 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 122.683 0.393 . . . . 0.0 110.79 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 80' ' ' GLY . . . . . 0.548 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -74.33 -28.83 63.11 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.046 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -98.61 97.64 5.05 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 122.821 0.449 . . . . 0.0 110.413 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 82' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 2.6 Cg_exo -76.1 -27.93 7.88 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.021 2.481 . . . . 0.0 114.293 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -81.94 116.15 21.44 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.962 0.411 . . . . 0.0 111.304 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -136.16 121.63 19.41 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.08 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -115.36 134.65 54.91 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.801 0.81 . . . . 0.0 110.464 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 86' ' ' LEU . . . . . 0.592 HD21 ' OG1' ' 1' ' 32' ' ' THR . 6.4 tp -145.67 133.95 21.74 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 113.349 -1.751 . . . . 0.0 107.555 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 12.8 t70 51.69 37.15 19.38 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.628 1.171 . . . . 0.0 111.844 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 53.4 m 68.97 10.19 7.79 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 112.953 -1.93 . . . . 0.0 111.852 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -124.61 151.64 44.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.974 0.893 . . . . 0.0 110.302 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.9 m -81.99 126.87 32.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.536 -1.665 . . . . 0.0 111.83 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 91' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 44.4 pt -110.51 169.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.339 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 92' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -113.16 93.87 27.82 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.15 124.37 3.76 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.46 2.107 . . . . 0.0 111.513 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 94' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -143.26 163.45 32.93 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.139 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -95.28 147.4 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 120.71 0.29 . . . . 0.0 110.773 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.98 165.91 10.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.848 0.859 . . . . 0.0 112.674 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 97' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' 1' ' 98' ' ' PRO . 25.6 m-85 -103.36 144.14 28.04 Favored Pre-proline 0 N--CA 1.446 -0.671 0 C-N-CA 123.446 0.698 . . . . 0.0 110.773 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 98' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' 1' ' 97' ' ' PHE . 15.0 Cg_exo -74.33 -175.95 2.48 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 123.197 2.598 . . . . 0.0 113.367 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -73.88 156.75 37.37 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.315 0.646 . . . . 0.0 112.659 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 51.85 92.02 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.451 1.101 . . . . 0.0 113.345 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -112.28 -175.91 2.79 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.823 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -110.03 126.03 29.86 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 119.621 -0.228 . . . . 0.0 110.639 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.49 173.62 14.18 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.485 2.123 . . . . 0.0 113.236 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -84.66 150.32 25.23 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.964 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 19.6 ptm -129.67 -14.99 4.03 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.963 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 2.6 t -98.99 160.61 3.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 O-C-N 123.46 0.475 . . . . 0.0 110.067 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 3.0 m -109.73 -55.29 2.45 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.638 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -98.1 142.24 30.04 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.476 0.485 . . . . 0.0 111.274 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 17.7 p -100.91 121.25 41.41 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.334 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -91.2 147.48 23.03 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.384 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 22.5 mttm . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.423 179.681 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 17.5 mmt . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.522 0.201 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -128.74 133.54 48.15 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.984 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -103.83 -35.52 8.15 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.714 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -88.81 -36.28 16.14 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -94.08 131.0 40.03 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 123.305 0.378 . . . . 0.0 111.34 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -108.26 149.07 29.1 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -123.34 -43.96 2.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.649 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 57.9 m -90.97 123.52 34.52 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 123.208 0.317 . . . . 0.0 111.7 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 9.7 p -91.51 159.21 16.05 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.677 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 42.2 p -87.5 130.72 34.6 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.39 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 15.0 t -108.87 -49.11 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.51 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.47 128.72 34.75 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.32 0.387 . . . . 0.0 111.713 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.96 163.56 14.9 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.72 70.43 0.5 Allowed Glycine 0 C--N 1.341 0.844 0 C-N-CA 121.41 -0.424 . . . . 0.0 112.521 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 9.1 t -138.73 13.89 2.71 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 123.769 0.335 . . . . 0.0 111.596 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -121.37 -46.41 2.28 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.534 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -75.11 8.64 2.46 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.449 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 pp -79.71 164.79 23.44 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -78.5 122.92 26.48 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.479 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -104.78 -15.46 15.21 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.316 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -82.25 148.78 28.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 55.0 m -93.07 160.61 14.78 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.542 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -137.04 79.93 1.78 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.366 0.603 . . . . 0.0 110.43 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.71 136.68 39.26 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.291 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.54 -1.39 2.09 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.741 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 22' ' ' LYS . . . . . 0.586 ' HG3' HG23 ' 1' ' 68' ' ' THR . 27.4 mttt -81.09 147.73 29.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 23' ' ' MET . . . . . 0.484 ' O ' ' HA ' ' 1' ' 66' ' ' PHE . 5.8 mtp -117.23 129.62 56.04 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.662 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -91.26 103.78 16.41 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 126.093 1.757 . . . . 0.0 109.088 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mm -92.28 109.88 22.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.291 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 26' ' ' GLY . . . . . 0.643 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -99.56 154.45 19.71 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 116.077 1.191 . . . . 0.0 116.077 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 27' ' ' GLY . . . . . 0.642 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 72.53 27.0 70.34 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 113.996 -1.102 . . . . 0.0 115.717 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 18.9 mt -58.11 170.88 0.61 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 117.964 0.882 . . . . 0.0 111.149 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 29' ' ' SER . . . . . 0.424 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 5.7 t -100.25 174.31 6.2 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.456 0.646 . . . . 0.0 110.388 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 30' ' ' TRP . . . . . 0.479 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.3 p-90 -72.75 -16.78 61.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.197 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -98.62 -24.98 14.87 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.995 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 32' ' ' THR . . . . . 0.593 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 1.0 OUTLIER -66.78 114.08 5.38 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.599 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 33' ' ' SER . . . . . 0.411 ' H ' ' HB3' ' 1' ' 36' ' ' SER . 57.8 m -104.22 160.21 26.78 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.287 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 34' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -56.45 -25.69 59.29 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.167 1.911 . . . . 0.0 112.374 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.9 -33.32 39.98 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.913 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 36' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' 1' ' 40' ' ' TYR . 19.9 t -70.81 -35.92 72.72 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.383 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 37' ' ' LEU . . . . . 0.453 ' HB3' ' SG ' ' 1' ' 50' ' ' CYS . 1.9 mt -72.77 -37.16 67.71 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.396 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 38' ' ' ARG . . . . . 0.621 ' O ' ' HB2' ' 1' ' 42' ' ' SER . 6.0 ttm180 -71.19 -42.05 69.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.664 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.44 -39.58 85.39 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.868 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 40' ' ' TYR . . . . . 0.712 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 2.5 t80 -71.91 -52.04 19.23 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-O 120.851 0.358 . . . . 0.0 111.641 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 41' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' 1' ' 37' ' ' LEU . 33.9 m-85 -71.5 -25.69 62.37 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 42' ' ' SER . . . . . 0.621 ' HB2' ' O ' ' 1' ' 38' ' ' ARG . 9.4 t -63.0 -14.04 42.81 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.5 1.143 . . . . 0.0 109.465 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 43' ' ' LYS . . . . . 0.712 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 14.8 mttt -82.48 -13.5 56.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 112.15 -2.295 . . . . 0.0 111.82 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -104.69 -31.15 9.5 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.305 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 45' ' ' GLY . . . . . 0.439 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -168.2 -163.26 21.85 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -102.82 132.77 48.77 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.826 0.822 . . . . 0.0 110.744 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 47' ' ' ILE . . . . . . . . . . . . . 4.9 mt -107.41 137.85 36.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 113.029 -1.896 . . . . 0.0 111.44 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -87.66 -41.7 13.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.974 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -164.7 157.38 16.62 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.251 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 50' ' ' CYS . . . . . 0.502 ' SG ' HG22 ' 1' ' 67' ' ' VAL . 43.4 t -135.36 150.58 49.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.286 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 27.4 ttt -145.42 135.92 24.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.919 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.47 125.19 63.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 113.659 -1.609 . . . . 0.0 107.653 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -69.53 117.02 10.62 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.141 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 38.7 mtt-85 -137.27 150.92 48.15 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.625 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.34 115.6 60.65 Favored Pre-proline 0 N--CA 1.44 -0.947 0 C-N-CA 122.918 0.487 . . . . 0.0 110.594 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -63.9 -8.97 17.25 Favored 'Trans proline' 0 C--N 1.363 1.313 0 C-N-CA 122.297 1.998 . . . . 0.0 113.36 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 19.9 p -82.18 -44.23 16.68 Favored 'General case' 0 C--N 1.346 0.423 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 74.8 p -118.49 -10.98 10.01 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt 61.5 12.38 4.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.406 1.082 . . . . 0.0 112.148 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -91.06 132.77 35.82 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.851 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 39.2 m -97.08 156.07 16.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.699 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -99.19 -11.12 21.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.34 43.21 4.37 Favored Glycine 0 C--N 1.339 0.708 0 O-C-N 123.351 0.407 . . . . 0.0 113.919 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -155.28 151.14 27.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.785 0.293 . . . . 0.0 111.013 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.72 -169.78 23.46 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 66' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' 1' ' 23' ' ' MET . 86.2 m-85 -138.57 158.91 43.35 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 125.084 1.353 . . . . 0.0 109.63 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 67' ' ' VAL . . . . . 0.502 HG22 ' SG ' ' 1' ' 50' ' ' CYS . 75.2 t -144.12 133.22 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 68' ' ' THR . . . . . 0.586 HG23 ' HG3' ' 1' ' 22' ' ' LYS . 1.5 m -105.44 105.46 15.51 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 113.615 -1.63 . . . . 0.0 111.5 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -81.81 124.61 29.81 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.82 -1.536 . . . . 0.0 112.069 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.31 3.05 9.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 71' ' ' ASP . . . . . 0.585 ' OD1' ' HB3' ' 1' ' 73' ' ' ALA . 11.6 t0 -132.01 134.11 24.79 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.745 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -73.39 -16.51 24.57 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 121.756 1.638 . . . . 0.0 111.89 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 73' ' ' ALA . . . . . 0.585 ' HB3' ' OD1' ' 1' ' 71' ' ' ASP . . . -77.53 -30.45 52.81 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.975 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 74' ' ' SER . . . . . 0.439 ' OG ' ' HA3' ' 1' ' 45' ' ' GLY . 5.1 t -69.88 -31.59 69.48 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.27 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 75' ' ' VAL . . . . . 0.739 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 9.4 t -69.99 -32.66 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.882 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -72.06 -40.29 68.43 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.17 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 77' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' 1' ' 73' ' ' ALA . 87.0 mttt -69.19 -40.3 78.15 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.659 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 78' ' ' VAL . . . . . . . . . . . . . 87.0 t -81.97 -32.0 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.679 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 79' ' ' LEU . . . . . 0.739 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.5 OUTLIER -67.03 -35.84 80.79 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 122.504 0.322 . . . . 0.0 111.092 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 80' ' ' GLY . . . . . 0.525 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -72.59 -16.21 77.67 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.52 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -98.94 97.9 5.63 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 122.805 0.442 . . . . 0.0 110.832 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 82' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 5.3 Cg_exo -78.45 -30.66 3.09 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.721 2.28 . . . . 0.0 113.767 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -87.37 115.45 24.79 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.925 0.393 . . . . 0.0 111.521 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -140.23 123.22 16.61 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.911 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -114.23 134.92 54.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 122.006 0.908 . . . . 0.0 110.798 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 86' ' ' LEU . . . . . 0.593 HD21 ' OG1' ' 1' ' 32' ' ' THR . 6.5 tp -142.31 129.13 20.54 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.106 -1.861 . . . . 0.0 107.527 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 7.6 t70 50.17 36.95 13.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.809 1.244 . . . . 0.0 111.834 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 15.0 t 70.02 12.13 7.75 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 112.987 -1.915 . . . . 0.0 111.432 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.55 135.54 55.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.9 m -77.29 123.25 26.22 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.261 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 91' ' ' ILE . . . . . 0.643 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 45.9 pt -107.88 168.59 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.427 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 92' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -115.82 93.7 38.57 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.94 124.2 3.82 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.54 2.16 . . . . 0.0 111.324 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 94' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.45 158.19 43.95 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.622 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 95' ' ' VAL . . . . . 0.422 HG23 ' HG ' ' 1' ' 79' ' ' LEU . 18.1 t -82.65 141.63 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.15 144.73 50.12 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -121.35 137.08 26.4 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.129 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -71.88 144.72 43.96 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.808 2.339 . . . . 0.0 113.07 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -115.28 -39.51 3.6 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.046 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -87.98 123.88 33.15 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.434 0.293 . . . . 0.0 111.67 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -128.55 173.15 10.5 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.299 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -107.4 108.12 61.31 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.146 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -82.35 174.24 10.04 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.517 2.145 . . . . 0.0 113.429 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -87.54 134.67 33.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.047 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 59.4 mtt -88.78 144.79 26.01 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.496 0.497 . . . . 0.0 111.502 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 45.5 t -115.7 -53.72 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.3 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 7.1 t -78.09 91.57 4.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.685 0.755 . . . . 0.0 111.949 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -118.54 -41.23 2.83 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.297 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 6.9 t -110.86 -40.97 4.37 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.412 0.445 . . . . 0.0 111.406 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -79.34 144.4 34.25 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.872 0.469 . . . . 0.0 111.794 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 14.3 tttp . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.47 -0.776 . . . . 0.0 111.289 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' 1' 1 ' -3' ' ' MET . . . . . . . . . . . . . 54.6 mtm . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 111.47 0.174 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' 1' 1 ' -2' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -129.88 140.52 50.96 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.327 0.392 . . . . 0.0 111.2 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' -1' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -126.7 -44.91 1.64 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.093 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 0' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -104.71 156.24 18.16 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.483 0.489 . . . . 0.0 110.794 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 1' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -88.06 -38.01 15.8 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.185 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 2' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -93.65 138.1 32.23 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.163 0.289 . . . . 0.0 111.258 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 3' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -114.62 136.83 52.61 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.194 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 62.7 m -101.22 126.07 47.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.127 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 5' ' ' THR . . . . . . . . . . . . . 7.0 t -106.16 137.85 43.37 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.267 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 6' ' ' SER . . . . . . . . . . . . . 49.8 p -87.84 158.73 18.65 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.405 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 t -97.97 -14.08 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.958 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.49 -51.01 4.09 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.056 0.223 . . . . 0.0 111.172 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.45 128.08 36.41 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.361 0.413 . . . . 0.0 110.892 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.42 70.93 0.23 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.98 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -151.27 -28.15 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.377 0.271 . . . . 0.0 111.658 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 12' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -95.08 -69.02 0.77 Allowed 'General case' 0 CA--C 1.534 0.352 0 O-C-N 123.38 0.425 . . . . 0.0 111.192 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -79.52 -4.83 53.16 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.575 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tp -84.37 152.05 24.31 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 15' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -89.57 140.73 29.26 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.394 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 16' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -113.14 -44.81 3.22 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.422 0.451 . . . . 0.0 111.631 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 17' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -84.84 130.23 34.69 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.25 0.344 . . . . 0.0 111.545 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m -140.6 -41.81 0.41 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.209 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -108.61 -25.79 10.71 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.401 0.438 . . . . 0.0 111.703 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.34 148.04 43.83 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.871 0.468 . . . . 0.0 111.846 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.96 -6.56 8.87 Favored Glycine 0 C--N 1.337 0.624 0 O-C-N 123.645 0.591 . . . . 0.0 113.307 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 22' ' ' LYS . . . . . 0.636 ' HG3' HG23 ' 1' ' 68' ' ' THR . 42.5 mttt -82.24 155.4 24.9 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.172 0.511 . . . . 0.0 112.309 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 23' ' ' MET . . . . . . . . . . . . . 5.4 mtp -117.83 151.77 36.69 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.227 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 24' ' ' PHE . . . . . 0.427 ' HD2' ' O ' ' 1' ' 65' ' ' GLY . 1.7 t80 -116.96 109.91 17.62 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.906 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 25' ' ' ILE . . . . . 0.51 HD12 ' CZ ' ' 1' ' 41' ' ' PHE . 1.4 mm -95.01 123.96 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 123.668 0.787 . . . . 0.0 109.933 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 26' ' ' GLY . . . . . 0.748 ' O ' ' HB ' ' 1' ' 91' ' ' ILE . . . -117.75 158.89 14.41 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.274 -0.875 . . . . 0.0 114.658 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 27' ' ' GLY . . . . . 0.62 ' O ' HG22 ' 1' ' 91' ' ' ILE . . . 70.91 21.71 78.22 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 115.474 0.949 . . . . 0.0 115.474 177.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 28' ' ' LEU . . . . . . . . . . . . . 16.2 mt -56.13 167.37 0.64 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.902 0.851 . . . . 0.0 110.687 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 29' ' ' SER . . . . . 0.434 ' OG ' ' HD1' ' 1' ' 30' ' ' TRP . 6.6 t -98.35 174.33 6.54 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.631 0.729 . . . . 0.0 110.574 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 30' ' ' TRP . . . . . 0.488 ' HD1' ' H ' ' 1' ' 30' ' ' TRP . 1.6 p-90 -71.57 -16.9 62.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.381 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -98.82 -24.43 15.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.978 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 32' ' ' THR . . . . . 0.614 ' OG1' HD21 ' 1' ' 86' ' ' LEU . 0.5 OUTLIER -69.91 114.26 7.92 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 33' ' ' SER . . . . . 0.503 ' OG ' ' HD2' ' 1' ' 34' ' ' PRO . 9.7 t -104.92 156.54 35.87 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.446 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 34' ' ' PRO . . . . . 0.546 ' O ' ' HB2' ' 1' ' 38' ' ' ARG . 12.8 Cg_endo -53.21 -25.18 28.95 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.219 1.946 . . . . 0.0 113.611 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.54 -29.46 41.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.969 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 36' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' 1' ' 40' ' ' TYR . 16.6 t -69.67 -47.02 64.76 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.597 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 37' ' ' LEU . . . . . 0.56 HD21 HG21 ' 1' ' 52' ' ' VAL . 0.2 OUTLIER -74.25 -30.9 62.36 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 121.226 -0.189 . . . . 0.0 110.792 178.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 38' ' ' ARG . . . . . 0.631 ' HE ' ' HB3' ' 1' ' 50' ' ' CYS . 21.0 ttm180 -66.39 -43.63 85.34 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.49 -36.77 79.38 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.923 177.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 40' ' ' TYR . . . . . 0.77 ' O ' ' HB2' ' 1' ' 43' ' ' LYS . 4.2 t80 -72.04 -49.58 35.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.502 0.721 . . . . 0.0 111.75 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 41' ' ' PHE . . . . . 0.51 ' CZ ' HD12 ' 1' ' 25' ' ' ILE . 36.7 m-85 -71.48 -26.34 62.65 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.852 0.861 . . . . 0.0 112.914 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 42' ' ' SER . . . . . . . . . . . . . 35.9 p -64.58 -14.05 55.89 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 122.413 1.101 . . . . 0.0 109.541 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 43' ' ' LYS . . . . . 0.77 ' HB2' ' O ' ' 1' ' 40' ' ' TYR . 14.3 mttt -79.58 -13.08 59.77 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 112.194 -2.275 . . . . 0.0 111.78 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 44' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -102.36 -34.48 9.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.219 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 45' ' ' GLY . . . . . 0.412 ' HA3' ' OG ' ' 1' ' 74' ' ' SER . . . -168.25 -161.05 17.3 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 46' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -101.91 132.66 47.57 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 121.761 0.791 . . . . 0.0 110.539 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 47' ' ' ILE . . . . . . . . . . . . . 5.4 mt -103.31 137.98 29.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 113.101 -1.863 . . . . 0.0 110.954 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 48' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -93.46 -40.18 10.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.751 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 49' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -156.64 157.73 35.75 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.709 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 50' ' ' CYS . . . . . 0.631 ' HB3' ' HE ' ' 1' ' 38' ' ' ARG . 10.2 t -144.88 150.27 36.78 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.692 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 51' ' ' MET . . . . . . . . . . . . . 24.8 ttt -154.06 134.47 13.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.516 -1.22 . . . . 0.0 112.767 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 52' ' ' VAL . . . . . 0.56 HG21 HD21 ' 1' ' 37' ' ' LEU . 58.7 t -127.6 124.76 64.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 113.836 -1.529 . . . . 0.0 107.21 175.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 53' ' ' MET . . . . . . . . . . . . . 19.0 mtp -72.12 114.81 10.62 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.616 -177.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 54' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -137.25 156.06 48.75 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.143 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.97 114.66 64.15 Favored Pre-proline 0 N--CA 1.446 -0.639 0 C-N-CA 122.703 0.401 . . . . 0.0 110.994 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 56' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.91 -8.51 3.23 Favored 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 123.047 2.498 . . . . 0.0 114.688 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 57' ' ' THR . . . . . . . . . . . . . 19.7 p -80.66 -44.36 18.93 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 58' ' ' THR . . . . . . . . . . . . . 61.1 p -129.05 -6.36 4.94 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.399 0.437 . . . . 0.0 111.987 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 59' ' ' LYS . . . . . . . . . . . . . 5.9 mptt 56.6 53.42 8.49 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 122.758 1.266 . . . . 0.0 112.107 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -98.37 129.31 45.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 112.666 -2.061 . . . . 0.0 111.03 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 61' ' ' SER . . . . . . . . . . . . . 12.8 t -97.07 137.55 35.96 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.641 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 62' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -95.1 -10.7 29.93 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.428 0.455 . . . . 0.0 111.694 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.07 41.3 4.97 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 116.13 -0.486 . . . . 0.0 113.715 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -156.79 149.15 23.24 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.925 0.362 . . . . 0.0 111.386 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 65' ' ' GLY . . . . . 0.427 ' O ' ' HD2' ' 1' ' 24' ' ' PHE . . . -163.45 -169.7 27.29 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 66' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -135.74 164.88 26.88 Favored 'General case' 0 N--CA 1.427 -1.613 0 C-N-CA 125.089 1.355 . . . . 0.0 109.431 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 67' ' ' VAL . . . . . . . . . . . . . 70.3 t -150.18 133.0 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.9 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 68' ' ' THR . . . . . 0.636 HG23 ' HG3' ' 1' ' 22' ' ' LYS . 1.6 m -105.68 105.04 14.9 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 113.296 -1.775 . . . . 0.0 111.343 -178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 69' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -83.12 123.16 29.25 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.035 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.49 1.82 13.15 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 71' ' ' ASP . . . . . 0.597 ' OD1' ' HB3' ' 1' ' 73' ' ' ALA . 15.4 t0 -129.26 132.32 24.23 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.378 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 72' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -73.41 -16.37 24.56 Favored 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 121.969 1.779 . . . . 0.0 111.666 176.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 73' ' ' ALA . . . . . 0.597 ' HB3' ' OD1' ' 1' ' 71' ' ' ASP . . . -77.3 -30.19 54.05 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.981 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 74' ' ' SER . . . . . 0.438 ' O ' HG23 ' 1' ' 78' ' ' VAL . 5.4 t -69.97 -31.8 69.7 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.327 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 75' ' ' VAL . . . . . 0.669 ' O ' ' HB2' ' 1' ' 79' ' ' LEU . 10.7 t -69.93 -32.04 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.581 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -71.32 -41.84 69.36 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.921 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 77' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' 1' ' 73' ' ' ALA . 53.5 mttm -65.88 -40.28 91.45 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.875 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 78' ' ' VAL . . . . . 0.438 HG23 ' O ' ' 1' ' 74' ' ' SER . 87.2 t -77.56 -32.41 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 79' ' ' LEU . . . . . 0.669 ' HB2' ' O ' ' 1' ' 75' ' ' VAL . 0.3 OUTLIER -62.67 -35.53 79.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.615 0.766 . . . . 0.0 111.95 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 80' ' ' GLY . . . . . 0.455 ' O ' ' HD3' ' 1' ' 82' ' ' PRO . . . -77.22 -15.37 81.62 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 115.91 -0.586 . . . . 0.0 113.4 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 81' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -98.76 99.38 7.58 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.072 0.549 . . . . 0.0 110.588 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 82' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' 1' ' 80' ' ' GLY . 6.2 Cg_exo -78.32 -34.91 1.37 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.519 2.146 . . . . 0.0 113.734 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 83' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -89.98 127.21 35.99 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.748 0.309 . . . . 0.0 111.48 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -137.62 119.59 15.38 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 85' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -114.68 134.63 54.93 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 122.037 0.923 . . . . 0.0 110.771 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 86' ' ' LEU . . . . . 0.614 HD21 ' OG1' ' 1' ' 32' ' ' THR . 5.7 tp -144.25 134.55 24.41 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 113.018 -1.901 . . . . 0.0 107.244 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 87' ' ' ASP . . . . . . . . . . . . . 9.1 t70 52.0 37.04 20.15 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.645 1.212 . . . . 0.0 111.558 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 88' ' ' SER . . . . . . . . . . . . . 58.2 m 68.58 11.27 8.29 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 112.805 -1.998 . . . . 0.0 112.037 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -126.58 152.13 47.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.899 0.857 . . . . 0.0 110.573 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 90' ' ' THR . . . . . . . . . . . . . 2.6 m -80.35 126.41 31.13 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.515 -1.675 . . . . 0.0 111.704 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 91' ' ' ILE . . . . . 0.748 ' HB ' ' O ' ' 1' ' 26' ' ' GLY . 43.2 pt -111.02 173.49 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.762 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -115.44 82.85 10.06 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -176.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.77 123.72 3.32 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.208 1.939 . . . . 0.0 111.443 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.95 148.54 28.53 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -80.73 141.62 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.867 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.29 159.01 31.99 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.944 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 97' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -108.39 126.48 29.51 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 122.943 0.497 . . . . 0.0 111.409 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 98' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -79.28 160.38 26.15 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.802 2.335 . . . . 0.0 113.28 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 99' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -103.38 136.97 42.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.94 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 100' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -103.21 169.17 8.71 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 123.38 0.425 . . . . 0.0 111.411 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.01 176.34 9.62 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 102' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 64.49 133.43 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 124.36 1.064 . . . . 0.0 112.76 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 103' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.8 -174.61 2.23 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.775 2.317 . . . . 0.0 113.255 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 104' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -80.45 143.62 33.25 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.717 0.407 . . . . 0.0 111.854 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 105' ' ' MET . . . . . . . . . . . . . 23.1 mmt -94.46 158.37 15.58 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.572 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 106' ' ' VAL . . . . . . . . . . . . . 34.9 t -106.83 -57.0 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 107' ' ' THR . . . . . . . . . . . . . 2.6 m -99.23 94.07 6.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.862 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 108' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -92.08 145.18 24.73 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.732 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 109' ' ' THR . . . . . . . . . . . . . 18.5 p -95.43 143.32 26.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.318 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 110' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -140.23 -45.46 0.42 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.186 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 111' ' ' LYS . . . . . . . . . . . . . 88.8 mttt . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.476 179.951 . . . . . . . . 0 0 . 1 stop_ save_